Endogenous Retroviruses and the Immune System by Young, GR
Endogenous Retroviruses
and the Immune System
George Robert Young
Submitted to University College London in part fulfilment
of the requirements for the degree of Doctor of Philosophy
2012
Division of Infection and Immunity
University College London
Gower Street
London
WC1E 6BT
Division of Immunoregulation
National Institute for Medical Research
The Ridgeway
London
NW7 1AA
2I, George Robert Young, confirm that the work presented in this thesis is my own.
Where information has been derived from other sources, I confirm that this has been
indicated in the thesis.
3Abstract
ABSTRACT 4
Initial sequencing of the human and mouse genomes revealed that substantial fractions
were composed of retroelements (REs) and endogenous retroviruses (ERVs), the latter
being relics of ancestral retroviral infection. Further study revealed ERVs constitute
up to 10% of many mammalian genomes. Despite this abundance, comparatively little
is known about their interactions, beneficial or detrimental, with the host.
This thesis details two distinct sets of interactions with the immune system. Firstly,
the presentation of ERV-derived peptides to developing lymphocytes was shown to
exert a control on the immune response to infection with Friend Virus (FV). A self
peptide encoded by an ERV negatively selected a significant fraction of polyclonal FV-
specific CD4+ T cells and resulted in an impaired immune response. However, CD4+
T cell-mediated antiviral activity was fully preserved and repertoire analysis revealed
a deletional bias according to peptide affinity, resulting in an effective enrichment of
high-affinity CD4+ T cells. Thus, ERVs exerted a significant influence on the immune
response, a mechanism that may partially contribute to the heterogeneity seen in human
immune responses to retroviral infections.
Secondly, a requirement for specific antibodies was shown in the control of ERVs. In a
range of mice displaying distinct deficiencies in antibody production, products from the
intestinal microbiota potentially induce ERV expression. Subsequent recombinational
correction of a defective murine leukaemia virus (MLV) results in the emergence of
infectious virus. In the long term, this leads to retrovirus-induced lymphomas and
morbidity. ERVs, therefore, provide a potential link between the intestinal microbiota
and a range of pathologies, including cancer.
Finally, a new computational tool, REquest, was developed for use in the above studies.
REquest allows the mining of retroelement (RE) and ERV expression data from the
majority of commercially available human and murine microarray platforms and allows
rapid hypothesis testing with publicly available data.
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1. INTRODUCTION 22
1.1 Retroviruses and retroelements
1.1.1 A brief history of retrovirology
Although unappreciated at the time, retroviruses as the causative agents of disease
have been studied since the late 1800s, with equine infectious anaemia (EIA) being the
first example (Valle´e & Carre´, 1904). Early work in domestic fowl similarly identified
diseases experimentally transmissible through cell-free filtrates (Ellermann & Bang,
1908; Rous, 1910, 1911), and avian leukosis virus (ALV) and the closely-related Rous-
sarcoma virus (RSV) were rapidly identified as the aetiologic agents. Somewhat later,
cell-free extracts were also shown to cause leukaemias in mice (L. Gross, 1951, 1957;
Friend, 1957; Rauscher, 1962).
RSV virions were shown to contain RNA rather than DNA (L. V. Crawford & E. M.
Crawford, 1961; Temin, 1963), so called ‘RNA tumour viruses’, but cell transformation
could also be shown to be stable through mitosis – a property not previously associated
with RNA viruses. To explain this discrepancy, Howard Temin proposed the ‘provirus’
hypothesis, where a DNA copy of the viral genome is produced that can integrate into
the host chromosomes (Temin, 1964). Whilst a logical explanation of the observations,
the hypothesis conflicted with a central tenet of molecular biology at the time – that
DNA could be transcribed to RNA, but not vice versa – and hence received little im-
mediate attention. This concept only gained acceptance through the independent and
parallel discovery of reverse transcriptase, the missing RNA-directed DNA-polymerase,
by Temin and Baltimore (Temin & Mizutani, 1970; Baltimore, 1970).
The requirement for stable chromosomal integration of proviruses raised the possibility
of their vertical inheritance through germ-line infection. Support for this principle came
through spontaneous oncogenesis in uninfected animals (Mu¨hlbock, 1955) and the po-
tential for radiological and chemical induction of infectious virions from untransformed
cells (Lieberman & H. S. Kaplan, 1959; W. P. Rowe, Hartley, Lander, Pugh & Teich,
1971; Weiss, Friis, Katz & Vogt, 1971). Inherited in a dominant Mendelian manner,
‘endogenous retroviruses’ (ERVs) have since been recognised as essentially universal
genomic features and have been found in virtually all well-studied eukaryotic genomes,
including that of humans (M. A. Martin, Bryan, Rasheedt & Khan, 1981; Repaske,
Steele, O’Neill, Rabson & Martin, 1985).
1.1.2 The Retroviridae
Whilst there is increasing evidence that a variety of viruses have the potential for
stable chromosomal integration (Horie, Honda et al., 2010; Horie & Tomonaga, 2011;
Tanaka-Taya et al., 2004; Belyi, Levine & Skalka, 2010), the requirement for a proviral
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stage remains the defining feature of retroviral replication (Fig. 1.1a). In this way,
retroviruses rely entirely on the transcriptional machinery of the host cell.
Figure 1.1: Retroviral replication and structure
(a)
(b)
(a) A simplified retroviral ‘life cycle’ showing receptor binding and entry, reverse
transcription and integration, translation of viral mRNA, protein product forma-
tion and assembly at the cell membrane. RNA species are shown in blue, DNA
species are shown in red. Virions bud from the cell and proteolytic cleavage of
proteins leads to condensation of the viral core to the ‘mature’, electron-dense
state. (b) The genome structure of a murine leukaemia virus. Shown are the
four coding genes along with the splice donator (SD) and acceptor (SA) for the
env mRNA product. Corresponding protein products are shown – matrix (MA),
p12, capsid (CA), nucleocapsid (NC), protease (PR), reverse transcriptase (RT),
integrase (IN), surface (SU), and transmembrane (TM).
Production of proviruses requires the presence of both a viral reverse transcriptase and
an integrase, and has a major bearing on the genome structure. Retroviral particles
contain dimers of the single-stranded positive-sense linear RNA genome, which is typ-
ically 7–11 kb in size. All retroviral genomes contain four main coding sequences (gag,
pro, pol and env), the order of which is vital to the correct level of gene expression, sub-
sequent cleavage and product formation, and is hence completely conserved amongst
known retroviruses (Jern & Coffin, 2008) (Fig. 1.1b).
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‘Simple’ retroviruses, such as murine leukaemia viruses (MLVs) (Fig. 1.1b), first se-
quenced completely in 1981 (Shinnick, Lerner & Sutcliffe, 1981), code only these four
genes, wherease ‘complex’ retroviruses encode for one or more additional accessory
genes. These are generally inserted before or after env and may translate into tran-
scriptional regulators (e.g. tax in HTLV-1), infectivity modulators (e.g. vif in HIV-1),
or superantigens (e.g. sag in MMTV), to name but a few functions. Whilst there is some
evidence of alternate splicing in simple retroviruses (De´jardin et al., 2000; Rasmussen
et al., 2010), translation of complex retroviral genomes necessitates multiple splicing
events and can initiate from transcription start sites giving both positive- and negative-
sense mRNA products.
Traditional classification of retroviral particles relied on the study of morphology in
negatively-stained electron micrographs (Bernhard, 1958). Virions were classified into
four groups: A-type (non-enveloped intracellular particles with an uncondensed, ‘imma-
ture’, electron-lucent core), B-type (extracellular, enveloped particles with condensed,
electron-dense acentric cores and prominent envelope spikes), C-type (extracellular,
enveloped particles with condensed, electron-dense central cores and unclear envel-
ope spikes (Fig. 1.1a)) and D-type (slightly larger extracellular particles with con-
densed, electron-dense, bar-shaped cores and unclear envelope spikes). This system
has, however, largely been replaced with placement according to phylogenetic relation-
ships (Fig. 1.2).
Figure 1.2: Retroviral phylogenetic tree
Phylogenetic tree of exogenous retroviruses, with colouring denoting simple (red)
or complex (blue) genomes. Modified from Weiss, 2006.
Retroviral infection and hence host tropism relies on the specific recognition of cell
surface receptors, and much work has identified the varying genes involved in viral
entry in many species. Viral evolution and host escape through receptor modification
are active areas of research (Soll, Neil & Bieniasz, 2010; Ribet et al., 2008; Tipper,
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Bencsics & Coffin, 2005) and the varying tropisms of MLVs, dictated by the env gene
sequence, have been particularly well studied (Stoye & Coffin, 1987) (Table 1.1).
Table 1.1: MLV cell-surface receptors
Tropism Receptor Infectivity
Ecotropic
mCAT-1
(Slc7a1 )
Certain species of Murinae, including
mouse and rat cells (Wang et al.,
1991; Albritton et al., 1989; Oie
et al., 1978).
Xenotropic Xpr1
Wide host range, lacking infectivity
in common strains of laboratory mice
(Tailor et al., 1999; Yang et al.,
1999).
Polytropic Xpr1
Wide host range, including infectivity
in mice (Tailor et al., 1999; Yang
et al., 1999).
Modified
polytropic
Xpr1
Wide host range, including infectivity
in mice (Tailor et al., 1999; Yang
et al., 1999).
Amphotropic
Pit2
(Slc20a2 )
Wide host range, including infectivity
in mice (Miller et al., 1994; van Zeijl
et al., 1994).
On successful binding of a receptor and entry of the cell, the viral genome is reverse
transcribed and, for the majority of retroviruses, enters the nucleus upon initiation of
mitosis (Roe, Reynolds, Yu & Brown, 1993) (Fig. 1.1a). Insertion site preferences are
determined by differences within the integrase (Harper, Sudol & Katzman, 2003; Zhu,
Dai, Fuerst & Voytas, 2003), but are also likely influenced by complex networks of
interactions with other retroviral and cellular proteins (Schaller et al., 2011), as well
as by secondary structures of target DNA (Sna´sˇel, Rosenberg, Pacˇes & Pichova´, 2009).
Accordingly, integration sites have been shown to vary considerably between retrovir-
uses (De Palma et al., 2005), and highly preferred target sites have been suggested in a
variety of systems (Shih, Stoye & Coffin, 1988). MLVs, for example, have been shown
to preferentially integrate in promoter-proximal regions and CpG islands (Lewinski et
al., 2006; Ambrosi, Cattoglio & Di Serio, 2008).
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1.1.3 Retroelements and endogenous retroviruses
The C-value paradox describes the discrepancy between genome size and apparent or-
ganismal complexity for a wide array of eukaryotes. Whilst ploidy has a major bearing
on genome size, much of remaining variability can be assigned to the relative pro-
portions of repetitive genetic elements. One of the most surprising results from the
sequencing of the human genome (Dunham, Shimizu, Roe & Chissoe, 1999; Interna-
tional Human Genome Sequencing Consortium, 2001) was the overall proportion of
transposable elements – ∼45% of the genome sequence, or ∼3x106 elements in total
(International Human Genome Sequencing Consortium, 2001). The later release of the
mouse genome (Mouse Genome Sequencing Consortium, 2002), as well as assemblies
for increasing numbers of other species, has revealed largely comparable figures, with
∼38% of the mouse genome corresponding to transposable elements (Mouse Genome
Sequencing Consortium, 2002).
Around 97% of transposable elements in the mouse genome are retroelements (REs)
(Mouse Genome Sequencing Consortium, 2002), utilising an RNA intermediate that is
reverse transcribed prior to re-insertion. The remaining fraction is composed of DNA
transposons, first identified by Barbara McClintock in the 1940s (McClintock, 1950).
REs can be broadly divided into two groups according to the presence or absence of
long terminal repeats (LTRs) (Fig. 1.3a). RE composition varies between species, with
humans having a lower fraction of LTR-bounded elements than mice and a substantially
different composition within this category (Mouse Genome Sequencing Consortium,
2002).
Non-LTR REs comprise long and short interspersed nuclear elements (LINEs and
SINEs) (Fig. 1.3a). LINEs are the most abundant REs within both the human and
mouse genomes (Mouse Genome Sequencing Consortium, 2002). Full-length LINE ele-
ments are autonomous, although the reverse transcriptase encoded frequently fails to
successfully transcribe the full length of the element, resulting in the majority of inser-
tions being 5’-truncated. Hence, although full length elements are 6–8 kb, the median
length of insertions is only around 1 kb (International Human Genome Sequencing
Consortium, 2001). SINEs (Fig. 1.3a) are non-autonomous elements, encoding no pro-
teins and relying on LINE-encoded proteins for their replication. These elements are
thought to be derived from small cellular tRNAs or the 7SL signal recognition particle
component (Kramerov & Vassetzky, 2011).
LTR-bounded elements, including ERVs, comprise nearly 8 and 10% of the human and
mouse genomes, respectively (International Human Genome Sequencing Consortium,
2001; Mouse Genome Sequencing Consortium, 2002). The flanking LTRs contain pro-
moters and regulatory regions necessary for transcription of the coding regions gag and
pol. Exogenous retroviruses are thought likely to have arisen through the addition of
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Figure 1.3: Retroelements and endogenous retroviruses
(a)
(b)
(a) Structure of the three main families of retroelements. Shown are promoter
regions (black), LTRs (blue), coding regions and polyadenylation (p(A)). Env,
required only for exogenous virion production, is present only in some cases and
is hence included in parentheses. (b) Phylogenetic tree of murine ERV reverse
transcriptase domains. Modified from McCarthy and McDonald, 2004; Stocking
and Kozak, 2008.
an env gene (Temin, 1980; Xiong & Eickbush, 1990) to this backbone, an event that
appears to have occurred independently several times to create separate viral lineages
(Malik, Henikoff & Eickbush, 2000). As with non-LTR elements, the majority of LTR-
bounded elements are not full length sequences, most being truncated to a solo-LTR
through homologous recombination (International Human Genome Sequencing Consor-
tium, 2001).
Murine ERVs can be classified phylogenetically into three distinct classes (Fig. 1.3b).
Endogenous MLVs, falling into Class I, constitute relatively small fractions of mouse
genomes and have been extensively characterised. Endogenous ecotropic MLVs (eM-
LVs) are generally present in single copies in strains with low incidence of leukaemia,
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with Emv1, Emv2, and Emv3 being present in the most commonly-used inbred strains
(Jenkins, Copeland, Taylor & Lee, 1982) (Table 1.2). Endogenous xenotropic, poly-
tropic and modified polytropic MLVs (xMLVs, pMLVs and mpMLVs) are present in a
further ∼50 copies, with considerable polymorphism between strains (Stoye & Coffin,
1988; Frankel, Stoye, Taylor & Coffin, 1990).
Table 1.2: Commonly-used inbred mouse lines possessing single
endogenous eMLVs
Emv1 Emv2 Emv3 Emv4 Emv5
A 3
BALB/c 3
CBA 3
C3H 3
SM 3
C57BL/6 3
C57BL/10 3
C57BR 3
DBA 3
LG 3
LP 3
Compiled from Jenkins et al., 1982.
Analysis of wild mouse species and outbred strains has suggested that endogenous
MLVs entered the mouse germline comparatively recently (Kozak & O’Neill, 1987). As
such, both endogenous eMLV and xMLV classes contain infectious members. There is
evidence across multiple species of continued acquisition of germ-line proviral insertions
(Tarlinton, Meers & Young, 2006; Elleder et al., 2012) and evidence from humans
suggests re-infection is a prominent factor in ERV accumulation (Belshaw, Pereira et al.,
2004), although loss of env and subsequent intracellular replication has equally resulted
in massive expansion within certain lineages (Magiorkinis, Gifford, Katzourakis, De
Ranter & Belshaw, 2012).
1.1.4 Retroelements in the genome – mutagenesis and disease
Although most REs are inactivated relics that have become fixed within a species,
often pre-dating a speciation event (Goodchild, Wilkinson & Mager, 1993; Tristem,
2000), there is unappreciated polymorphism for younger elements within many species.
Studies of the human genome have suggested that retrotransposition plays a significant
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role in individual genomic structural variation (Konkel, Wang, Liang & Batzer, 2007;
Kidd, Cooper et al., 2008; Bennett et al., 2008; Kidd, Graves et al., 2010; C. R. L.
Huang et al., 2010; Beck et al., 2010; Karimi et al., 2011; Reichmann et al., 2012) and
can result in somatic mosaicism (Baillie et al., 2011). Whilst the majority of these
variations are amongst SINEs and LINEs, there is also some polymorphism for ERVs
(Kidd, Graves et al., 2010; Belshaw, Dawson et al., 2005).
Given the mutagenic potential of transposition, there are significant epigenetic and
transcriptional controls on REs (Bourc’his & Bestor, 2004; Lavie, Kitova, Maldener,
Meese & Mayer, 2005; Changolkar, Singh & Pehrson, 2008). Analysis of the human
and mouse transcriptomes has revealed around 10 times the number of transcripts than
recognised genes (Cheng et al., 2005; The FANTOM Consortium & RIKEN Genome
Exploration Research Group and Genome Science Group, 2005), however, and a further
analysis of 1% of the human genome suggested around 80% of bases were transcribed
(The ENCODE Project Consortium, 2007). Thus, these control mechanisms are un-
likely to be absolute even after embryogenesis, where necessary epigenetic modifications
are suggested to allow a transient period of activity (Kano et al., 2009; H. M. Rowe
et al., 2010; Matsui et al., 2010; Macfarlan, Gifford, Agarwal et al., 2011; Macfarlan,
Gifford, Driscoll et al., 2012; Guallar et al., 2012). Some control may also be imposed
post-transcriptionally, therefore, and a suite of cellular factors are suggested to have
roles in the control of REs (Thomas & Schneider, 2011; Arjan-Odedra, Swanson, Sherer,
Wolinsky & Malim, 2012), including ABOBEC family members (MacDuff, Demorest
& Harris, 2009; Wissing, Montano, Garcia-Perez, Moran & Greene, 2011) and TREX1
(Crow et al., 2006; Stetson, Ko, Heidmann & Medzhitov, 2008).
Where these mechanisms are evaded and novel integrations are seen, long-term evolu-
tionary pressure can act as a further protection mechanism by conferring an advantage
on their subsequent mutation or deletion. ERV and LINE insertions both within and
in the vicinity of genes are comparatively under-represented, a phenomenon increas-
ingly apparent with increasing age of the insertion (Medstrand, van de Lagemaat &
Mager, 2002; Nell˚aker, Keane et al., 2012). Probability of permanent integration is also
associated with neighbouring gene function, with highly-conserved housekeeping genes
having few proximate insertions (van de Lagemaat, Landry, Mager & Medstrand, 2003;
Nell˚aker, Keane et al., 2012).
The potential for novel integrations to cause disease or obvious phenotypic change has
long been studied. In mice alone, three separate integrations of REs are known to
alter fur characteristics. Integration of an intra-cisternal A particle (IAP) has been
seen to cause the agouti phenotype (also causing susceptibility to obesity, diabetes
and tumourigenesis (Duhl, Vrieling, Miller, Wolff & Barsh, 1994)) and separate MLV
integrations to cause the hairless (Stoye, Fenner, Greenoak, Moran & Coffin, 1988)
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and dilute phenotypes (Jenkins, Copeland, Taylor & Lee, 1981; Hutchison, Copeland
& Jenkins, 1984). Interestingly, proviral insertions have also recently been seen to
cause the hooded and Irish hooded coat phenotypes in rats (Kuramoto et al., 2012).
Further work in mice has also associated REs with cleft-palate (Juriloff et al., 2005)
disorders and lupus-nephritis (Yoshiki, Mellors, Strand & August, 1974), amongst other
conditions.
The involvement of REs in human disease is far more controversial; although novel
integrations can be seen in certain cases (Iskow et al., 2010; E. Lee et al., 2012),
varied expression in others (Herbst, Sauter & Mueller-Lantzsch, 1996; Wentzensen
et al., 2007; Frank et al., 2008; R. Contreras-Galindo, M. H. Kaplan, Leissner et al.,
2008; Lamprecht et al., 2010), and the establishment of immune responses against their
products (Sauter et al., 1996; Wang-Johanning et al., 2008), determining causal links is
fraught with difficulty. In many cases, expression of REs may simply result from global
transcriptional changes resulting from cellular transformation, with immune responses
to RE-derived proteins merely representing their status as novel immune targets.
1.1.5 Retroelements in the genome – co-option and function
Whilst housekeeping genes may be relatively protected from nearby insertion of REs,
‘rapidly evolving’ genes, such as those involved in stress response and defence, have
an increased likelihood of proximate insertion events (van de Lagemaat et al., 2003;
Nell˚aker, Keane et al., 2012). The occasional presence of REs within exonic regions
further suggests a potential role for transposable element integration in gene evolution
and diversification (Nekrutenko & W.-H. Li, 2001). Indeed, given the density of repetit-
ive elements within mammalian genomes and the potential variability in the impacts of
their integration, it is perhaps unsurprising that many integrations might have positive
impacts for the host.
Bioinformatic screens of human gene promoter regions suggest that ∼25% contain se-
quences derived from transposable elements (Jordan, Rogozin, Glazko & Koonin, 2003;
van de Lagemaat et al., 2003; Conley, Piriyapongsa & Jordan, 2008), including ERVs
(Buzdin, Kovalskaya-Alexandrova, Gogvadze & Sverdlov, 2006). In certain cases, in-
sertions have obvious and definable impacts. In the human genome, for example, the
integration of an ERV upstream of a pancreatic amylase allows its expression and release
into saliva (Samuelson, Phillips & Swanberg, 1996), whilst another likely contributes
the NF-κB-responsive expression of interferon (IFN)λ1 (Thomson et al., 2009).
Through co-option by the host, REs can have an even more direct impact. An abund-
ance of retroviral envelope protein expression in the human placenta suggested a po-
tential functional role (Venables, Brookes, Griffiths, Weiss & Boyd, 1995), a hypothesis
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later borne-out in the discovery of syncytins (Mi et al., 2000; Blaise, de Parseval, Be´nit
& Heidmann, 2003). Interestingly, the fusogenic and immunomodulatory role of syncyt-
ins in placentation has been independently replicated in rodents (Dupressoir, Marceau
et al., 2005), lagomorphs (Heidmann, Vernochet, Dupressoir & Heidmann, 2009), car-
nivores (Cornelis et al., 2012), and bovids (Dunlap et al., 2006; Baba et al., 2011), and
knock-out and knock-down studies have shown their crucial significance (Dunlap et al.,
2006; Dupressoir, Vernochet et al., 2009).
ERV-derived proteins can also be used by the host in the prevention of retroviral in-
fection through mechanisms such as receptor blockade, with the mouse Fv4 gene, a
co-opted retroviral envelope (Ikeda, Laigret, Martin & Repaske, 1985; Ikeda & Sug-
imura, 1989; Limjoco, Dickie, Ikeda & Silver, 1993), and endogenous Jaagsiekte sheep
retroviruses (JSRVs) (Spencer, Mura, Gray, Griebel & Palmarini, 2003) both func-
tioning in this manner. Similarly, Fv1, operating after viral entry but before proviral
integration, is derived from a retroviral gag sequence (Best, Le Tissier, Towers & Stoye,
1996) and shows evidence of strong positive selection through mouse evolution (Yan,
Buckler-White, Wollenberg & Kozak, 2009).
Larger structural changes, such as genomic translocations, inversions, duplications, or
deletions, can also be mediated by REs. An analysis of 35 human ERVs, for example,
suggested that 6 of those studied had undergone inter-element recombination (Hughes
& Coffin, 2001). Events such as these can impact surrounding genomic areas and have
allowed the recent expansion of the glycophorin gene family during primate evolution
(Rearden, Magnet, Kudo & Fukuda, 1993). Where elements occur in unusually high
density, for example LINE elements in both the human and mouse allosomes (Inter-
national Human Genome Sequencing Consortium, 2001; Mouse Genome Sequencing
Consortium, 2002) (reaching densities of 89% of a 0.5 Mb region of human chromo-
some X (International Human Genome Sequencing Consortium, 2001)), these events
can be far larger. Analysis of the human allosomes suggests a LINE-mediated ∼4 Mb
translocation from the X to the Y chromosome, followed by its subsequent inversion,
again mediated by LINE-LINE recombination (Schwartz et al., 1998).
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1.2 The immune system
1.2.1 A high-level perspective
After the physical and chemical barriers to infection provided by environmental sur-
faces, an immune system constitutes the principal means of pathogen control, providing
discrimination between ‘self’ and ‘non-self’. Pathogens vary greatly, not only in their
modes of pathogenesis, but also in structure, size, and complexity, meaning a dynamic
and coordinated system is required for their control. Ultimately, a successful immune
response will result in the control or clearance of a pathogen, whilst limiting off-target
impacts and damage to the host.
Immune systems differ considerably between organisms and whilst some elements are
shared, differing systems of varying natures and complexities have evolved in response
to the ubiquitous presence of pathogens. Antimicrobial peptides, such as defensins,
represent the oldest shared system of pathogen control and comparisons of genome
sequences from plants and humans shows their conservation throughout evolutionary
history (Ganz, 2003). Innate pathogen-associated molecular pattern (PAMP) sensors
that control the expression of these molecules are intrinsically linked to this history,
and receptors such as Toll, in Drosophila melanogaster, are again highly conserved
(as Toll-like receptors – TLRs – in other organisms) (Hoffmann, Kafatos, Janeway &
Ezekowitz, 1999; Barreiro et al., 2009). Some lineages have diversified these receptors
to provide highly specific innate immune responses, and 222 TLR genes are seen in
Strongylocentrotus purpuratus (the purple sea urchin) (Rast, Smith, Loza-Coll, Hibino
& Litman, 2006) in comparison to only 10 in humans. The mammalian adaptive im-
mune system is thought to descend from the acquisition of enzymes to allow controlled
somatic recombination (Agrawal, Eastman & Schatz, 1998), first seen in cartilagin-
ous fish, which allowed the virtually instantaneous ability to produce variable antigen
receptors (see Section 1.2.2).
Broadly, the mammalian immune system can be divided into the innate (non-specific)
and adaptive (pathogen-specific) responses, each comprising both cellular and humoral
components. Innate immune components are for the most part constitutively present
and hence provide an immediate and maximal response to infection. In contrast, the
adaptive immune system requires time to develop an effective response, but is pathogen-
specific and includes facility for immunological memory, allowing a more rapid response
in the case of re-infection.
All immune cells ultimately derive from a pluripotent haematopoietic stem cell popula-
tion in the bone marrow. This gives rise to both the common myeloid progenitor (CMP
– for innate immune cells) and the common lymphoid progenitor (CLP – for adaptive
immune cells). The CLP in turn gives rise to both B and T lymphocytes, although T
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cell progenitors migrate to the thymus for their continued development into either the
αβ and γδ T cell lineages.
1.2.2 Variable antigen receptors – form and function
Effective functioning of the adaptive immune response relies on the ability of responding
cells to target a highly diverse array of antigens with a high level of specificity. Whilst
some pathogens may have single immunodominant antigen epitopes, against which the
majority of either a T or B cell response is directed, others will present many targets
simultaneously (Doolan et al., 2003). To further complicate the requirements, the
selection pressures imposed by an immune response can provoke a pathogen to vary its
antigen repertoire. This may be through methods such as escape mutation, but complex
pathogens may also invoke expression changes and cyclic or phased use of redundant
proteins. Where a particular pathogen is endemic to an area, this variability can occur
both at the individual and population level (A. Jalloh, van Thien et al., 2006; A. Jalloh,
M. Jalloh & Matsuoka, 2009).
Both T and B cells possess variable antigen receptors – T cell and B cell receptors
(TCRs and BCRs, Fig. 1.4), respectively – produced through a complex system of
somatic gene re-arrangement first realised for the BCR (Hozumi & Tonegawa, 1976;
Weigert, Gatmaitan, Loh, Schilling & Hood, 1978).
Figure 1.4: The T and B cell receptors
(a) (b)
(a) Stylised structure of IgG. Colouring shows heavy (H – red and green) and light
(L – orange and blue) chains and constant (C) and variable (V) regions are marked.
The light chain, CH1 and VH comprise the Fab region and the CH2 and CH3
regions comprise the Fc region. (b) Stylised structure of the TCR. Colouring shows
the α (green) and β (red) chains, with the variable (V) and constant (C) regions
marked. Transmembrane region and cytoplasmic tail are shown underneath.
The BCR (Fig. 1.4a), or immunoglobulins (Ig), can either be cell-associated or secreted
as antibodies. Immunoglobulins are constructed in a uniform manner from heavy and
light chains to form a variable region, involved in antigen binding, and a constant
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region, which distinguishes the five classes of immunoglobulin (IgM, IgD, IgG, IgA,
and IgE). The two ‘arms’ of the immunoglobulin molecule are termed Fab (fragment
antigen binding) and the ‘stem’ as Fc (fragment crystallisable).
The light chain variable region is formed through the recombination of two gene regions
(V – variable, and J – joining), whereas the variable region of the heavy chain is formed
from three (V, D – diversity, and J). The potential diversity created by this system
comes from the number of genes within each region (∼70 V and ∼10 J genes for the light
chain, and ∼40 V, ∼25 D, ∼5 J genes for the heavy chain within the human genome)
and the potential for random selection within this pool, but also from variability in the
recombination process causing small nucleotide insertions or deletions.
The αβTCR (Fig. 1.4b), analagous to the Fab region of the BCR, is comprised of two
chains, each possessing a constant and variable region. Similarly again, the variable
region of the TCR α locus consists of a V and J region, whereas the β locus also
contains a D gene region. Gene diversity is larger for the TCR loci, however, with ∼70
V and ∼60 J genes for the α chain and ∼50 V, 2 D and ∼15 J genes for the β chain.
The system of somatic recombination used to generate these receptors provides a far
larger potential receptor pool than the total number of circulating T or B cells. The
estimated size of the TCR repertoire in mice, for example, is around 1013 (Nikolich-
Zugich, Slifka & Messaoudi, 2004) and whilst many re-arrangements may result in non-
functional TCRs, this figure remains far larger than the total number of circulating T
cells (1–2 x 108 in an adult mouse). Even amongst genetically identical mouse lines,
therefore, this sampling effect means that between two individuals, only around 20%
of TCRs are shared (Bousso et al., 1998; Maryanski et al., 2001).
1.2.3 The T cell
T lymphocyte development in the thymus results in the formation of two lineages,
divided according to the structure of their TCR – αβ and γδ. The former further
differentiate into two groups categorised according to their co-receptor expression –
CD4+ (‘helper’) and CD8+ (‘cytotoxic’) T cells. On activation, CD4+ T cells are
primarily immunomodulatory, whereas CD8+ T cells are involved in the direct killing
of infected cells.
T cell activation depends on two complementary signalling routes through an interac-
tion with an antigen presenting cell (APC). Peptides are presented in complex with
major histocompatibility complex (MHC) molecules and are bound by a TCR, along
with the appropriate CD4 or CD8 co-receptor (Fig. 1.5). Secondly, a positive signal
must come through the binding of the T cell CD28 receptor to the co-stimulatory mo-
lecules CD80 or CD86 on the surface of the APC. Further interactions, such as between
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CD40 and CD40L, or CTLA-4 and CD80 and CD86, may either contribute to or inhibit
activation.
Figure 1.5: Antigen presentation to T cells
(a) (b)
The interactions of (a) MHC class II with the TCR and co-receptor of CD4+ T
cells and (b) MHC class I with the TCR and co-receptor of CD8+ T cells. The
peptide bound between the TCR (green) and either MHC molecule (blue) is shown
in black. CD4 and CD8 co-receptors are shown in red.
When a strong positive interaction occurs, the binding T cell is caused to clonally divide
to give large numbers of cells with identical specificities. This allows the enrichment
of pathogen-specific T cells within the circulating population and efficient control of
the infection. The specific path of differentiation taken by a T cell depends on the
cytokine milieu present at the point of its activation, however, and determines its cy-
tokine production and cellular interactions (J. Kim, Woods, Becker-Dunn & Bottomly,
1985; Mosmann, Cherwinski, Bond, Giedlin & Coffman, 1986; Cherwinski, Schumacher,
Brown & Mosmann, 1987; Amsen et al., 2004) (Fig. 1.6).
CD4+ T cells activated in the presence of interleukin (IL)-12 differentiate into Th1
cells, producing IL-2 and IFNγ. Conversely, activation in the context of IL-4 causes
differentiation into Th2 cells, producing IL-4, IL-5, and IL-13 (Fig. 1.6). Although some
plasticity remains, either route of polarisation, and subsequent cytokine production,
inhibits the differentiation of cells into the opposing subset (Fernandez-Botran, Sanders,
Mosmann & Vitetta, 1988). Further CD4+ T cell subsets have since been identified,
each defined by the cytokines required for polarisation, cell-surface protein expression,
and cytokine production and function.
CD8+ T cells prompt the apoptosis of infected cells through the targeted release of
vesicles containing perforin and granzymes. Perforin polymerises to create cylindrical
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Figure 1.6: CD4+ T cell subsets
Necessary polarising factors (left) and the effector profile (right) of the commonly
recognised CD4+ T cell subsets.
transmembrane pores in the target cell that allow the influx of water and salts. Gran-
zyme proteases are also suggested to enter target cells through these pores, activating a
cascade that results in the initiation of programmed cell death and cleavage of cellular
DNA. Whilst cytotoxic killing is primarily achieved by CD8+ T cells, there is also some
evidence of CD4+ T cells having direct antiviral effects. MHC class II-restricted killing
was first seen in vitro (Jacobson et al., 1984; Lukacher, Morrison, Braciale, Malissen &
Braciale, 1985), but has subsequently also been noted ex vivo (Appay et al., 2002) and
in vivo (Jellison, Kim & Welsh, 2005).
A successful immune response to an infection results in the clearance of the pathogen
and hence clearance of the epitopes against which T cell responses were mounted. At
this point, the majority of cells are induced to apoptose through ‘neglect’, but a small
fraction remain as memory cells. These remain for long periods and provide the basis
for immunological memory, rapidly dividing to give a population of effector cells on
re-infection.
1.2.4 The B cell
Where T cells act by recognising peptide epitopes with membrane-bound receptors,
B cells act by secreting their BCR to circulate in the blood and lymph. Antibodies,
and humoral immunity, work in a variety of ways to clear pathogens and circulating
products or toxins through engagement of the innate immune system.
The majority of B cell activation occurs through interaction with CD4+ T cells. Na¨ıve
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B cells express both IgM and IgD, and cell-surface immunoglobulins can bind and inter-
nalise antigens for processing and presentation on MHC class II molecules. This process
acts as a first positive signal to the cell, but full activation requires a further stimulus
delivered through CD40 when a CD4+ T cell binds the presented peptide-MHC com-
plex. The interaction of CD40 with CD40L, as well as the binding of cytokines, such
as IL-4 from Th2 cells, promotes the proliferation of the B cell and affinity maturation.
Affinity maturation describes the incremental gains in antibody specificity brought
about by multiple rounds of somatic hypermutation (targeted point mutation of the
immunoglobulin V regions) and cell division. Upon each round, cells with increased af-
finity for antigen are selected, whilst mutations resulting in detrimental changes to the
BCR cause cell death and, subsequently, phagocytosis of the cell. Signalling through
CD40 also induces class switch recombination, where the previously re-arranged V re-
gion is paired with a different C region to give different classes of immunoglobulin.
Similarly to T cell differentiation, the specific nature of the recombination largely de-
pends on the local cytokine milieu. In the mouse, IL-4 (from Th2 cells) primarily
induces switching to IgG1 and IgE, for example, whereas IFNγ (from Th1 cells) pro-
motes recombination to IgG2a and IgG3.
Activated B cells differentiate from their na¨ıve state into plasmablasts, beginning to
secrete antibodies, but continue to divide until forming terminally differentiated plasma
cells. Alternatively, cells will progress to a memory phenotype to contribute to immun-
ological memory functions. Plasma cells are highly specialised to secrete antibodies of a
designated class, each of which contribute to humoral immunity in a different manner.
Humoral immunity can be broadly divided into three functions: neutralisation, op-
sonisation, and complement activation. Neutralisation of pathogens or their products
involves their binding by antibodies to block their access to targeted cellular receptors
and is primarily through IgG and IgA antibodies. Neutralised pathogens are sub-
sequently phagocytosed and degraded. In a similar manner, opsonisation involves the
coating of a pathogen such that it can be recognised by innate immune cells for pha-
gocytosis. This is predominantly through the action of IgG1 antibodies. Antibody
coating with either IgM or IgG3 in this manner can also recruit proteins of the innate
complement system to directly kill or promote the phagocytosis of bacteria.
The ultimate function of antibodies is, therefore, in mediating ingestion by phagocytic
cells, a process that relies on the invariant nature of the constant regions of the immun-
oglobulin heavy chain. The varying heavy chains present on class switched antibodies
are also selectively bound by membrane-bound Fc receptors to allow their specific
internalisation and transport across epithelial surfaces. This allows the secretion of
IgA across the gastro-intestinal epithelium, for example, an important primary defence
against infection by food and water-borne pathogens.
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1.2.5 Importance and immunodeficiency
Many immunodeficiencies have been characterised in humans and subsequently studied
in animal models. Deficiencies can be seen in both the innate and adaptive immune
systems and can have varying impacts according to the severity, number, and relative
redundancy of systems impacted. Highlighting the co-operative nature of the immune
response, many deficiencies have convergent effects and are characterised by similar
susceptibilities and diseases.
The earliest immunodeficiencies studied in humans related to antibody production,
with X-linked agammaglobulinemia (XLA) being the first described in 1952 (Bruton,
1952). This disease has subsequently been linked to the Btk tyrosine kinase, involved
in B cell development. Mutation of this protein largely arrests development of B cell
precursors, giving greatly reduced titres of all antibody classes. XLA patients (along
with those suffering similar deficiencies, such as chronic variable immunodeficiency –
CVID) are characterised by their poor defence against extracellular bacteria, including
staphylococci and streptococci, but can be treated effectively with regular antibody
infusions. Deficiencies in the complement system have analagous impacts, including
increased susceptibility to extracellular bacterial infections.
More severe immunodeficiencies generally result from defects involving T cell differenti-
ation, thus impacting both arms of the adaptive immune system through the inability to
produce T cell-dependent antibody responses. These conditions are grouped as severe
combined immunodeficiency (SCID) disorders and are most commonly linked to muta-
tions impacting cytokine signalling and to mutations in the enzymes required for the
somatic recombination of TCR and BCR genes. Both RAG1 and RAG2 proteins are
required for V(D)J recombination in developing lymphocytes, for example, and muta-
tions result in complete blocks in T and B cell development, or limited and abnormal
development of T cells alone, such as in Omenn syndrome. Similar defects can result
from mutations impacting thymic function, MHC function, and antigen presentation.
The negative effects of primary immunodeficiencies are generally seen by adulthood in
humans, but a range of secondary (acquired) conditions can develop throughout life.
One of the most striking examples of this is immunocompromisation through human
immunodeficiency virus (HIV) infection and subsequent development of acquired im-
mune deficiency syndrome (AIDS). Infection leads to the gradual decline in CD4+ T
cell numbers and their functional impairment, eventually resulting in inadequate im-
mune responses to opportunistic infections of ubiquitous pathogens. Ultimately, over
25% of AIDS-related deaths are due to opportunistic infections (Bonnet et al., 2005).
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1.3 Aims of this work
Whilst endogenous retroviruses and retroelements have long been studied by virologists,
comparatively little work has centred around their potential interactions with the im-
mune system. As such, these concepts represent under-studied and highly intriguing
areas of research.
The relevance of this area is only highlighted by issues surrounding the use of retroviral
vectors in human gene therapy (Donahue et al., 1992; Purcell et al., 1996; Howe et al.,
2008; Zhang et al., 2008), and in the use of non-human tissues and cells in engraft-
ment or in therapy of conditions such as liver and renal failure (Wilson et al., 1998;
Cunningham et al., 2004; Di Nicuolo et al., 2010). Further, the rogue expression of
these elements in transformed or infected cells, discussed in Section 1.1.4, suggests the
possibility of their use as secondary immune targets (Takahashi et al., 2008). In the
absence of better understanding of their ranges of expression, including in situations of
infection and disease (Evans, Alamgir et al., 2009), as well as potential unknown func-
tionality, however, the induction of a response against such ubiquitous self-antigens is
a potentially dangerous possibility (Ludewig et al., 2000).
The work described in this thesis examines the interaction between ERVs and the
immune system, investigating these links from both angles: the impact of ERVs on the
immune system, and the impact of the immune system on ERVs. The mouse model
has numerous benefits in the field of immunology and the extensive use of congenic,
transgenic, and knock-out mice has greatly facilitated this work. A large amount of
further work has centred on the parallel development of a software, REquest, that allows
the analysis of ERV and RE expression using commercial microarrays.
1.3.1 A word on structure
This section has served to provide a global background to the areas covered within
the thesis, but given the varied directions of the research, both chapters contain a
further introduction and aims, as well as independent results and conclusions. Thus,
each chapter can largely be considered separately, and indeed have been published as
independent studies. REquest is presented as a longer section of the methods chapter.
Publications resulting from this work have been bound at the rear of the thesis.
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2.1 Mice
Mouse strains used within this thesis are detailed in Table 2.1. Origins or breeding
colony identifiers are listed alongside full and shorter strain names, the latter being
used to identify strains throughout the thesis. Sources listed are detailed in Table 2.2.
All congenic strains used are backcrossed to the recipient strain for a minimum of
10 generations. All mice obtained from external sources were introduced into animal
houses via implantation of embryos into pseudopregnant females to facilitate the re-
moval of adventitious agents.
Mice bred within NIMR are pathogen tested according to guidelines from the Federa-
tion of European Laboratory Animal Science Associations (FELASA, www.felasa.eu)
(Nicklas et al., 2002) to confirm absence of various viral, bacterial, mycoplasmal, and
fungal pathogens, as well as endo- and ecto-parasites.
Unless otherwise stated, all mice used for this work were aged between 4 and 8 weeks.
Table 2.1: Mouse strains
Strain Alias Source Ref
C57BL/6J B6
NIMR-B1 JAX
UMICH CIML
RCHCI NCI
129S8/SvEvNimrJ 129S8 NIMR-B1
A/J A NIMR-B1
B6.A-Emv2-/- Emv2-/- NIMR-B2
Young,
Ploquin et al.,
2012
B6 mice (Emv2+/+) congenic for the null allele at the Emv2 integration site
(Emv2-/-) from A strain mice. See Section 2.1.1 for more information.
B6 EF4.1 B6 EF4.1 NIMR-B2
Antunes et al.,
2008
B6 mice transgenic for a TCRβ chain from an env122-141-specific CD4
+ T cell clone.
Mice have a polyclonal T cell population with increased frequencies of clones specific
to env122-141L.
B6-Emv2-/- EF4.1
Emv2-/-
EF4.1
NIMR-B2
Young,
Ploquin et al.,
2012
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... Table 2.1 continued ...
Strain Alias Source Ref
Emv2-/- mice crossed to carry the env122-141-specific TCRβ chain from B6 EF4.1.
129 EF4.1 129 EF4.1 NIMR-B2
129 mice crossed to carry the env122-141-specific TCRβ chain from B6 EF4.1.
B6.A-Fv2s Fv2s NIMR-B2
Marques et al.,
2008
B6 mice (Fv2r) congenic for the dominant Fv2s allele from A strain mice, conferring
susceptibility to Friend virus.
B6.C3H-Fv1n Fv1n NIMR-B2
Pike et al.,
2009
B6 mice (Fv1b) congenic for the Fv1n allele from C3H mice, conferring permissiveness
to N-tropic viruses.
B6.SJL-PtprcaPep3b B6 CD45.1 NIMR-B1
Mice have an allelic form of CD45 (CD45.1 / Ly5.1), allowing determination of donor
and host-derived (CD45.2) cells.
(B6 CD45.1 x B6)F1 CD45.1/2 NIMR-B1
Progeny of a B6 x B6 CD45.1 mating, such that mice are CD45.1/2 syngeneic. This
allows the determination of donor cells from both CD45.1 or CD45.2 mice within a
single mouse.
B6.129S7-Rag1tm1Mom Rag1-/-
NIMR-B1 JAX
UMICH
RCHCI
Mombaerts
et al., 1992
Targeted disruption of recombination activating gene 1 (Rag1 ), preventing V(D)J
recombination and blocking development of mature T and B lymphocytes.
B6-Rag1-/-Emv2-/- Rag1-/-Emv2-/- NIMR-B2
Emv2-/- crossed to Rag1-/- and hence lacking mature T and B lymphocytes.
B6.129P2-Tcratm1Mjo Tcra-/- NIMR-B2
Philpott et al.,
1992
Targeted disruption of the T cell receptor alpha chain (Tcra), preventing formation
of the αβ T cell lineage.
B6.129S7-Tcrdtm1Mom Tcrd-/- NIMR-B2
Itohara et al.,
1993
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... Table 2.1 continued ...
Strain Alias Source Ref
Targeted disruption of the T cell receptor delta chain (Tcrd), preventing formation
of the γδ T cell lineage.
B6.129S2-H2dlA
b1-Ea H2-A,E-/- NIMR-B2
Cosgrove
et al., 1991
Targeted disruption of histocompatibility 2 (H2 ) loci Ab to Ea, preventing peptide
presentation on MHC class II and CD4+ T cell development.
B6.129S7-Ighatm1Grh Igha-/- RCHCI
Harriman
et al., 1999
Targeted disruption of the immunoglobulin heavy constant alpha chain region, block-
ing production of IgA.
B6.129P2-Pigrtm1Rast Pigr-/- RCHCI
Uren et al.,
2003
Targeted disruption of the polymeric immunoglobulin receptor, blocking transcytosis
of dimeric IgA and pentameric IgM across mucosal surfaces.
B6.CBA-Aicdatm1Hon Aicda-/- NCI
Muramatsu
et al., 2000
Targeted disruption of activation-induced cytidine deaminase, preventing production
of class-switched antibodies.
B6.129S7-Igh-Jtm1Dhu Igh-j-/- RCHCI
Chen et al.,
1993
Targeted disruption of the immunoglobulin heavy chain joining region, blocking de-
velopment of mature B lymphocytes.
B6.129S2-Ighmtm1Cgn Ighm-/-
NIMR-B2 JAX
NCI
Kitamura
et al., 1991
Targeted disruption of immunoglobulin heavy constant mu (Igh-6 ), blocking devel-
opment of mature B lymphocytes.
B6-Ighm-/- MD4 Ighm-/- MD4 NIMR-B2
Goodnow
et al., 1988
Ighm-/- mice transgenic for a Hen-egg lysozyme (HEL)-specific BCR.
B6.129P2-Myd88tm1Aki Myd88-/- NIMR-B2
Adachi et al.,
1998
B6.129P2-Myd88tm1.1Defr Myd88-/- JAX
Hou et al.,
2008
Targeted disruption of Myeloid differentiation primary response gene 88 (Myd88 ),
impairing TLR signalling, amongst other pathways.
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... Table 2.1 continued ...
Strain Alias Source Ref
B6.129S1-Tlr7tm1Flv Tlr7-/- JAX CIML
Lund et al.,
2004
B6.129P2-Tlr7tm1Aki Tlr7-/- LRI
Hemmi,
Kaisho et al.,
2002
Targeted disruption of Toll like receptor 7 (Tlr7 ), preventing the recognition of
single-stranded RNA.
B6.129P2-Tlr9tm1Aki Tlr9-/- CIML
Hemmi,
Takeuchi
et al., 2000
Targeted disruption of Toll like receptor 9 (Tlr9 ), preventing the recognition of
unmethylated CpG DNA.
Table 2.2: Mouse sources
NIMR-B1
SPF facility handing the large-scale breeding of frequently used
mouse strains. Mice are maintained with autoclaved diet and
neutral pH, doubly filtered, and UV-irradiated water.
NIMR-B2
SPF IVC breeding facility handing congenic, transgenic and
mutant mouse strains. Mice are bred with autoclaved diet and
acidified (pH 2.5) water.
UMICH
Germ-free mouse strains provided by the University of Michigan
Unit for Laboratory Animal Medicine (ulam.med.umich.edu)
(Ann Arbor, US). Strains are re-derived via sterile caesarian
section of pregnant females and maintained in germ-free
conditions with autoclaved diet and autoclaved distilled water.
JAX
The Jackson Laboratory (jaxmice.jax.org) (Bar Harbor, US)
SPF breeding facility provides mouse strains bred in IVCs with
sterilised diet and acidified (pH 2.8–3.2) water.
CIML
SPF breeding colony located at the University Marseille-Luminy
Centre for Immunology (ciml.univ-mrs.fr) (Marseille, France).
Mouse strains are maintained with autoclaved neutral pH water.
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... Table 2.2 continued ...
NCI
SPF breeding facilities provided by the US National Institutes of
Health National Cancer Institute (cancer.gov) (Frederick /
Bethesda, US). Mouse strains are offered autoclaved neutral pH
water.
RCHCI
SPF breeding facilities provided by the Swiss Federal Institute
of Technology Zu¨rich (ethz.ch) (Zu¨rich, Switzerland). Mouse
lines are maintained on IVCs with autoclaved neutral pH water.
LRI
SPF breeding facilities at the London Research Institute (LRI),
Cancer Research UK (london-research-institute.org.uk). Strains
are maintained on autoclaved water. Mice from this source were
transferred into the NIMR quarantine facility and bred before
testing.
All Rag1-/- mice detailed were established by independent re-derivation of a common
stock obtained from JAX. Between units, these stocks have been maintained by homo-
zygous breeding for between 12 and 45 filial generations (F12 to F45). The Ighm
-/-
JAX stock had been maintained to F15. Ighm
-/- mice at NIMR have recently been
re-derived twice. The first colony was maintained for 16 months (F4) on neutral pH
water before being offered acidified water for F12, whilst the second was maintained
on a diet of neutral pH water for 7 months (F1–F2) prior to sampling. Myd88
-/- mice
at NIMR and JAX have been established for around F16 and F5, respectively. Tlr7
-/-
mice have been maintained by homozygous breeding for F11 at LRI, F5 at JAX, and
F9 at CIML.
2.1.1 Generation of Emv2 -/- congenics
Emv2 -/- B6 background mice were created by the serial backcrossing of the Emv2
integration site from the A strain, null for this proviral integration on chromosome 8.
Congenics were backcrossed for 12 nuclear generations. Lack of Emv2 was validated by
PCR using both the nearby D8Mit49 microsatellite marker (Fig. 2.1a), polymorphic
between in A (Emv2-/-) and B6 (Emv2+/+), and using primers flanking and within
the proviral integration (Fig. 2.1b).
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Figure 2.1: Emv2 typing by PCR
(a) (b)
Typing PCRs for (a) D8Mit49 and (b) the Emv2 integration. PCR products are
shown on a 2% agar gel run in TBE buffer. Primers are listed in Table 2.3.
2.1.2 Ethics statement
All animal experiments were approved by an independent ethical committee within
NIMR, and conducted according to local guidelines and UK Home Office regulations
under the Animals Scientific Procedures Act 1986 (ASPA). Where mice have been
obtained from external sources, all experiments, breeding, and procedures were con-
ducted according to local guidelines and regulations, and subsequent to approval from
respective ethical committees.
Animals were culled by an approved Schedule I method according to Home Office policy.
2.2 Primers
All primers listed were obtained from Eurofins MWG Operon (Ebersberg, Germany).
Table 2.3: Primers
Primer Sequence (5’–3’) Length (nt)
Genotyping primers
D8Mit49 F TCTGTGCATGGCTGTGTATG 20
D8Mit49 R TGGTGTGCTGCTGATGCT 18
D8Mit49 microsatellite marker ∼640 kb downstream the Emv2 integration on B6
chromosome 8. Product is 130 or 152 bp in A or B6 mice, respectively.
Emv2 3’ F ACCCACTAAGTAACCCAGGCTGCCTCAGCT 30
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... Table 2.3 continued ...
Primer Sequence (5’–3’) Length (nt)
Emv2 5’ R GACCAGAATAGAAAGACGTTCAAGTGAGCT 30
Emv2 LTR R CGCGGGTACAGAAGCGAGAAGCGAGCTGAT 30
Flanking and internal primers for the exact integration site of Emv2 on B6 chromo-
some 8. Emv2 3’ F and Emv2 LTR R give a 250 bp product when Emv2 is present.
Emv2 3’ F and Emv2 5’ R give a 400 bp product when Emv2 is absent (Young,
Ploquin et al., 2012).
Housekeeping and normalisation primers
HPRT F TTGTATACCTAATCATTATGCCGAG 25
HPRT R CATCTCGAGCAAGTCTTTCA 20
Hypoxanthine-guanine phosphoribosyltransferase (HPRT ) is used as a housekeeping
gene against which RNA expression levels can be normalised. 92 bp product.
Ifnar1 F AAGATGTGCTGTTCCCTTCCTCTGCTCTGA 30
Ifnar1 R ATTATTAAAAGAAAAGACGAGGCGAAGTGG 30
Interferon alpha beta receptor 1 (Ifnar1 ) is used as a gene against which DNA levels
can be standardised. 150 bp product.
Expression primers (spliced)
eMLV spenv F CCAGGGACCACCGACCCACCGT 22
eMLV spenv R TAGTCGGTCCCGGTAGGCCTCG 22
Spliced ecotropic MLV env. 116 bp product (Young, Ploquin et al., 2012).
MMTV F AGAGCGGAACGGACTCACCA 20
MMTV R TCAGTGAAAGGTCGGATGAA 20
Spliced MMTV env. 105 bp product.
Expression and DNA quantitation primers (non-spliced)
eMLV env F AGGCTGTTCCAGAGATTGTG 20
eMLV env R TTCTGGACCACCACACGAC 19
Ecotropic MLV env. 1 bp mismatch to Emv2 corrected from original reverse primer
sequence. 169 bp product (Yoshinobu et al., 2009).
eMLV pol F CACTTTGAGGGATCAGGAGCC 21
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Primer Sequence (5’–3’) Length (nt)
eMLV pol R CTTCTAGGTTTAGGGTCAACACCTGT 26
Ecotropic MLV pol. 76 bp product (Lo¨tscher et al., 2007).
xMLV F TCTATGGTACCTGGGGCTC 19
xMLV R GGCAGAGGTATGGTTGGAGTAG 22
Xenotropic MLV env. 201 bp product (Yoshinobu et al., 2009).
pMLV F CCGCCAGGTCCTCAATATAG 20
pMLV R AGAAGGTGGGGCAGTCT 17
Polytropic MLV env. 163 bp product (Yoshinobu et al., 2009).
mpMLV R CGTCCCAGGTTGTATAGAGG 20
Modified polytropic MLV env. mpMLV R used with pMLV F to give 151 bp product
(Yoshinobu et al., 2009).
MusD F GTGCTAACCCAACGCTGGTTC 21
MusD R CTCTGGCCTGAAACAACTCCTG 22
175 bp product (Karimi et al., 2011).
IAP F AAGCAGCAATCACCCACTTTGG 22
IAP R1 CAATCATTAGATGTGGCTGCCAAG 24
IAP R2 CAATCATTAGATGCGGCTGCCAAG 24
IAP R1 and IAP R2 to be mixed 1:1 for use. 97 bp product (Karimi et al., 2011).
GLN F CGTAAGGACCCTAGTGGCTG 20
GLN R GCACTCACTCTTCTTCACTCTG 22
155bp product (Karimi et al., 2011).
MuERV-L F ATCTCCTGGCACCTGGTATG 20
MuERV-L R AGAAGAAGGCATTTGCCAGA 20
50 bp product (Macfarlan, Gifford, Agarwal et al., 2011).
Emv2 AC F CCTGGGTTTGCGGAAATGGCAC 22
Emv2 GG F CCTGGGTTTGCGGAAATGGCGG 22
Emv2 mut R TTTGGCGTAGCCCTGCTTCTCG 22
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Primer Sequence (5’–3’) Length (nt)
Primers to distinguish between transcripts corrected at G-3576-C and deriving from
RARVs (Emv2 GG F and Emv2 mut R) or uncorrected transcripts (Emv2 AC F
and Emv2 mut R) deriving from Emv2 itself. 192 bp product for both reactions.
eMLV / RARV DNA amplification primers
RARV pol F ATCGGGCCTCGGCCAAGAAAG 21
RARV pol R CCGGGAGAGGGAGTAAGGTGGC 22
Primers used to amplify the region surrounding the Emv2 inactivating point muta-
tion. 708 bp product.
RARV 5-pol F GCGCCAGTCCTCCGATAGACT 21
RARV 5-pol R CCGGGAGAGGGAGTAAGGTGGC 22
Primers used to amplify the first half of RARV genomes for subsequent sequencing.
4074 bp product.
RARV pol-3 F ATCGGGCCTCGGCCAAGAAAG 21
RARV pol-3 R TGCAACAGCAAAAGGCTTTATTGG 24
Primers used to amplify the second half of RARV genomes for subsequent sequencing.
4909 bp product.
2.3 RNA expression assays
Tissue samples were disturbed through vibration with 3 mm tungsten carbide beads in
a TissueLyser LT machine (Qiagen, Hilden, Germany). Total RNA was isolated with
TRI-reagent (Sigma-Aldrich, St Louis, US) according to the manufacturer’s instruc-
tions, precipitated with isopropanol (Fisher Scientific, Loughborough, UK) and washed
in 75% ethanol (Fisher Scientific). DNase digestion and cleanup was performed with
the RNeasy Mini Kit (Qiagen) and RNase-free water (Qiagen) was used throughout
the protocol.
cDNA was produced with the high capacity reverse transcription kit (Applied Biosys-
tems, Carlsbad, US) with an added RNase-inhibitor (Promega Biosciences, Madison,
US). cDNA was cleaned with the QIAquick PCR purification kit (Qiagen) and eluted
with nuclease-free water (Qiagen).
To prevent ‘contamination’ with other endogenous MLV sequences in the relative
2. METHODS 50
quantitation of corrected and uncorrected eMLV transcripts, cDNAs were instead re-
verse transcribed using a single primer specific to the eMLV env. Samples were split
in half and reverse transcribed using both the high capacity reverse transcription
kit (Applied Biosystems) and the Omniscript RT kit (Qiagen) using the primer 5‘-
TTCTGGACCACCACACGAC-3‘.
Purified cDNA was used as template for the amplification of target gene transcripts with
SYBR Green PCR Master Mix (Applied Biosystems). PCR protocols were run on an
ABI Prism SDS 7000 or 7900HT (Applied Biosystems) cycler. Target gene expression
values were calculated against the housekeeping gene Hprt using the ∆CT method:
Value = 2(Hprt CT – target CT) x 104
This was chosen such that for a representative CT value for Hprt, a CT of 40 (the
length of a standard PCR program) determined for a target gene would have a value of
1 arbitrary unit. Related to this, a theoretical detection limit of 2 arbitrary units is also
displayed as dashed horizontal line on graphs of qRT-PCR data. For eMLV expression
in particular, values above 103 were considered to be elevated above background levels
of variation.
For transcriptional profiling with microarrays, purified RNA samples were firstly checked
for quality using the Agilent bioanalyzer (Agilent, Santa Clara, US). Synthesis of cDNA,
probe labelling, and hybridisation were performed using the Mouse Gene 1.0 ST oli-
gonucleotide microarray kit (Affymetrix, Santa Clara, CA, USA). GeneChips were
scanned with an Affymetrix GeneChip Scanner and analysed using GeneSpring GX
(Agilent).
2.4 DNA extraction and assays
DNA was extracted from small tissue samples, cell suspensions and cell lines by Pro-
teinase K digestion in a buffer of 100 mM TRIS, 5mM EDTA, 200 mM NaCl, and
0.2% SDS. DNA was precipitated with isopropanol and washed with ethanol before
re-suspension. Larger tissue samples were similarly digested, but DNA was extracted
with phenol prior to precipitation with isopropanol and ethanol washing.
Determination of eMLV copy number was performed by qRT-PCR on DNA isolated
from tissues of interest. Copy number was calculated with the ∆∆CT method using
Ifnar1 as a reference, using DNA from the spleen of a B6 mouse as a control (assigned a
value of 1 copy/haploid genome, N). The same DNA samples were used for array com-
parative genome hybridisation analysis, performed by Atlas Biolabs (Berlin, Germany)
using SurePrint G3 Mouse CGH 4x180K microarray kits (Agilent).
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2.5 Sequencing and sequence analysis
PCR products were purified with the QIAquick PCR purification kit (Qiagen) and
sequenced at Source BioScience (Cambridge, UK). Sequence analyses, comparisons and
alignments were performed with Vector NTI v11.5 (Invitrogen, Carlsbad, US).
RARV contigs were aligned against B6 MLVs (Jern, Stoye & Coffin, 2007) using
MAFFT (Katoh, Misawa, Kuma & Miyata, 2002) within UGENE (Okonechnikov, Go-
losova & Fursov, 2012). Distance plots were calculated with RDP (Recombination De-
tection Program) v4.16, using a 100 bp scanning window and a 10 bp shift (D. P. Martin
et al., 2010). RARV phylogenetic analyses were performed with PHYLIP (Phylogeny
inference package) v3.2 within UGENE.
For assessment of microbial diversity, colonic content was collected from culled mice
either within NIMR or at RCHCI (frozen samples were shipped to NIMR for further
processing). DNA was isolated using the QIAamp DNA Stool Mini Kit (Qiagen).
DNAVision (Gosselies, Belgium) performed high-throughput sequencing of amplicons of
bacterial DNA encoding the 16S ribosomal RNA with a Roche FLX Genome Sequencer
and conducted read assignation. Validity of assignation was confirmed by comparison to
assignation performed on the Ribosomal Database Project website (rdp.cme.msu.edu)
(Cole et al., 2009).
2.6 Media and culture conditions
Room temperature cell incubation, antibody staining, FACS sorting, and tissue collec-
tion was performed with air-buffered Iscove’s Modified Dulbecco’s Medium (AB IMDM)
containing 25 mM HEPES buffer and L-glutamine, and supplemented with 0.21% NaCl,
60 µg/ml penicillin, and 100 µg/ml streptomycin (Invitrogen).
Erythrocyte lysis was performed with Ammonium-Chloride-Potassium (ACK) buffer
(0.15 M NH4Cl, 1 mM KHCO3, 0.1 mM EDTA, pH 7.2-7.4).
Cells were cultured with Iscove’s Modified Dulbecco’s Medium (Sigma-Aldrich) supple-
mented with 5% heat inactivated foetal calf serum (FCS) (BioSera, Ringmer, UK), 2
mM L-glutamine, 100 µg/ml penicillin, 100 µg/ml streptomycin, and 10-5 M mercapto-
ethanol. Cell lines and primary cells for longer study were incubated in an atmosphere
of 95% humidity, 5% CO2, and 37
◦C.
Unmodified Dulbecco’s phosphate-buffered saline (DPBS with no added Ca or Mg)
(Gibco/Invitrogen) was used for dilution of viral stocks prior to inoculation.
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2.7 Isolation of primary cells
Single cell suspensions were prepared by mechanical disruption of tissues through a
70 µm cell strainer (Falcon/BD, Franklin Lakes, US). Splenocyte suspensions were
subjected to erythrocyte lysis by brief ACK treatment, before being washed and re-
suspended in AB IMDM.
Peritoneal macrophages were collected by injecting 5 ml AB IMDB at 4◦C into the peri-
toneal cavity of culled mice. The peritoneum is massaged to disturb loosely adherent
cells and the fluid aspirated into the same syringe.
Bone marrow cells were flushed from the femurs and tibiae of culled mice with cell cul-
ture medium. For the production of bone marrow-derived dendritic cells (BM-DCs),
bone marrow cell suspensions were supplemented with 10% granulocyte macrophage
colony-stimulating factor (GM-CSF) obtained from supernatants of X63 cells transfec-
ted with mouse Csf2. 5x106 cells were plated in 10 cm cell culture plates and incubated
for a period of 7 days. At this point, dendritic cells could typically be obtained at a
purity of 40–70%.
Enrichment of primary cells was performed using EasySep immunomagnetic positive
selection (StemCell Technologies, Vancouver, Canada) according to the manufacturer’s
instructions. Briefly, single cell suspensions were produced at a concentration of 1x108
cells/ml and stained with a relevant phycoerythrin (PE)-conjugated antibody for 30
minutes at 4◦C. Cells were washed and a PE selection cocktail was added at 25 µl/ml.
Cells were incubated at room temperature for 15 minutes and magnetic beads added
at 25 µl/ml. Cells were incubated at room temperature for a further 10 minutes and
the tube containing the cells placed on an EasySep magnet (StemCell Technologies).
Cells are left for 7 minutes to ensure those bound with magnetic beads are attracted to
the sides of the tube. For positive selection of target cells, the supernatant, containing
cells not bound to magnetic beads, was poured off and captured cells re-suspended.
This selection was repeated twice more, balancing purity against incremental losses of
target cells. For negative selection of target cells, the supernatant was collected and
replaced on the magnet twice more, with cells captured by the magnet being discarded.
Typical purity, as assessed by FACS, of purified populations was greater than 92%.
For adoptive transfer of immunomagnetically-enriched primary cells, 1x106 CD4+ T
cells were injected into the tail vein of recipient mice in 100 µl IMDM.
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2.8 Fluorescence Activated Cell Sorting
Cell suspensions obtained from disrupted tissues or peritoneal exudates were stained
with a range of directly fluorochrome-conjugated antibodies against cell-surface mark-
ers. Antibodies were obtained from eBiosciences (San Diego, US), CALTAG/Invitrogen,
BD Biosciences, or BioLegend (San Diego, US) and are listed in Table 2.4.
Table 2.4: Directly fluorochrome-conjugated antibodies
Specificity Clone Fluorochrome
CD4 GK1.5 / RM4-5 APC / APC a750 / FITC / PE / PE TxR
CD8a 53-6.7 / 5H10 APC / FITC / PE / PE TxR
CD11b M1/70 APC / PE
CD19 MB19-1 / 6D5 APC / FITC / PE / PE TxR
CD25 PC61.5 APC / FITC / PE
CD43 1B11 PE
CD44 IM7 APC / APC a750 / FITC / PE
CD45.1 A20 APC / APC eF780 / FITC / PE
CD45.2 104 APC / APC Cy7 / PE
CD69 H1.2F3 FITC
B220 RA3-6B2 APC / PE / PE TxR
F4/80 BM8 APC / PE
Gr1 RB6-8C5 APC / FITC / PE
Ly6-C HK1.4 FITC
MHCII M5/114.15.2 FITC / PE
Ter119 TER-119 APC / PE
TCRβ H57-597 APC / FITC
Vα2 B20.1 APC / FITC / PE
Vα3.2 RR3-16 FITC
IgG1 A85-1 FITC
IgG2a/c R19-15 FITC
IgG2b R12-3 FITC
IgM R6-60.2 PE
MLV SU staining was determined with use of the 83A25 rat IgG2a antibody (Evans,
Morrison, Malik, Portis & Britt, 1990). This primary reagent was stained with a biot-
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inylated anti-rat IgG2a secondary antibody (clone RG7/1.30, BD Biosciences), which
was in turn treated with a streptavidin conjugated to PE or PE TxR (BioLegend or
CALTAG/Invitrogen) for analysis by FACS.
4- and 8-colour cytometry was conducted on FACSCalibur (BD Biosciences), CyAn
(Dako, Fort Collins, US), or FACSVerse (BD Biosciences) machines. Data analysis was
performed with FlowJo v8.7 (Tree Star, Ashland, US) or Summit v4.3 (Dako) analysis
softwares.
Cell suspensions for FACS sorting were maintained on ice or at 4◦C and stained with rel-
evant fluorochrome-conjugated antibodies for surface markers. Sorting was performed
using MoFlo cell sorters (Dako) by the NIMR Cell Sorting facility, typically yielding
cell purities of higher than 98%.
Where necessary to prevent non-specific antibody binding, FcBlock (antibody clone
2.4G2, produced within NIMR) was added to stains. Being a rat IgG2a antibody, this
was not used in combination with 83A25 for the determination of MLV SU product
levels.
2.9 Isolation and analysis of infectious MLVs
Plasma samples were obtained from mice and centrifuged for 45 mins at an 256 g at
20◦C with Mus dunni cells transduced with the XG7 replication-defective retroviral
vector. This encodes a green fluorescent protein (GFP) under the control of a hu-
man cytomegalovirus (CMV) promoter and contains a neomycin-resistance gene under
the control of the LTR (Bock, Bishop, Towers & Stoye, 2000). Maintenance of GFP
expression was ensured by constant selection with 1 mg/ml G418 antibiotic.
Cells were cultured for 10-14 days and culture supernatant transferred to Mus dunni
cells. The presence of infectious MLVs was thus assessed by the quantity of pseudotyped
XG7 vector in this supernatant, the presence of which causes Mus dunni cells to be
GFP+ by FACS after a period of 3 days.
N- or B-tropism of isolated viruses was determined by addition of serially diluted cul-
ture supernatants from Mus dunni XG7-transduced cells to either B- or N-3T3 cells.
Infection was quantified according to the GFP positivity of these cells after 3 days. N-
and B-tropic F-MLV were used to provide estimates of infectivity in cell lines of the
opposing tropism. Results were expressed as a ratio of the percentage of GFP+ B-3T3
cells to that of N-3T3 cells.
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2.10 Histology
Tissue samples were collected into formalin immediately after culling of mice. Section-
ing for histological analysis, staining with haematoxylin and eosin, and examination
was performed by Dr Mark Stidworthy (IZVG Pathology, Leeds, UK).
2.11 Electron microscopy
Electron microscopy was performed by the dedicated service provided within NIMR.
Samples were immersion fixed in 2% glutaraldehyde/2% paraformaldehyde and post-
fixed in 1% osmium tetroxide using 0.1 M sodium cacodylate buffer (pH 7.2). Aqueous
uranyl acetate was followed by dehydration through a graded ethanol series and pro-
pylene oxide. Samples were then embedded in Epon and 50 nm sections mounted on
pioloform coated grids and stained with ethanolic uranyl acetate followed by Reynold’s
lead citrate. Samples were viewed with a JEOL 100EX transmission electron micro-
scope (JEOL, Tokyo, Japan) equipped with an ORIUS 1000 CCD camera (Gatan,
Pleasanton, US).
2.12 Friend Virus
Friend virus (FV) is a complex of a replication incompetent spleen focus-forming virus
(SFFV) and Friend murine leukaemia virus (F-MLV), a replication competent helper
virus. Stocks used within NIMR contain the polycythemia-inducing SFFV variant
(SFFVP). The FV-B complex is propagated for 12 days in vivo in a permissive strain
(BALB/c) and prepared for use as a 10% w/v spleen homogenate. All viral stocks
were free of Sendai virus, Murine hepatitis virus, Parvoviruses 1 and 2, Reovirus 3,
Theiler’s murine encephalomyelitis virus, Murine rotavirus, Ectromelia virus, Murine
cytomegalovirus, K virus, Polyomavirus, Hantaan virus, Murine norovirus, Lympho-
cytic choriomeningitis virus, Murine adenoviruses FL and K87, and Lactate dehydro-
genase elevating virus.
Prepared spleen homogenate is briefly centrifuged to pellet debris, and supernatant
diluted 1:5 with DPBS for injection. Experimental mice receive an inoculum of ∼1,000
spleen focus-forming units (SFFU) injected in 100 µl via the tail vein. Where adoptive
transfer was combined with FV infection, two separate injections were given at the
same time, or else within a 24 hour period.
FV infection was determined by FACS using surface staining for the glycosylated viral
gag matrix (MA) product (glyco-Gag) using the monoclonal mouse IgG2a 34 antibody
(Chesebro, Britt et al., 1983), followed by a secondary anti-mouse IgG2a conjugated
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to a fluorochrome. Alternatively, anaemia was assessed by analysis of complete blood
counts determined with a VetScan MHII haematology analyser (Abaxis, Union City,
US). Blood was collected into heparinised capillary tubes from a small incision of the
tail. Red blood cell (RBC) counts of uninfected controls were ∼9.95x106/mm3 of whole
blood. FV-induced splenomegaly was expressed as spleen index, a ratio of spleen weight
(mg) to body weight (g).
2.13 FV-neutralising and cell-binding antibody titre as-
says
FV-neutralising serum antibody titres were determined in vitro using Mus dunni cells
transduced with the replication-defective retroviral XG7 vector (see Section 2.9). These
cells were infected with B-tropic F-MLV and the culture supernatant, containing ∼1500
infectious units (iu)/ml of psuedotyped XG7 vector, was harvested. Serial dilutions of
sera from infected and control mice were mixed with this supernatant and incubated
for 30 mins at 37◦C in IMDM +5% FCS. This was finally added to Mus dunni cells
and incubated for 3 days, after which the percentage of GFP+ cells was determined by
FACS. The dilution of serum resulting in 75% neutralisation was taken as the neutral-
ising antibody titre.
The F-MLV-infected cell-binding serum antibody titre was determined by FACS. Serial
dilutions of serum were added to Mus dunni cells infected with F-MLV and antibodies
binding cells were secondarily bound with fluorescently labelled anti-mouse IgG1 (clone
A85-1), anti-mouse IgG2a/c (clone R19-15), anti-mouse IgG2b (clone R12-3), or anti-
mouse IgM (clone R6-60.2). Starting from an initial dilution of 1:50, sera were 2-fold
serially diluted and the median fluorescence intensity (MFI) of staining was recorded.
Data were fitted to a sigmoidal curve, and the last positive dilution on the curve to give
staining over twice the level of background was taken as the binding antibody titre.
This measure was used, as opposed to determination of titre based on half the maximal
response, as no samples showed signs of reaching a maximum plateau.
2.14 Hybridoma production
Cell suspensions were prepared from spleens and lymph nodes of B6 EF4.1 or Emv2 -/-
EF4.1 mice and stimulated in vitro with 10-7 M or 10-5 M env122-141L peptide and
4 ng/ml recombinant human IL-2 for 4 days. CD4+ T cells were immunomagnetically
enriched and plated in 96-well plates with TCRαβ-negative BW5147 thymoma cells to
produce hybridoma cell lines. Fusion and hybridoma generation over the following 5
days was assessed by microscopy, with individual clones being selected and transferred
2. METHODS 57
to tissue culture flasks. Hybridomas were selected in culture medium supplemented
with Hypoxanthine-Aminopterin-Thymidine (HAT) and weaned into normal culture
medium with the use of Hypoxanthine-Thymidine (HT).
2.15 Stimulation assays
F-MLV env124-138L peptide, as well as the Y and YS env mutants, were produced
within NIMR. Peptides used for determination of hybridoma TCR specificity, mutating
the three TCR contact points through the range of natural amino acids, were produced
by GenScript (Piscataway, US).
Single cell suspensions were prepared from spleens, thymi, and lymph nodes, as ap-
propriate. 5x105 cells/well of a 96-well plate were stimulated with peptides at varying
concentrations. Responding cells were determined as having upregulated CD69 after 18
hours (before cell division or death) by FACS. Co-staining for CD40L was performed in
control experiments to confirm the accurate identification of cells responding to peptide
stimulation.
For assessment of T cell activity over a period of 3 days, cells were labelled with CFSE
prior to stimulation. CFSE dilution, occurring at cell division, was determined by
FACS.
1x105 hybridoma cells were stimulated with peptides presented by 5x104 B6 BM-
DCs in 96-well plates and responsiveness was assessed through determination of IL-2
production. After 18 hours, culture supernatants were added to wells containing the
IL-2 dependent CTLL-2 cell line and cell viability was determined after a further 18
hours with the use of AlamarBlue (Invitrogen). Fluorescence at 590 nm (excitation
at 530 nm) was determined with a Safire2 plate reader (Tecan Group, Ma¨nnedorf,
Switzerland).
2.16 Tra gene usage determination
Proportions of Vα2+ and non-Vα2 CD4+ T cells were determined with anti-Vα2
(B20.1) and anti-Vα3.2 (RR3-16) monoclonal antibodies. Only a proportion of Vα3+
CD4+ T cells stain with RR3-16, however, hence accurate determination of Trav and
Traj region usage was determined by qRT-PCR amplification of expressed genes and
subsequent sequencing using primers from the literature (Casanova, Romero, Widmann,
Kourilsky & Maryanski, 1991). Identification of gene usage from sequence data and
confirmation that rearrangements were capable of producing functional TCRs were
performed on the International Immunogenetics Information System website (imgt.org).
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2.17 Computational and statistical methods
Local installs of NCBI BLAST+ 2.2.27 were used to create BLAST databases and
perform BLASTn. Python 3.2.2 was used to produce scripts to create, handle, and
query multi-process BLASTn.
Statistical analysis and graphing was performed within SigmaPlot 12 (Systat Soft-
ware, Erkrath, Germany). Where normally-distributed data satisfied variance cri-
teria, comparisons were performed with unpaired Student’s t-tests. Where data were
not normally-distributed or failed variance criteria, non-parametric two-tailed Mann-
Whitney Rank Sum or Wilcoxen Signed Rank test were used instead. Assessment
of bacterial diversity was performed by ANOVA with Bonferroni multiple comparison
correction. Tumour incidence rates were compared by log-rank survival analysis of
Kaplan-Meier curves.
Microarray data was separately analysed within GeneSpring GX (Agilent) using Benjamini-
Hochberg false discovery rate (FDR) correction for multiple comparisons.
2.18 REquest : determining retroelement expression with
microarrays
RNA microarrays, similarly to Northern blotting, rely on nucleotide complementarity
to hybridise specific sequences from within a sample of interest. A sample to be inter-
rogated is labelled with a fluorescent marker before being allowed to hybridise to fixed
complementary cDNA probes. Captured nucleotide fragments are retained in place
upon washing, allowing their abundance to be quantified by relative fluorescence. The
first publication of this technique monitored the expression of 45 Arabidopsis thaliana
cDNAs (Schena, Shalon, Davis & Brown, 1995), using an automated gridding robot to
print cDNA probes onto a glass slide. This technique, the ‘spotted microarray’, was
developed rapidly to accommodate over 1,000 individual probes (DeRisi et al., 1996),
but separate development of in situ methods of probe synthesis (Fodor et al., 1991)
allowed for massive parallelisation and the rapid production of microarrays with over
16,000 and 65,000 separate probes (Lockhart et al., 1996).
The necessity of RNA intermediates in the replication of REs and ERVs allows as-
sessment of their transcriptional activity by both PCR-based approaches and RNA
microarray. Significant labour has resulted in the production of spotted microarrays
specifically for the assessment of retroviral activity (Seifarth, Spiess et al., 2003). The
requirement for custom equipment, technologies, and analysis techniques prevents their
application in the majority of exploratory settings, however, as use requires either pre-
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existing or a priori knowledge. In the absence of specific targeting, the high levels of
sequence specificity required in the design of microarray probes (He, Wu, Li, Fields &
Zhou, 2005) also prevents the determination of expression for more diverse or distantly
related members of various RE families. Further, the expense and expertise required
makes these tools available to only a small subset of researchers.
In comparison, commercial microarray platforms are frequently used in exploratory set-
tings and across varying research areas, ranging from developmental biology to immun-
ology. In addition, increasing numbers of species can be investigated in this manner.
The possible existence of probes within commercial microarrays that report RE or ERV
expression is, therefore, a tempting prospect, and would allow researchers to monitor
or identify expression patterns in parallel with those of cellular genes.
Successful identification and annotation of RE and ERV-specific microarray probes
relies on the accurate and unambiguous identification of repetitive sequences within the
genome of interest. This can either be done de novo, with predictive algorithms and
self-alignment techniques, or by comparison against a compiled database of elements.
Database-reliant programs such as RepeatMasker (Smit, Hubley & Green, 1996) and
CENSOR (Kohany, Gentles, Hankus & Jurka, 2006) are capable of identifying far larger
total areas of repetitive sequences and can be used to ‘mask’ genomes to facilitate faster
indexing and unambiguous searching.
Comparison of the genome co-ordinates of microarray probes between masked and
unmasked sequences can thus be used to identify probes corresponding to REs, and
significant numbers of probes have previously been identified in this way (Barbosa-
Morais et al., 2010). However, the majority of work has centred on the exclusion
of these probes as confounding factors, rather than on their specific analysis. An
extension of this theory has allowed the identification and analysis of RE-specific probes
within three popular microarray platforms (Reichmann et al., 2012). ∼3% of probes
within the Illumina Mouse WG-6 v2.0 platform potentially reported RE expression,
and, respectively, ∼2% and ∼5% of probes within the Affymetrix Murine Genome
U74Av2 and Mouse Expression 430 2.0 microarrays (Reichmann et al., 2012).
This methodology, whilst successfully identifying differentially regulated REs from
within microarray datasets, lacks fine annotation of individual REs, and clusters ele-
ments at a relatively high level. For example, an element found to correspond to
RLTR-int, MuLV-int and RLTR4 Mm sequences (Reichmann et al., 2012) can be re-
cognised as the single-copy ecotropic MLV Emv2. Probes reporting Emv2 expression
were correctly identified as Mela-specific (Melanoma antigen, corresponding to the
Emv2 env mRNA, NCBI GeneID 17276) in the manufacturer’s annotations and hence
re-annotation in this instance resulted in the loss of valuable information.
The published methodology has thus been extended to further microarray platforms
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(Table 2.5), but also improved to allow the annotation, where possible, of probes corres-
ponding to low copy number RE classes. The use of commercially available microarrays
in this manner not only facilitates the discovery of novel associations and future transla-
tional research, but also allows the enhanced re-analysis of previously obtained data and
informative data-mining from thousands of publicly available microarray experiments.
Table 2.5: Mouse microarray platforms
Total Probe
Microarray probes length (nt)
Affymetrix (affymetrix.com)
Murine Genome U74Av2 ∼ 200,000 25
Mouse Genome 430A 2.0 ∼ 250,000 25
Mouse Genome 430 2.0 ∼ 500,000 25
Mouse Gene 1.0 ST ∼ 900,000 25
Mouse Exon 1.0 ST ∼ 4,780,000 25
Agilent (genomics.agilent.com)
Mouse GE 44K v2 ∼ 45,000 60
SurePrint G3 Mouse GE 60K ∼ 62,000 60
SurePrint G3 Mouse Exon 180K ∼ 181,000 60
SurePrint G3 Mouse Exon 400K ∼ 420,000 60
Illumina (illumina.com)
Mouse Ref-8 v2.0 ∼ 25,000 50
Mouse WG-6 v2.0 ∼ 46,000 50
Operon (operon.com)
Mouse AROS v4 ∼ 36,000 50–70
Exonic Evidence Based Oligonucleotide (microarray.com)
MEEBO ∼ 39,000 70
The latest version of the mouse RefSeq (Pruitt, Tatusova & Maglott, 2007) genome
(GRCm38, Mm10) was downloaded, along with the latest RepBase Update database
(Jurka et al., 2005). RepeatMasker was used to identify repetitive elements within the
genome sequence, with 46.4% in total being masked. Probes from one previously stud-
ied microarray platform, Illumina Mouse WG-6 v2.0, were downloaded as a test set and
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a Python script was produced to localise probes to the genome through BLASTn and
record the total number of sites sharing ≥95% homology with the probe. A further Py-
thon script was produced to determine if individual probe co-ordinates were contained
within sequence regions masked by RepeatMasker, as described previously (Reichmann
et al., 2012), and lists of probes identified were compared to those published.
This workflow identified marginally more elements in total (1453 compared to 1438 –
Fig. 2.2a), with broadly similar overall frequencies (data not shown). Overall, ∼90% of
probes identified in this workflow were identical to those described previously (Fig. 2.2a).
Much of the difference is likely explained by the combined use of a more recent RepBase
Update library, the latest genome assembly and potentially varying program settings.
To investigate the latter possibility, the analysis was repeated using CENSOR to pro-
duce the required masking data. CENSOR masked a lower overall percentage of the
genome (39.1%), which resulted in identification of fewer total probes, although overall
correspondence with those identified using RepeatMasker was high (Fig. 2.2b). Com-
bination of probes identified with the use of either program improved overall identific-
ation and reduced discrepancy to those identified previously (Reichmann et al., 2012)
(Fig. 2.2c).
∼81% of probes identified within this microarray were likely to be specific to individual
elements within the genome, with those remaining sharing ≥95% homology with a
median of 12 sites. The methodology outlined, using masking data from both Re-
peatMasker and CENSOR, was applied to a number of popular microarray platforms
(Table 2.5) and numbers of identified LTR-bounded elements, SINEs, and LINEs are
shown in Table 2.6.
Further, microarray probes were additionally screened for specific reactivity to a library
of MLVs and MMTVs endogenous to the B6 genome and compiled from the literature
(Jern, Stoye & Coffin, 2007) and genome searches. Individual elements within B6 mice
were identified in this manner, but these elements are highly polymorphic (Stoye &
Coffin, 1988; Frankel et al., 1990) and thus mappings are non-transferable between
strains. Further work could, however, apply this method to the genomes of other
sequenced mouse strains (Yalcin et al., 2011).
This workflow has also applied to a number of human commercial microarrays and
together with probes identified for murine microarrays, a Python tool, REquest, was
developed to allow the mining of RE and ERV expression from commercial microarray
data. After normalisation routines and determination of significantly up- or down-
regulated probes, REquest can be applied to comma separated value (csv) lists of
probes to identify those reporting the expression of REs and ERVs, allowing the user
to specifically investigate their expression patterns in relation to various treatments or
conditions.
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Figure 2.2: RE-specific probe identification
(a)
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(a) Comparison of probes identified previously (Reichmann et al., 2012) with those
identified using RepeatMasker. (b) Probes identified with masking data from Re-
peatMasker or CENSOR, and (c), probes identified using both RepeatMasker and
CENSOR in comparison to those identified previously (Reichmann et al., 2012).
Table 2.6: RE- and ERV-specific probes within commercial murine
microarrays
Microarray LTR SINE LINE
Affymetrix (affymetrix.com)
Murine Genome U74Av2 1625 507 1424
Mouse Genome 430A 2.0 2341 841 2590
Mouse Genome 430 2.0 8580 4431 11803
Mouse Gene 1.0 ST 4294 2229 4528
Mouse Exon 1.0 ST 65787 37480 48308
Agilent (genomics.agilent.com)
Mouse GE 44K v2 639 233 323
SurePrint G3 Mouse GE 60K 709 256 336
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... Table 2.6 continued ...
Microarray LTR SINE LINE
SurePrint G3 Mouse Exon 180K 216 69 83
SurePrint G3 Mouse Exon 400K 1114 303 378
Illumina (illumina.com)
Mouse Ref-8 v2.0 132 65 147
Mouse WG-6 v2.0 453 305 556
Operon (operon.com)
Mouse AROS v4 425 209 199
Exonic Evidence Based Oligonucleotide (microarray.com)
MEEBO 225 103 59
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Chapter 3
Endogenous retroviruses and T
cell development
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3.1 Introduction
3.1.1 Friend virus
Charlotte Friend first described a retroviral agent responsible for transmission of leuk-
aemia between mice in 1957 (Friend, 1957; de Harven & Friend, 1960), showing that
the acute erythroblastosis seen on inoculation of newborn mice with Ehrlich murine
carcinoma cells could subsequently cause disease in adult mice through serial transfer
of cell-free splenic filtrates.
Friend originally described a virus that caused the development of anaemia, anaemia-
inducing Friend virus (FVA); however, after some years of research a new disease charac-
teristic was observed in some viral isolates. Rather than the development of anaemia,
infection resulted in polycythemia, and the viral isolate was termed polycythemia-
inducing Friend virus (FVP) or, subsequently, spleen focus-forming virus (SFFV).
Both types of virus were seen to target erythroid progenitors to induce an immediate
erythroblastosis and massive splenomegaly in susceptible strains of mice. Subsequent
research has revealed that Friend virus (FV) exists as a pair of co-transmitted viruses
– the replication competent helper virus, now known as Friend MLV (F-MLV), and
a replication incompetent SFFV, which may either be anaemia-inducing (SFFVA) or
polycythemia-inducing (SFFVP).
SFFV env encodes a truncated glycoprotein of 55 rather than 70 kDa, gp55, result-
ing from the likely recombination of its original ecotropic env (a truncated form being
retained at the carboxy-terminus of the resulting protein) with an endogenous pMLV
sequence (forming the amino-terminus) (Clark & Mak, 1984). gp55, given its unusual
character, is retained in the cell membrane of infected cells and has been shown to inter-
act with the erythropoietin receptor (EpoR) (J.-P. Li, D’Andrea, Lodish & Baltimore,
1990). This interaction results in heightened sensitivity to erythropoietin (Epo), in
SFFVA, or complete Epo independence in the case of SFFVP. Further, gp55 recruits
a short form of the Stk receptor tyrosine kinase, encoded by Fv2s (Persons et al.,
1999), constitutive activation of which allows the survival and proliferation of infected
erythroid precursors and the associated erythroblastosis. Fv2r/r mice have a dele-
tion of the promoter for short-form Stk, and are hence resistant to SFFVA/P-induced
erythroblastosis and splenomegaly.
Although SFFV causes rapid expansion of its target cell population, the resulting cells
are not tumourigenic. Thus, erythroleukaemia is induced through a ‘two-hit’ model,
where a second integration is required to cause transformation. SFFV has been shown
to cause this through insertional transactivation of Spi-1, with a proviral integration
being found here in around 95% of tumours studied (Moreau-Gachelin, Tavitian &
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Tambourin, 1988). Additionally, subsequent mutation or disruption of the p53 tumour
suppressor gene can contribute to tumour growth (Mowat, Cheng, Kimura, Bernstein
& Benchimol, 1985).
3.1.2 CD4+ cells in Friend virus infection
Early work with FV centred around viral immunology and, as early as 1959, Friend had
demonstrated effective immunisation against viral challenge through use of a formalised
viral preparation (Friend, 1959). Much further work has concentrated on determining
the exact roles of the adaptive immune system in the control of infection. Even in mice
that mount an effective immune response, however, FV is never completely cleared, and
a low-level of chronic infection is established for the life of the host (Chesebro, Bloom,
Wehrly & Nishio, 1979). Thus, FV mirrors HIV infection and, as such, presents a
valuable mouse model for its study.
CD4+ T cells act to control both CD8+ T cell and B cell responses, but have also been
shown to have direct anti-viral effects (Hasenkrug, Brooks & Dittmer, 1998; Iwashiro,
K. Peterson, Messer, Stromnes & Hasenkrug, 2001; Pike et al., 2009; Nair et al., 2010).
Their importance is borne-out by the relevance of MHC alleles in determining the
outcome of infection – resistance in adult mice is strongly associated with the domin-
ant H2-Ab allele (Miyazawa, Nishio & Chesebro, 1988; Hasenkrug & Chesebro, 1997).
Mice carrying H2-Ab, such as the B6 strain, mount strong CD4+ T cell responses,
class switch FV-specific antibodies and respond strongly to vaccination regimens. In
comparison, mice carrying H2-Ak/k, a low recovery allele, lack a strong CD4+ T cell re-
sponse and fail to class switch FV-specific antibodies, resulting in lack of responsiveness
to vaccination and poor control of infection (Hasenkrug & Chesebro, 1997).
The immunodominant H2-Ab-restricted F-MLV antigen has been determined as the
env122-141 region (DEPLTSLTPRCNTAWNRLKL, Fig. 3.2) (Iwashiro, Kondo et al.,
1993; Shimizu et al., 1994) and previous work has resulted in the generation of a
transgenic mouse carrying a TCRβ chain from a CD4+ T cell clone generated against
this peptide (Antunes et al., 2008). B6 EF4.1 mice have a fixed TCRβ chain that
pairs with endogenous TCRα chains to form a polyclonal CD4+ T cell repertoire
with elevated numbers of env122-141-specific CD4
+ T cells (∼4% of total). Individual
CD4+ T cells carrying the endogenous Vα2 chain were identified as having above
average specificity and affinity for their cognate antigen (Antunes et al., 2008) and
expand to be the dominant subset at the peak of FV infection (Ploquin, Eksmond &
Kassiotis, 2011). Even in the absence of CD8+ T and B cells, adoptive transfer of
purified B6 EF4.1 CD4+ T cells alone has been shown to have a significant protective
effect in vivo, reinforcing the vital importance of CD4+ T cell-mediated protection in
the FV model (Pike et al., 2009).
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3.1.3 T cell development and the prevention of autoimmunity
Prior to release into the periphery, developing T cells undergo both positive and neg-
ative selection. Somatic recombination of variable, diverse, and joining gene regions
(V(D)J recombination) creates separate α and β chains that pair to form the heterodi-
meric TCR (see 1.2.2). This process results in a wide array of α and β chains, the
majority of which are unable to bind peptide-MHC complexes when paired, or even
produce a functional TCR. Development of thymocytes progresses through a number
of discernible stages designed to remove these cells and to prevent the development of
potentially auto-reactive clones (Fig. 3.1).
Figure 3.1: Thymocyte development
A schematic of T cell development in the thymus, showing αβ or γδ lineage choice
and division of the αβ lineage to CD4+ and CD8+ T cells.
Within the αβ lineage, ‘double positive’ (CD3+CD4+CD8+) thymocytes are com-
mitted to programmed cell death unless sufficient signalling through TCR binding is
achieved, along with successful binding of either a CD4 or CD8 co-receptor. 13-17-mers
and 8-9-mers of self-peptide are presented on MHC class II and MHC class I, respect-
ively (Rudensky, Preston-Hurlburt, Hong, Barlow & Janeway, 1991) (Fig. 1.5). This
process of positive selection ensures only TCR heterodimers capable of recognising pep-
tides bound to the host’s MHC alleles will continue development. Surviving thymocytes
cease expressing one of either the CD4 or CD8 co-receptors, becoming ‘single positive’.
Whilst there is also control of the peripheral T cell response through CD4+ regulatory
T cells (Treg cells – Fig. 1.6) (Zheng & Rudensky, 2007; Wing & Sakaguchi, 2010), re-
moval of self-reactive thymocytes is highly important. Thus, thymocytes having strong
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reactivity to presented self-peptides are prompted to apoptose prior to the release of
mature na¨ıve T cells and antigen specific responses are encouraged (Huseby, Crawford,
White, Kappler & Marrack, 2003).
Both positive and negative selection of thymocytes rely on their exposure to self pep-
tides, therefore. Many proteins have highly tissue- or temporally-specific expression
patterns, however, and comparatively few are truly ubiquitous. To prevent potential
autoimmune responses to these proteins, the AIRE (autoimmune regulator) protein
functions as a powerful transcriptional transactivator to promote the expression of
200–1,200 tissue-specific genes, protein formation and epitope presentation to develop-
ing thymocytes (Anderson et al., 2002; Derbinski et al., 2005; Taniguchi & Anderson,
2010). This allows the negative selection of highly reactive TCRs, with mutations
impacting AIRE functionality causing diseases associated with autoimmune pathology
(Conteduca et al., 2010).
3.1.4 Endogenous retroviruses in T cell selection
Strong CD4+ and CD8+ T cell responses are known to be directed against retroviral
antigens in a variety of instances, including in the CT26 colorectal carcinoma and the
B16 melanoma (White, Roeder & Green, 1994; Coppola, Lam, Strawbridge & Green,
1995; A. Y. C. Huang et al., 1996; Rosato et al., 2003) and immunisation against
specific viral epitopes has been shown to encourage tumour rejection in certain cases
(Kershaw et al., 2001; Specht et al., 1997; Slansky et al., 2000).
When considered with regard to the immune system, ERVs can be seen in two lights:
firstly as virally derived sequences (in some cases retaining replication competency and
infectious potential) and secondly as ‘self’. In the latter case, with around six times
the number of proviruses than cellular genes in the mouse genome (see 1.1.3), if even a
small number maintain partial open reading frames (ORFs), a large number of peptides
may potentially be produced that could be presented to developing thymocytes.
Thus, ERVs have the potential to strongly impact T cell development through either
positive or negative selection of thymocytes and the imposition of biases in TCRα or
β chain usage. Bias in TCR V region selections are seen frequently in immunity and
variations can often be seen to correlate with differences in protective capacity (Turner,
Doherty, McCluskey & Rossjohn, 2006; Bridgeman, Sewell, Miles, Price & Cole, 2011).
3.1.5 Emv2
A screen of the B6 proteome for peptides sharing homology with the F-MLV env122-141
region reveals the single endogenous eMLV Emv2. This provirus shares 80% homology
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with F-MLV at the nucleotide level and is highly similar to F-MLV within the critical
env122-141 region (Fig. 3.2).
Figure 3.2: Sequence and contact residues of the
immunodominant H2-Ab-restricted F-MLV epitope
Amino acid sequence of the immunodominant H2-Ab-restricted F-MLV epitope,
top, showing the central env123-140 region. Marked are H2-A
b contact residues
(blue) and contact points for the donor TCRβ chain from the SB14-31 hybridoma
(red). The corresponding epitope from Emv2 is shown underneath, with the single
amino acid substitution in bold and the amino acid position indicated.
Emv2 is a complete eMLV provirus located on chromosome 8 of B6, B6-derived and
closely related strains (Jenkins et al., 1982; McCubrey & Risser, 1982; Kozak & W. P.
Rowe, 1982). Whilst not annotated in the reference genome assembly, the position
of Emv2 can be determined by BLASTn search with probes for the ecotropic env
(Young, Kassiotis & Stoye, 2012). Although retaining all open reading frames, Emv2
is inactivated by a single point mutation impacting the viral reverse transcriptase (G-
3576-C within pol) (M. Li, Huang, Zhu & Gorelik, 1999). Further, Emv2 encodes an
N-tropic capsid protein that would be restricted by the action of Fv1b in B6 mice.
3.1.6 Aims
Previous work has shown that the high-avidity of Vα2 CD4+ T cells in the B6 EF4.1
system (seen both at a polyclonal (Antunes et al., 2008) and clonal level (Young,
Ploquin et al., 2012)) is due to interactions within the core epitope region, rather than
stabilising or alternate interactions with flanking sequences, as suggested for some other
TCR-peptide-MHC interactions (Carson, Vignali, Woodland & Vignali, 1997). As such,
reactivity is retained to variously N-truncated epitopes (Young, Ploquin et al., 2012).
The mechanism causing the observed expansion and dominance of Vα2 CD4+ T cells
upon FV infection is unknown, however. This bias may be introduced through a pro-
liferative advantage or a system of favoured survival, but may also result from thymic
selection. The potential role of ERVs in determining responsiveness to retroviral in-
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fection is a largely unstudied area, yet due to their similarity, these elements have a
large potential to impact the course of thymocyte development when expressed as self
antigen. In support of this theory, peripheral B6 EF4.1 CD4+ T cells have a na¨ıve
phenotype (Antunes et al., 2008), suggesting a potential role for ERV-mediated thymic
deletion of cells bearing otherwise auto-reactive TCR heterodimers.
This project thus aimed to outline the contribution of the endogenous eMLV Emv2,
if any, to FV immunity using the B6 mouse model and the pre-established B6 EF4.1
transgenic system. Ultimately, this was to investigate the mechanism of TCRα chain
selection and usage, and to determine the origin of the high-avidity CD4+ T cell
response seen in B6 mice.
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3.2 Results
3.2.1 Characterisation of Emv2 expression and generation of Emv2
null congenics
Prevention of peripheral auto-reactivity through thymic selection necessitates the ex-
pression of tissue-specific self peptides in epithelial cells of the thymic medulla (mTECs).
qRT-PCR can be used to assess the expression of defined transcripts, but has the po-
tential to overlook instances of transient expression that may occur either naturally or
through changes in expression mediated by infection or environmental factors. Thus,
the observed absence of a particular transcript does not exclude the possible involve-
ment of the gene in thymic selection events.
Emv2, being the only eMLV of B6 mice, is well placed for study with congenic systems,
and B6 background Emv2-/- congenic mice were generated by crossing to the A strain
(see Section 2.1.1). These mice were also subsequently crossed to the B6 EF4.1 line to
generate Emv2-/- EF4.1.
Thymic expression of Emv2 was determined by qRT-PCR using primers designed to
distinguish between mRNA and contaminating genomic DNA (see Section 2.2) and
using Emv2-/- mice to assess background amplification levels (Fig. 3.3). Expression
was low, where detected, and was seen at a similar frequency in secondary lymphoid
tissue from B6 mice, as well as in the liver and lung (data not shown). No expression
was seen in the same tissues from Emv2-/- mice (Fig. 3.3). This was indicative of low
level uniform expression in B6 mice, including expression in the thymus.
Figure 3.3: Emv2 expression in B6 and Emv2-/- mice
Comparison of Emv2 expression in the thymi (Th) and spleens (Sp) of B6 and
Emv2-/- mice (p<0.001 for both comparisons). Each symbol represents an indi-
vidual mouse. Dashed line indicates detection limit.
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3.2.2 Deletion of env122-141L-specific CD4
+ T cells by Emv2
Even where mRNA is transcribed, however, a range of controls surround protein pro-
duction and many of these may specifically target mRNAs resulting from RE and ERV
transcription. Hence separate work by colleagues investigated the potential role for
Emv2 in thymic selection of env122-141-specific CD4
+ T cells by assessment of react-
ivity to the core env124-138L or Y epitopes (Fig. 3.2). Polyclonal populations of B6
EF4.1 CD4+ T cells (Fig. 3.4a) and individual hybridoma cell lines derived from these
cells (Fig. 3.4b) were activated when treated with env124-138Y, although to a lesser
extent than when presented with their cognate antigen, env124-138L. Assessment of
individual hybridoma clones indicated that whilst the difference in activation poten-
tial was around 5-fold (Fig. 3.4b), individual TCR heterodimers could respond to both
peptide epitopes.
Figure 3.4: Clonal and polyclonal responses to env124-138
(a) (b)
In vitro determination of responsiveness to env124-138L or Y. (a) FACS analysis
of CFSE dilution in primary B6 EF4.1 CD4+ T cells incubated for three days in
the presence of absence of 10-5 M peptide. Numbering denotes percentages of cells
determined as CFSE- and are averages of 4 mice per condition. (b) Fluorescence
quantitation of AlamarBlue, representing the IL-2 production of 3 hybridoma lines
generated in response to stimulation with 5x10-6 M env124-138L peptide. p<0.001
between env124-138L and Y stimulation, and p=0.002 between env124-138Y and
unstimulated control.
The retention of reactivity to both env124-138L and Y, despite the observed thymic
expression of Emv2, suggested that any Emv2 -mediated deletion was not causing com-
plete tolerance to either epitope, and that any impacts were likely to be more complex.
Initial assessment of the polyclonal response to env124-138L between B6 EF4.1 and
Emv2-/- EF4.1 mice revealed around 35% of potentially env124-138L-reactive CD4
+
T cells were deleted in the presence of Emv2 (Fig. 3.5).
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Figure 3.5: Emv2 -mediated deletion of
env124-138L-reactive CD4
+ T cells
Frequency of env124-138L-specific (determined as CD69
+) primary CD4+ T cells
in B6 EF4.1 and Emv2-/- EF4.1 mice. Plotted are means ±SEM of 9 mice per
group from 3 experiments. p=0.003 between groups.
Thus, despite differences in affinity to env124-138Y, and its limited expression, Emv2
was causing the deletion of a significant proportion of developing transgenic CD4+ T
cells in the B6 EF4.1 strain.
3.2.3 Antiviral activity is retained despite Emv2 -mediated selection
Given the large difference in the proportions of CD4+ T cells responding to env124-138L
stimulation between B6 EF4.1 and Emv2-/- EF4.1 mice (Fig. 3.5), a variation in the
potential response to F-MLV in a FV infection might also be expected.
To firstly investigate the size of this impact outside of the EF4.1 transgenic system, B6
and Emv2-/- mice were infected. Whilst both strains effectively controlled infection to
similar levels by day 14 post-inoculation, Emv2 -deficient mice displayed significantly
lower numbers of infected erythroid precursor cells (Ter119+glyco-gag+) in the spleen
at the peak of infection (Fig. 3.6).
This reinforced the importance of Emv2 in thymic selection, but also highlighted the
immunological relevance in a non-transgenic setting. Whilst CD4+ T cells are known
to have direct effector functions in FV infection, the difference in FV control could
potentially also have been explained through impingement of ‘helper’ functionality. To
investigate these links, separate work characterised the CD8+ T cell responses at the
peak of infection and assessed binding antibody titres. Levels of CD8+ T cell activation
were not found to significantly differ at day 7 post infection (Fig. 3.7a) and titres of
IgG (Fig. 3.7b) and IgM (Fig. 3.7a) were equally low at this early time point.
Potential FV-neutralising and binding antibody titre differences were further investig-
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Figure 3.6: Control of FV in Emv2 -sufficient and -deficient
mice
Mean percentage ±SEM of FV-infected erythroid precursors (glyco-
Gag+Ter119+) in whole spleens of B6 and Emv2-/- mice at specified time
points after FV inoculation. Points represent 8–19 mice per group. p=0.04 for
day 7 comparison. Dashed line indicates detection limit.
ated through transfer of B6 EF4.1 or Emv2-/- EF4.1 cells to Tcra-/- mice and sub-
sequent FV infection. In this setting, any differences in antibody production must
result from functionality of the donor T cells. Although there was a slight increase
in FV-neutralising antibody titre at day 7 post infection in hosts receiving Emv2-/-
EF4.1 cells (Fig. 3.7d), this difference was not significant. Both sets of donor cells also
similarly induced binding IgG and IgM responses (Figs. 3.7e and 3.7f).
In the absence of apparent differences in CD4+ T cell ‘helper’ functionality, it was
likely that the contrast observed in FV susceptibility between B6 and Emv2-/- mice
was due to controls mediated directly by CD4+ effector T cells. To investigate their
functionality directly, EF4.1 CD4+ T cells were isolated from either Emv2 -sufficient
or -deficient mice and transferred into the same type of host prior to FV infection.
Their relative antiviral capacity was subsequently determined by measuring levels of
Ter119+glyco-gag+ cells at day 7.
Both types of donor CD4+ T cells gave almost complete protection from FV infection
at the peak of infection and no significant differences were observed (Fig. 3.8a). Wild-
type B6 mice are relatively resistant to FV infection, however, and whilst unable to
completely clear virus, naturally control the infection within 21 days. It was possible,
therefore, that potential differences in the protective capacity of cells from either donor
strain were being overlooked, and the experiment was repeated with Fv2s congenic mice,
which are highly susceptible to infection. In this setting, the protective effects of cells
from either donor were greatly reduced, but, importantly, remained equal (Fig. 3.8b).
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Figure 3.7: Differences in FV infection are not explained by
loss of ‘helper’ functionality
(a) (b) (c)
(d) (e) (f)
B6 and Emv2-/- mice were infected with FV and (a) percentage of CD44hiCD43+
cells in total CD8+ T cells, and F-MLV-infected cell-binding (b) IgG and (c) IgM
antibody titres were determined at day 7 post infection. Each symbol represents
an individual mouse. Separately, Tcra-/- recipients given purified CD4+ T cells,
as indicated and inoculated with FV. (d) Titres of FV-neutralising antibodies were
determined at the specified points after infection. F-MLV-infected cell-binding (e)
IgG and (f) IgM antibodies were determined at day 7 post infection. Plotted are
means ±SEM of 11–12 mice per group. Dashed lines indicate detection limits.
Both B6 and Fv2s mice still retain functional immune systems prior to the introduc-
tion of the donor transgenic cells, however. It therefore remained possible that slight
differences in the antiviral effects of the donor cells were being masked or equalised.
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Figure 3.8: Equal effector activity in Emv2 -selected and
-non-selected CD4+ T cells
(a) (b)
(c) (d)
Mice received purified CD4+ T cells, as indicated, and were inoculated with FV for
study at day 7 post infection. FACS detection of FV-infected erythroid precursors
(glyco-Gag+Ter119+) in whole spleens of (a) B6 (p<0.001 for comparisons of mice
receiving cells to the no transfer control) and (b) Fv2s mice (p=0.08 and p=0.003
between no cells and B6 EF4.1 and Emv2-/- cells, respectively). (c) Measurement
of spleen index (spleen weight to body weight ratio) (p=0.001 and p=0.004 between
no cells and B6 EF4.1 and Emv2-/- cells, respectively) and (d) anaemia (p<0.001
for comparisons of mice receiving cells to the no transfer control) in Rag1-/-Fv2s
mice. Each symbol represents an individual mouse. Dotted lines indicate detection
limits.
To this end, Rag-/-Fv2s mice, lacking both T and B cells and carrying the Fv2 sus-
ceptibility allele, were used as hosts. The protective capacity of cells in this setting can
be established by assessment of the splenomegaly that develops as a result of infection
and the anaemia caused by bone marrow pathology. In both of these measures, both
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types of donor cells were again comparable (Figs. 3.8c and 3.8d).
Whilst Emv2 may mediate a large deletion of env122-141L-specific CD4
+ T cells,
therefore, the ‘helper’ and effector capacity of both Emv2 -selected and -non-selected
appeared equal.
3.2.4 Emv2 -mediated selection increases the avidity of the CD4+ T
cell response
As Emv2 expression did not compromise CD4+ T cell-mediated control of FV infection
despite causing the deletion of around 35% of potentially env124-138L-responsive cells,
it was likely that these cells were not significantly contributing to the immune response
in FV infection. To determine why this would be the case, the nature of this population
was investigated.
The necessitated cell transfer experiments required the precise distinction of donor and
host cells, thus EF4.1 cells selected either in the presence or absence of Emv2 were trans-
ferred into CD45.1/.2 syngeneic recipient mice. Donor cells, identifiable as CD45.2+,
could thus be precisely distinguished from host cells, identified as CD45.1+CD45.2+,
by flow cytometry. Significantly higher numbers of donor cells from Emv2-/- EF4.1
mice were seen to respond to FV in vivo (Fig. 3.9a), consistent with previous differ-
ences identified in vitro (Fig. 3.5).
Determination of Vα usage within responding populations indicated comparable num-
bers of cells from either donor using the endogenous Vα2 (Fig. 3.9a). The significantly
higher expansion of donor cells from Emv2-/- EF4.1 mice was, therefore, accounted
for by an increase in numbers of low-avidity non-Vα2 CD4+ T cells (Fig. 3.9a). The
size of this cell population in fact caused a switch from a predominantly high-avidity
(Vα2+) response in B6 EF4.1 CD4+ T cells to a predominantly low-avidity (non-Vα2)
response in equivalent cells from Emv2-/- EF4.1 donors (Fig. 3.9b).
3.2.5 Presentation of env122-141Y causes the removal of non-Vα2
CD4+ T cells
Differences in development of non-Vα2 CD4+ T cells could be realised by two paths
– firstly, control of the proportions of Vα2+ and non-Vα2 CD4+ T cells within the
na¨ıve population or, secondly, control of their relative avidity to the core epitope of
env122-141L, and hence influence over their proliferative capacity.
To investigate this further, EF4.1 CD4+ T cells selected in Emv2 -sufficient of -deficient
mice were stimulated with titrations or env124-138L peptide. No significant effect on
the overall avidity at which Emv2 -selected cells responded to the peptide was observed
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Figure 3.9: Emv2 -mediated selection removes non-Vα2
CD4+ T cells
(a) (b)
Purified CD4+ T cells from the mice indicated (CD45.2+) were adoptively trans-
ferred into CD45.1/.2 syngeneic recipients. Mice were simultaneously inoculated
with FV and expansion of donor cells was determined at day 7 post infection.
(a) Absolute numbers of total responding (determined as CD69+), Vα2+ and
non-Vα2 donor cells (p=0.009 between total and p<0.001 between non-Vα2 cells).
(b) relative frequency of Vα2+ cells within donor populations (p<0.001 between
donors). Each symbol represents an individual mouse.
(Fig. 3.10a). As seen in vivo (Fig. 3.9a), the numbers of Vα2+ cells responding within
this population was comparable between both types of donor cells (Fig. 3.10b), and,
accordingly, avidity for peptide was unchanged (Fig. 3.10c). In comparison, signific-
antly larger proportions of non-Vα2 cells from Emv2-/- mice responded to stimulation
(Fig. 3.10b). Correspondingly, the avidity of responding CD4+ T cells was 3-fold
higher when selected in Emv2 -deficient mice, although remained substantially lower
than Vα2+ cells from either donor (Fig. 3.10c).
Taken together, the increase in total frequency and partial increase in env124-138L
avidity of non-Vα2 cells in Emv2-/- EF4.1 mice likely account for the preferential
expansion of this population upon FV infection (Fig. 3.9b). The predominance of the
non-Vα2 cell population was separately confirmed at a range of peptide concentrations
for both peripheral CD4+ T cells (Fig. 3.11a) and CD4+CD8- thymocytes (Fig. 3.11b).
Thus, Emv2 mediated a significant thymic selection event that significantly altered
clonal composition of env124-138L-reactive CD4
+ T cells.
The preferential deletion of non-Vα2 CD4+ T cells would necessitate that these cells
are capable of reacting to env124-138Y. Percentage of env124-138Y-responsive Vα2
+
CD4+ T cells were similar whether Emv2 -selected or -non-selected (Fig. 3.12a) and has
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Figure 3.10: Avidity for env124-138L is unchanged by
Emv2 -mediated selection
(a) (b)
(c)
(a) Response of indicated CD4+ T cells to a titration of env124-138L peptide.
(b) frequency of responding (determined as CD69+) and (c) functional avidity of
Vα2+ (left) and non-Vα2 CD4+ (right) T cells across this titration. p=0.002
between non-Vα2 cells at the highest concentration in (b). Numbers in (c) repres-
ent the ED50. Data are means ±SEM of 9–12 mice per group from 3 experiments.
similarly low avidity for the peptide (Fig. 3.12b), only responding at the highest con-
centration of peptide. In comparison, non-Vα2 cells from Emv2-/- EF4.1 mice showed
an over 70-fold increase in avidity for env124-138Y (Fig. 3.12b) and a corresponding
3.5-fold increase in the percentage of responding cells (Fig. 3.12a).
Thus, selection by Emv2 did not impact Vα2+ CD4+ T cells due to their low avidity
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Figure 3.11: Deletion of non-Vα2 env124-138L-reactive
cells is a thymic event
(a) (b)
Frequency of Vα2+ CD4+ (CD8-) T cells from the (a) spleens and (b) thymi of the
indicated mice responding (determined as CD69+) to a titration of env124-138L
peptide. Data in (a) are means ±SEM of 9–12 mice per group from 3 experiments.
Data in (b) are the means ±SEM of 8–10 mice per group, p=0.002 for 10-6 M
comparison.
for env124-138Y. However, non-Vα2 cells display a greatly increased cross-reactivity,
including to env124-138Y, and are hence deleted as thymocytes in Emv2 -sufficient mice.
3.2.6 Emv2 shapes the depth of the env124-138L-responsive CD4
+
T cell repertoire
Whilst selection by Emv2 might not impact the high-avidity (Vα2+) response to FV
infection in vivo or strongly affect the avidity of these cells to env124-138L peptide, a
significant difference in the development of non-Vα2 cells was noted. These CD4+ T
cells were significantly less responsive to env124-138Y peptide stimulation, a reduction
in repertoire depth that may potentially impact control of viral escape mutants. The
magnitude of the change in overall repertoire depth was, therefore, investigated.
Reactivity to a further mutation of the core epitope, env124-138YS, was firstly assessed.
The LT-128,129-YS mutant represents a functional sequence derived from the co-opted
retroviral env at the Fv4 locus found in some strains, but importantly, has different
amino acids at two of the three points identified as contacting the TCR (see Fig. 3.2).
Whilst very few Vα2+ or non-Vα2 CD4+ T cells responded to env124-138YS stimu-
lation, development in the absence of selection by Emv2 produced a 7-fold increase in
3. T CELL DEVELOPMENT 81
Figure 3.12: Avidity for env124-138Y in Emv2 -selected and
-non-selected EF4.1 CD4+ T cells
(a)
(b)
Response of indicated CD4+ T cells to a titration of env124-138Y peptide. (a) fre-
quency of responding (determined as CD69+) and (b) functional avidity of Vα2+
(left) and non-Vα2 CD4+ (right) T cells across this titration. p=0.001 between
non-Vα2 cells at the highest concentration in (a). Numbers in (b) represent the
ED50. Data are means ±SEM of 9–12 mice per group from 3 experiments.
the magnitude of the low-avidity response (Fig. 3.13a).
Previous work had suggested that B6 EF4.1-derived Vα2+ CD4+ T cell hybridomas
had the ability to respond to env124-138Y, but that this response was impaired in
comparison to when stimulated with the cognate antigen (Fig. 3.4b). To extend this
finding to env124-138YS responsiveness and to include Emv2 -selected TCRs, Emv2
-/-
EF4.1-derived hybridomas were generated and stimulated with a variety of peptides.
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Figure 3.13: Selection by Emv2 reduces the depth of the
TCR repertoire
(a)
(b) (c)
(a) Frequency of env124-138YS-reactive CD4
+ T cells (determined as CD69+)
isolated from the indicated mice. Cells were stimulated with 10-5 M peptide.
Data are means ±SEM of 9 mice per group from 3 experiments. p<0.001 for non-
Vα2 comparison. (b) and (c) show responsiveness (determined by IL-2 produc-
tion) of hybridomas derived from B6 EF4.1 and Emv2-/- EF4.1 mice, respectively.
Hybridomas were stimulated with 5x10-1 M env124-138L, Y, or YS peptide, or
incubated in the absence of peptide (–).
Hybridomas were generated via stimulation with env124-138L, thus of all Vα2
+ hy-
bridomas, none were seen to respond to env124-138Y or env124-138YS more strongly
than to their cognate antigen (Figs. 3.13b and 3.13c). Equally, the responsiveness of
non-Vα2 hybridomas to mutant peptides was not significantly greater than that of
Vα2+ hybridomas derived from the same strain (Figs. 3.13b and 3.13c). Thus, whilst
hybridomas generated against env124-138L had some limited reactivity to mutant pep-
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tides, the majority of non-Vα2 cells developing in the absence of Emv2 -mediated se-
lection were likely to be distinct from those displaying env124-138L-reactivity. This
also indicated that selection by Emv2 did not reduce the apparent cross-reactivity
of TCRs, and that non-Vα2 hybridomas did not have inherent increases in peptide
cross-reactivity.
Interestingly, separate work by colleagues cloning and sequencing expressed endogenous
Vα genes suggested all non-Vα2 hybridomas from both B6 EF4.1 and Emv2-/- EF4.1
mice were members of the Trav9 family, encoding Vα3, although only a subset could
be stained with the anti-Vα3.2 antibody RR3-16 (Table 3.1).
Table 3.1: Vα3 usage in EF4.1 hybridomas
Clone
Vα3.2
staining
TRAV TRAJ AA junction
H13 + 9D-4*04 31*01 CAVEGGNNRIFF
H14 – 9N-4*01 17*01 CALSNSAGNKLTF
H18 + 9N-2*01 31*01 CVLSRNSNNRIFF
L23 – 9N-4*01 27*01 CALDNTNTGKLTF
E2H8 – 9N-4*01 17*01 CALSNSAGNKLTF
E2H10 – 9N-4*01 21*01 CALSGPNYNVLYF
E2L8 – 9N-2*01 16*01 CVLSGSSSGQKLVF
E2L18 + 9N-3*01 58*01 CAVRQGTGSKLSF
To further investigate the ability of specific TCRs to tolerate mutations at each of the
three residues identified as contacting the env122-141L peptide, individual hybridomas
were screened with peptides mutated at each of these positions through the range of
all natural amino acids (Figs. 3.14 and 3.15). Amino acids that elicited at least 40% of
the maximal determined response for each hybridoma individually were listed in order
of the magnitude of the induced response (Fig. 3.16).
All Vα2+ hybridomas, whether Emv2 -selected or -non-selected, displayed strong pref-
erence for the amino acids representing the un-mutated env124-138L peptide, respond-
ing most strongly to leucine at position 128, threonine at position 129, and asparagine
at position 133 (Figs. 3.16a to 3.16c). Similar hydrophobic amino acids were accepted
at position 128 for all Vα2+ hybridomas, followed by the smaller hydrophobic amino
acid valine, although none reacted significantly to tyrosine at this position. Whilst
some similar amino acids could be recognised at position 128, Vα2+ hybridomas were
less able to respond to mutations at positions 129 and 133 (Figs. 3.16a to 3.16c).
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Non-Vα2 hybridomas stimulated with the same range of peptides displayed significantly
different amino acid preference to Vα2+ hybridomas at position 128, with only one of
eight preferring leucine (Fig. 3.16a). Notably, all non-Vα2 hybridomas responding to
leucine (E2L8, H13, and L23) also prefered threonine at position 129 and asparagine at
position 133 (Figs. 3.16a to 3.16c), representing the index sequence. Where clones did
not respond to leucine at this position, reactivity could be enhanced through further
changes at position 133 (Fig. 3.16c).
Interestingly, valine and the closely related isoleucine were highly preferred by the
majority of both Emv2 -selected and -non-selected non-Vα2 hybridomas at position
128 (Fig. 3.16a), but two Emv2 -selected TCRs showed highly heterogenous reactivity,
responding to polar, non-polar, hydrophobic, and hydrophilic amino acids of a variety
of sizes.
Together, these results confirmed the preference of Vα2+ TCRs for leucine at position
128 and suggested that these were unaffected by Emv2 -mediated thymic selection, with
no changes in cross-reactivity or repertoire depth being seen. Non-Vα2 hybridomas
displayed noticeably different amino acid preferences at this position, and selection by
Emv2 appeared to increase reactivity, suggesting a potential switch in TCR contact
point, likely to position 127.
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Figure 3.14: TCR cross-reactivity in Emv2 -selected and
-non-selected Vα2+ hybridomas
B6 EF4.1- (left) and Emv2-/- EF4.1-derived (right) hybridoma lines stimulated
with a library of 5x10-6 M peptides in which the three positions contacting the
TCR are individually replaced with all possible natural amino acids. Responses
are measured through IL-2 production. Data are the means of triplicate cultures.
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Figure 3.15: TCR cross-reactivity in Emv2 -selected and
-non-selected non-Vα2 hybridomas
B6 EF4.1- (left) and Emv2-/- EF4.1-derived (right) hybridoma lines stimulated
with a library of 5x10-6 M peptides in which the three positions contacting the
TCR are individually replaced with all possible natural amino acids. Responses
are measured through IL-2 production. Data are the means of triplicate cultures.
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Figure 3.16: Order of amino acid preference at defined
TCR contact residues
(a)
(b)
(c)
B6 EF4.1- and Emv2-/- EF4.1-derived hybridoma lines stimulated with a library
of peptides (5x10-6 M) in which the three positions contacting the TCR are indi-
vidually replaced with all possible natural amino acids. Responses are measured
through IL-2 production. Data are amino acids substitutions at each position that
elicited >40% of the maximal response, listed in decreasing order of IL-2 produc-
tion.
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3.3 Discussion
The processes of somatic recombination that generate variable lymphocyte antigen
receptors can produce massive diversity (see Section 1.2.2), a functionality that is vital
to the effective recognition and control of a diverse array of pathogens. However the
nature of these events is inherently random and as such receptors must be screened for
functionality and auto-reactivity prior to release of developing cells into the periphery.
Positive and negative selection of thymocytes relies on the large-scale presentation of
self-peptides in order to ensure sufficient compatibility with self MHC molecules, whilst
preventing excessive reactivity (see Section 3.1.3). The process of negative selection is
thought to decrease the frequency, avidity, and cross-reactivity of TCRs recognising
peptide epitopes sharing homology with self peptides and to encourage antigen specific
responses.
Despite contributing far larger proportions of mammalian genomes than generally ap-
preciated, the impact of REs and ERVs on the development of the immune response
has not been thoroughly investigated. Previous work in the literature has suggested
the involvement of self peptide epitopes derived from endogenous MLVs in the positive
selection and enhancement of peripheral survival of CD4+ T cells with specificity for
an unrelated moth cytochrome C peptide restricted by H2-Ek (Ebert, Jiang, Xie, Li &
Davis, 2009). Thus whilst epitopes derived from ERVs have been shown to be presen-
ted in complex with MHC, their potential impact on immunity to exogenous retroviral
infection has been largely unstudied.
The sole eMLV of B6 mice, Emv2, shares strong homology with the immunodominant
H2-Ab-restricted epitope of F-MLV, the helper component of FV. FV represents a well-
characterised murine retroviral infection model and much previous work has resulted
in the generation of the B6 EF4.1 transgenic mouse, carrying a fixed TCRβ chain
derived from a F-MLV antigen, env121-144L. Together, these components allowed an
unparalleled opportunity to determine the contribution of an ERV to the immune
response to retroviral infection, and investigation of the underlying controls surrounding
the high-avidity response to F-MLV seen in the commonly used B6 strain.
This work has outlined the role of Emv2 in deletion of around 35% of env124-138L-
reactive CD4+ T cells from the potential responding polyclonal population seen in
Emv2-/- EF4.1 mice. Further, selection by Emv2 removed CD4+ T cells carrying TCRs
capable of responding to a variety of env mutants and natural variants, theoretically
impairing the ability of responding cells to detect escape mutants.
Interestingly, however, negative selection in this way promoted the formation of a high-
avidity response to F-MLV in Emv2 sufficient mice, skewing the clonal composition in
favour of Vα2 CD4+ T cells by the preferential deletion of low-avidity clones. Whilst
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negative selection removed a significant fraction of potentially F-MLV-reactive CD4+
T cells, therefore, assessment of effector functionality within the remaining population
suggested that antiviral activity was unaffected. This finding suggested that Vα2+ and
non-Vα2 CD4+ T cells contribute unequally to the immune response to FV infection,
with the majority of control being exerted through the high-avidity response.
Although these data do not show an effect on antibody responses to F-MLV at early
time points, the high similarity of Emv2 to F-MLV also has the potential to impact
these responses. This work has focussed on differences in control of FV at the peak of
viral infection, before the formation of a strong antibody response, and hence does not
exclude the possibility of antibody-mediated effects at later time points.
3.3.1 Derived work
H2-Ab, as noted previously (Section 3.1.2), has been identified as vital to a strong re-
sponse to F-MLV, allowing antibody class switching and effective immunisation (Miyazawa,
Nishio & Chesebro, 1988; Hasenkrug & Chesebro, 1997). However, both the closely-
related B6 and B10 strains used in much early research both carry Emv2, thus com-
plicating conclusions regarding the absolute contribution of H2-Ab alone.
Separate work has since investigated this relationship using a variety of strains and
crosses with 129S8 mice, which whilst carrying H2-Ab, have no endogenous eMLVs
(Jenkins et al., 1982). Similarly to Emv2-/- EF4.1 mice, 129S8 EF4.1 have comparable
frequencies of responding Vα2+ CD4+ T cells to B6 EF4.1, but greater proportions
of responding non-Vα2 cells (Fig. 3.17a). Surprisingly, however, the avidity of Vα2+
CD4+ T cells from 129S8 EF4.1 mice for env124-138L was greatly reduced in com-
parison to equivalent cells from B6 EF4.1 and Emv2-/- EF4.1 mice (Fig. 3.17b), and
caused a predominantly low-avidity response across a range of peptide concentrations
(Fig. 3.17c).
These data implied that a large contribution towards the high-avidity response of B6
came from outside of either H2 or eMLV loci. Further separate study within the group
has identified the role of the endogenous Trav loci in formation of this response. The
F1 generation of a cross of Tcra-/- and 129S8 EF4.1 mice, only able to generate Vα
chains from Trav loci inherited from the 129S8 parent, were notably unable to form
a high-avidity response to env124-138L stimulation (Fig. 3.18a) and the responding
population was dominated by low-avidity (non-Vα2) clones (Fig. 3.18b).
The high-avidity response of B6 background mice consequently relies on three separate
factors. H2-Ab is required for the presentation of env121-141L, but a high-avidity
response cannot be generated without the necessary Trav genes encoded at the Tcra
locus. Separately, the endogenous eMLV Emv2 is responsible for the negative selection
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Figure 3.17: The contribution of H2-Ab to high-avidity
F-MLV responses
(a) (b)
(c)
(a) Frequency of env124-138L-reactive Vα2
+ and non-Vα2 CD4+ T cells from the
strains indicated when incubated with 10-5 M peptide (p=0.016 between non-Vα2
cells). (b) Functional avidity of the indicated Vα2+ (left) and non-Vα2 (right)
CD4+ T cells to stimulation with a titration of peptide, and (c) frequency of
Vα2+ CD4+ T cells across these concentrations of peptide. Responsiveness was
determined by CD69 expression. Numbers in (b) represent ED50. Data are means
±SEM of 4–8 mice from 3 experiments.
of a significant proportion of low-avidity clones, such that the high-avidity response
can dominate the response to F-MLV in B6 background mice.
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Figure 3.18: The contribution of Trav to high-avidity
F-MLV responses
(a) (b)
(a) Functional avidity and (b) frequency of Vα2+ CD4+ T cells responding (de-
termined as CD69+) to stimulation with a titration of env124-138L peptide. Num-
bers in (a) represnet ED50. p<0.001 for comparison of (B6 x 129 EF4.1)F1 to
both other strains for 10-7 M in (b). Data are means ±SEM of 4–8 mice per group
from 3 experiments.
3.3.2 Implications of this work
A single related study has previously investigated the impact of an endogenous eMLV,
Emv1 of BALB/c mice, on the rejection of CT26 tumour cells (McWilliams et al., 2008).
Emv1 could be shown to mediate deletion and impairment of avidity of env-reactive
CD4+ T cells in an expression-dependent manner, a conclusion that would, perhaps,
be expected in the light of a traditional view of negative selection of thymocytes.
In comparison, this work, whilst mirroring the deletion of a large proportion of env-
reactive thymocytes, has also revealed the counter-intuitive requirement of this selection
for the formation of high-avidity responses to F-MLV in B6 background mice. This
conclusion provides an important proof of principle, showing that negative selection
in this manner cannot be expected to impair the immune response in every case, and
highlights the complex and multifactorial nature of thymocyte selection.
The ability to form effective immune responses can be mediated by comparatively few,
or indeed single, self peptide epitopes derived from a potential pool of several thousand
presented to developing thymocytes at any one time. Separate work by colleagues de-
rived from this study has emphasised the involvement of TCR V region allelic variation
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and MHC haplotypes in thymic selection and mimics previously outlined results from
studies of the human response to Epstein-Barr virus (EBV). In this case, polymorphism
in TRBV9 has been linked to a high-avidity response to the EBNA-1 protein when in
combination with a specific MHC class I molecule, HLA-B*3501 (Gras et al., 2010).
Although there is much debate surrounding the involvement of REs and ERVs in hu-
man disease (see Section 1.1.4), the possible interaction of epitopes derived from these
elements with development of immune responses represents a separate and fascinating
research prospect.
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Chapter 4
Immune control of retroelement
expression
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4.1 Introduction
4.1.1 Activating retroelement expression
Mechanisms of ERV activation have been long-studied and various radiological (Lieber-
man & H. S. Kaplan, 1959; W. P. Rowe et al., 1971), chemical (Lowy, Rowe, Teich &
Hartley, 1971) and mitogenic factors (Moroni & Schumann, 1975; Greenberger, Phillips,
Stephenson & Aaronson, 1975) have been characterised that are capable of promoting
endogenous retroviral particle formation from untransformed cells.
Related research focussed on HIV has suggested that viral replication can be both pos-
itively and negatively regulated by a variety of cellular pathways induced by cytokine
signalling (Fauci, 1993). These concepts can also be applied to REs, and ERV expres-
sion has been shown to be induced by factors related to immune activation. Transcripts
initiating from HERV-H integrations have been detected upon T cell activation in vitro,
for example, and are likely induced in an autocrine manner (Kelleher, Wilkinson, Free-
man, Mager & Gelfand, 1996). Further, HERV-W, -K family, and -H RNA products can
be seen on treatment of macrophages with phorbol-12-myristate-13-acetate (PMA) and
lipopolysaccharide (LPS) (Johnston et al., 2001), and tumour necrosis factor (TNF)α
and IL-1α and β have been seen to induce HERV-R expression in cell cultures (Kat-
sumata et al., 1999). Interestingly, several factors, including IL-1β, TNFα, and LPS,
have also been noted to have similar roles in the induction of endogenous MLV tran-
scripts in murine cells (Itoh et al., 1992; Baudino, Yoshinobu, Dunand-Sauthier, Evans
& Izui, 2010).
The dynamic nature of RE and ERV expression is highlighted by comparison of ex-
pression profiles between tissues (Seifarth, Frank et al., 2005; Ahn & H.-S. Kim, 2009).
The most abundantly and globally expressed families were HERV-E, -F, -W, and ERV9
within class I elements, and HML-2, -4, and -6 within class II (HERV-K family) ele-
ments. Broadly, expression potential was seen to correlate with estimated element age,
and includes the majority of elements highlighted above.
4.1.2 Controlling retroelement expression
As discussed previously (see 1.1.4), large-scale epigenetic and transcriptional controls
are placed on the expression of REs within the mammalian genome. Further post-
transcriptional controls may also be active in the management of REs. APOBEC family
members, for example, have been implicated in the control of LINE retrotransposition
(MacDuff et al., 2009; Wissing et al., 2011), although the primary role of these factors
is thought to remain in mutagenesis of sequences prior to their integrase-mediated
insertion (Jern, Stoye & Coffin, 2007; Armitage et al., 2008).
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Whilst many cell-intrinsic controls may be outlined, the potential roles of the innate
and adaptive immune responses on RE expression are largely unexplored. Equally, the
possible impacts of confounding factors, such as infection, are relatively understudied
areas. For example, whilst the impact of heterologous infection on HIV expression
has been well characterised and many viruses are known to stimulate expression in
vitro (Rosenberg & Fauci, 1989), this knowledge has only recently been applied to
ERVs. Encouragingly, many parallels can be noted, and HIV infection itself has been
suggested to increase HERV-K family expression (R. Contreras-Galindo, Lo´pez, Ve´lez
& Yamamura, 2007; R. Contreras-Galindo, M. H. Kaplan, A. C. Contreras-Galindo et
al., 2012). Further, herpes simplex virus (HSV)-1 and influenza A virus (IAV) infection
have been proposed to elevate HERV-W expression (W. J. Lee, Kwun, Kim & Jang,
2003; Nell˚aker, Yao et al., 2006) and interactions have been noted with Epstein-Barr
virus (EBV) infection (H. Gross et al., 2011).
Mammals have long-standing relationships with a large range of microbial species,
with interactions ranging from mutualism to parasitism, and noticeable effects on RE
expression are unlikely to be confined to viral infections. The gastrointestinal tract
plays host to the largest of these interactions, both in terms of total surface area (250-
400 m2 in humans) and in the numbers involved (estimated at 1014 bacterial cells).
Reaching densities of 1011-1012 cells/g of luminal content, the total size of the gut
microbiota is an order of magnitude larger than the total number of cells in the human
body (Guarner & Malagelada, 2003). Thus, the impacts of dysbiosis can be severe, and
the ecology of the gastrointestinal tract is a large area of current research.
TLR4, responsible for sensing bacterial LPS, has previously been seen to affect recom-
bination and selection of MMTVs within mice (Jude et al., 2003). Indeed successful
vertical transmission of MMTVs has subsequently been suggested to depend on the
presence of the microbiota (Kane et al., 2011), and a following study implicated gut
flora in increased poliovirus and reovirus pathogenesis (Kuss et al., 2011).
4.1.3 The microbiome in health and disease – structure and function
Large-scale sequencing efforts have recently facilitated the study of microbial diversity
across multiple individuals and body sites (Arumugam et al., 2011; The Human Micro-
biome Project Consortium, 2012). Systematic sampling of human gastrointestinal mi-
crobial communities would require invasive collection procedures, however, and hence
current understanding of the gut microbiota largely centres around study of colonic
communities. Even with this caveat, these studies have shown significant variation in
the composition between individuals, with three main clusters being revealed by prin-
cipal component analysis, each dominated by a different bacterial genus (Bacteroides,
Prevotella, or Ruminococcus). Each grouping displayed differing metabolic specialisms,
4. RETROELEMENT EXPRESSION 96
but bacterial composition was, for the most part, not seen to be significantly impacted
by age, host nationality (and likely dietary differences), or variables such as body mass
index (Arumugam et al., 2011).
Differences noted in bacterial enzymatic pathways link to the suggested relevance of
the gut microbiome in overall host metabolism and dietary energy retrieval. A major
function of the colonic bacteria is proposed to be in the ‘secondary digestion’ of dietary
carbohydrates, unabsorbed sugars, and alcohols (Guarner & Malagelada, 2003), as
well as in metabolism of the lumen mucus (Arumugam et al., 2011) and absorption
of dietary calcium, magnesium, and iron (Nicholson et al., 2012). Changes in host
metabolic requirements, for example in pregnancy, have accordingly been associated
with corresponding changes in composition of the microbiota (Koren et al., 2012).
Microbial composition has been linked for some time with development of the gastrointest-
inal tract, including epithelial cell differentiation (Gordon, Hooper, McNevin, Wong &
Bry, 1997) and crypt cell production (Alam, Midtvedt & Uribe, 1994). Given the in-
trinsic exposure to microbial products, it is perhaps unsurprising that associations have
also been made to the development of the immune system. Upon exposure to micro-
bial products, intra-epithelial lymphocyte populations expand and promote antibody
production in gut-associated lymphoid tissues (GALT) (Guarner & Malagelada, 2003).
At least 80% of human plasma cells are located in the GALT and produce more IgA
than all other immunoglobulin isotypes combined (Fagarasan, Kawamoto, Kanagawa
& Suzuki, 2010), much of which is secreted into the gut lumen and can be seen coating
bacteria in stool samples (van der Waaij, Limburg, Mesander & van der Waaij, 1996).
IgA secretion is suggested to prevent bacterial translocation through neutralisation (see
Section 1.2.4) (Brenchley et al., 2006) and to clear translocated microbial products
(Reid et al., 1997), to mediate tolerance to intestinal microbial communities (D. A.
Peterson, McNulty, Guruge & Gordon, 2007), and to regulate the expansion of certain
immunogenic species (Suzuki et al., 2004). A variety of other impacts have also been
characterised, including control of immune homeostasis through polarisation of CD4+
T cells to a Th1, Th17, or Treg phenotype (Mazmanian, Liu, Tzianabos & Kasper,
2005; Ivanov et al., 2009; Geuking et al., 2011; Atarashi et al., 2011), and control of
natural killer T cell (NKT) populations (Olszak et al., 2012).
4.1.4 Aims
Initial work reported in this thesis has centred on the impact of the endogenous eMLV
Emv2 on the development of the immune response, a little-studied area of research.
A converse control, whereby the immune system might act to control RE or ERV
expression, is a tempting possibility and is poorly addressed in the literature.
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This section investigates the relevance of the adaptive immune system in the control
of REs and uses the advantages offered by knockout and transgenic mouse systems to
dissect various cellular and humoral requirements.
The gut microbiota represents a large area of current study, but the field is in relative
infancy and its potential significance in mouse experimentation (and its application
to humans) is likely yet to be fully appreciated. Thus the possibility that the gut
microbiota, similarly to MMTV pathogenesis, influences the expression of REs and
ERVs is a tantalising prospect. This link was be investigated alongside the relevance
of the adaptive immune system.
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4.2 Results
4.2.1 eMLV transcripts are increased in immunodeficiency
Mice deficient for recombination activating gene 1 (Rag1 ) are unable to perform the
somatic V(D)J recombination events necessary for the development of variable antigen
receptors on both B and T cells. In the absence of either the TCR or BCR, appropri-
ately, cells are unable to mature and development is blocked at an early stage. Whilst
these mice lack an adaptive immune response, the innate immune system is not known
to be compromised, and these mice thus represent a useful tool to investigate the impact
of the adaptive immune system at a high level.
Transcriptional profiling of FACS-sorted peritoneal macrophages, an invariant cell type
between wild-type B6 and Rag1-/- mice, was performed with Affymetrix Mouse Gene
1.0 ST microarrays. Surprisingly, the two transcripts with the highest fold-increase in
macrophages derived from Rag1-/- mice were found to correspond to eMLV env and gag
transcripts (transcription clusters 10,582,545 and 10,582,549, respectively, Fig. 4.1a).
At the B6 genome level, both transcripts can be matched to Emv2 (see Section 3.1.5),
with the most highly upregulated transcript, Mela (Melanoma antigen), corresponding
to the Emv2 spliced env mRNA product.
This expression was confirmed by qRT-PCR for eMLV spliced env in the same cell type
(Fig. 4.1b), with around a 4-log increase in expression being seen in Rag1-/- samples. To
investigate this in greater detail and to determine how widespread the increased eMLV
expression was in immunodeficient mice, seven tissues were sampled and expression
evaluated by qRT-PCR. Although expression of eMLV varied between tissues, Rag1-/-
mice displayed consistently higher levels of eMLV expression than immunocompetent
B6 controls (Fig. 4.1c).
Detailed analysis of the microarray profiling data using REquest (see Section 2.18),
a program to mine RE expression from commercial microarray data, revealed further
changes in the expression of ERVs. 10 transcription clusters found significantly up-
regulated (x¯ 1.9-fold) in Rag1-/- peritoneal macrophages were found to correspond to
endogenous MMTVs, and 4 to endogenous MLVs (x¯ 1.7-fold upregulated), although
probes did not distinguish between xenotropic, polytropic and modified polytropic
(x/p/mpMLV) host tropisms.
These data gave an apparent link to wider changes in ERV expression in immunode-
ficiency and were thus investigated in greater detail. qRT-PCR primers reporting the
expression of a variety of ERV families were firstly tested and compared in Rag1-/- and
control B6 spleen samples (Fig. 4.2a). Whilst there was a trend towards increased ex-
pression of x/p/mpMLVs within Rag1-/- mice, only the difference in eMLV expression
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Figure 4.1: eMLV expression is elevated in Rag1-/- mice
(a)
(b) (c)
Peritoneal macrophages were isolated and FACS-sorted from B6 and Rag1-/- mice
and transcription profiled by Affymetrix Mouse 1.0 ST microarray. (a) >4-fold
upregulated genes in Rag1-/- compared to B6 for triplicate assays using cells isol-
ated from 40 mice per group. (b) qRT-PCR with primers for eMLV spliced env
in peritoneal macrophages. p=0.024 between groups. Symbols represent groups of
20 mice. (c) qRT-PCR for eMLV spliced env for the indicated tissues from B6 and
Rag1-/- mice. p=0.02 for spleen, p=0.032 for ileum, p=0.004 for colon, p=0.001
for lung, p=0.016 for muscle, and p=0.009 for kidney. Symbols in (c) represent
individual mice. Dashed lines represent the detection limit.
was significant. The expression of these ERV families was further compared across the
previously obtained tissue samples. Significant upregulation of pMLV expression was
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noted in the lungs and quadriceps muscle tissue of Rag1-/- mice, along with xMLV and
MusD element expression in the lungs (Fig. 4.2b).
Figure 4.2: ERV expression across B6 and Rag1-/- tissues
(a)
(b)
(a) qRT-PCR for the indicated ERVs within spleens of B6 and Rag1-/- mice.
p<0.001 for eMLV. (b) qRT-PCR for the indicated ERV for a range of tissues
from B6 and Rag1-/- mice. p=0.033 and p=0.035 for pMLV in the lungs and
muscles, respectively, p=0.024 for xMLV in the lungs, and p=0.037 for MusD in
the lungs. Each symbol represents an individual mouse. Dashed lines denote the
limit of detection.
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Thus, a lack of T and B lymphocytes in Rag1-/- mice could be associated with large
increases in eMLV expression across a range of tissues. Although noticeably more
modest, increases in the expression of other ERV families were also seen.
4.2.2 eMLV transcripts are increased in antibody deficiency
Use of Rag1-/- mice did not allow distinction of effects mediated by either T of B cells,
thus the exact cause of elevated eMLV expression was dissected further with a number
of more selectively lymphocyte deficient mice.
Tcra-/- and Tcrd-/- mice lack αβ and γδ T lymphocytes due to targeted disruption
of the TCRα and δ chains, respectively. H2-A,E-/- mice are unable to present peptide
on MHC class II molecules, and consequently have greatly impacted CD4+ T cell
development. Around 5% of CD4+ T cells remain in these mice, but display a greatly
disturbed phenotype and are unable to contribute to germinal centre reactions. In
this way, both Tcra-/- and H2-A,E-/- display an inability to produce class-switched
antibodies through a lack of CD4+ T cell function. Ighm-/- mice have a targeted
disruption of the immunoglobulin heavy chain, preventing production of functional
BCRs and hence blocking B cell development. Ighm-/- MD4 mice are transgenic for a
Hen-egg lysozyme (HEL)-specific BCR, allowing the development of B cells displaying
a single specificity.
Of these strains, only Ighm-/- and Ighm-/- MD4 mice displayed equivalent levels of
eMLV expression to Rag1-/- (Fig. 4.3). Tcra-/-, Tcrd-/-, and H2-A,E-/- mice, in
spite of varying T cell deficiencies and inabilities to produce class-switched antibodies,
all maintained low levels of eMLV expression that were equivalent to wild-type B6
(Fig. 4.3).
To extend these findings to other antibody deficient mice, Tlr7-/- and Myd88-/- were
studied. TLR signalling has been associated with the control of B cell responses, and
several studies have linked deficiencies with impaired responses to immunisation and
even retroviral infection (Browne & Littman, 2009; Browne, 2011). However, detailed
characterisation of these mice has identified significant global deficiencies in levels of
natural antibodies (Pasare & Medzhitov, 2005; Demaria et al., 2010), complicating
these conclusions. Both Tlr7-/- and Myd88-/- mice displayed high levels of eMLV
spliced env mRNA, suggesting the lowered levels of natural antibodies in these mice are
insufficient to control expression (Fig. 4.4a). This result was mirrored in tissue samples
collected from specific pathogen-free (SPF) mice housed at the Centre d’Immunologie
de Marseille-Luminy (CIML) (Fig. 4.4b).
Together, these data suggested a crucial requirement for B cells, manifested through
their provision of specific antibodies, in the control of eMLV expression in immun-
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Figure 4.3: eMLV expression in selectively immunodeficient
mice
qRT-PCR for eMLV spliced env in spleens from the indicated lymphocyte deficient
strains. p<0.001 between B6 and Rag1-/-, Ighm-/-, and Ighm-/- MD4 mice. Each
point represents an individual mouse. Dashed line indicates the limit of detection.
odeficiency. In this way, varyingly antibody deficient mice displayed elevated eMLV
expression levels. Given the control of eMLV expression in Tcra-/-, Tcrd-/-, and H2-
A,E-/- mice, this strongly suggested that these antibodies could be produced in the
absence of CD4+ T cell help. To confirm these data and to define the specific immun-
oglobulins required in the control of eMLV expression, SPF activation-induced cytidine
deaminase (AID)-deficient Aicda-/- mice were tested at the NCI Center for Cancer Re-
search (NCI). These mice are unable to recombine gene regions necessary for production
of antibodies other than IgM.
In agreement with the low eMLV expression seen in the absence of CD4+ T cell help,
Aicda-/- mice were able to control eMLV levels (Fig. 4.4c). Thus, IgM alone appeared
both necessary and sufficient for the control of eMLV expression.
4.2.3 Cell-surface MLV glycoprotein can be stained in antibody defi-
cient mice
To further gauge the global levels of eMLV expression in high-expressing strains, varying
cell types were assayed by FACS using the 83A25 antibody (Evans, Morrison et al.,
1990) to stain MLV surface (SU) glycoprotein. With few exceptions, this neutralising
rat-IgG2a antibody, derived from immunisation of a rat with polytropic F-MLV, reacts
strongly with MLVs of all tropisms (Evans, Morrison et al., 1990). Cell types unaffected
by Rag1 -deficiency were examined in these mice, whilst T and B cell MLV SU levels
4. RETROELEMENT EXPRESSION 103
Figure 4.4: eMLV expression in varying antibody
deficiencies
(a) (b) (c)
qRT-PCR for eMLV spliced env mRNA from the spleens of the indicated strains.
(a) p<0.001 between B6 and either Myd88-/- or Tlr7-/- mice. (b) p=0.003 between
B6 and Tlr7-/-. (c) p=0.024 between Ighm-/- and Aicda-/-. Each symbol repres-
ents an individual mouse. Dashed lines denote detection limits.
were assayed using Ighm-/- MD4 mice.
Determined as a whole, 60–80% of splenocytes from Rag1-/- mice stained positively
with 83A25 (Fig. 4.5a), with only background levels of staining being seen in control
animals. Levels of staining varied across cell types within individual Rag1-/- mice but
remained consistently higher than the equivalent cell type from B6 controls (Fig. 4.5b).
CD4+, CD8+ and B cells from Ighm-/- MD4 were also seen to stain to a high level
(Fig. 4.5c), showing that expression could also be seen in lymphocytes.
Not only is the expression of eMLV (and potentially other endogenous MLVs) increased
in antibody deficiency, therefore, but this expression can be linked to formation of
protein products that are processed and transported, allowing staining on the cell
surface. Further, increased levels of staining can be seen in all cell types studied from
Rag1-/- or Ighm-/- MD4 mice, suggesting a wide-ranging, or indeed global increase in
expression in these mice.
4.2.4 Infectious virus can be isolated from Rag1-/- mice
Such high levels of eMLV mRNA expression, coupled with the large range of tissues
and cells staining with 83A25, was partially suggestive of an infection scenario rather
than dysregulation of endogenous MLVs. Emv2, the only endogenous eMLV of B6
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Figure 4.5: MLV SU levels across cell types
(a)
(b)
(c)
FACS analysis of MLV SU expression using the 83A25 antibody. (a) 83A25 staining
in whole spleen suspension from B6 and Rag1-/- mice. MLV SU expression in the
indicated cell types of (b) Rag1-/- and (c) Ighm-/- MD4 mice. Numbers in figures
show percentage positivity. Plots are representative of 4 mice per group.
background mice, whilst replication incompetent and restricted by the action of Fv1b
in B6 mice (see Section 3.1.5), is known to have recombined in several settings to pro-
duce infectious exogenous virus. In this way, Emv2 -derived sequences are thought to
have contributed almost totally to MelARV (Hayashi et al., 1992; Pothlichet, Man-
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geney & Heidmann, 2006; M. Li et al., 1999), but also to exogenous eMLVs causing
myeloid leukeamias in BXH-2 mice (Turcotte et al., 2005) and to the BM5eco ecotropic
helper component of the LP-BM5 murine AIDS (MAIDS) retroviral complex (Chat-
topadhyay, Sengupta, Fredrickson, Morse III & Hartley, 1991; Coppola et al., 1995).
Further, provided the eMLV env was retained in a recombination event, the spliced
env primers used would not discriminate between functional and non-functional tran-
scripts derived from either novel integrations of replication competent exogenous virus,
orEmv2, respectively.
Production of replication competent eMLVs would firstly necessitate expression and
co-packaging of two endogenous retroviral sequences within a single cell, followed by
recombination during reverse transcription in a target cell. In the case of Emv2, either
a single large recombination event could correct the G-3576-C mutation and convert the
capsid from N- to B-tropism, or multiple events would be required to fulfil the same
function. To initially test the possibility that infectious eMLVs derived from Emv2
were present in Rag1-/- mice, primers were designed to distinguish between transcripts
containing G or C at position 3576. cDNA was produced using a reverse transcription
reaction initiated with a separate primer specific to ecotropic env, and PCR (Fig. 4.6a),
followed by qRT-PCR (Fig. 4.6b), suggested that the majority of these transcripts were
corrected at position 3576.
This finding implied the presence of infectious eMLV within these mice, thus the pres-
ence of infectious virus was directly tested through incubation of sera with permissive
Mus dunni cells. Remarkably, sera isolated from both young (6 weeks) and older (25
weeks) Rag1-/- mice, but not age-matched control B6 mice, were confirmed to contain
infectious exogenous MLVs, termed Rag1-/- mouse-associated retroviruses (RARVs).
Three RARVs (2–4) were isolated from 6 week old Rag1-/- serum samples and a further
four (5–8) from 25 week old mice. These RARVs were capable of replicating within
murine cell lines in vitro and, on sequencing of the region surrounding the Emv2 point
mutation, indeed showed reversion at position 3576 (Fig. 4.7a), as previously suggested.
Conversion to B-tropism was assessed through determination of replicative potential in
B- and N-3T3 cells, and can be expressed as a ratio of B:N tropism (Figs. 4.7b and 4.7c).
All seven RARVs were seen to display B-tropism, implying a likely recombination event
or events within the Emv2 gag.
To assess the means by which tropism was altered in the viral isolates, all seven RARVs
were sequenced and analysis of amino acid sequences from the viral capsid confirmed
that all RARVs were B-tropic (Kozak & Chakraborti, 1996) (Fig. 4.8a). Interestingly,
sequence comparison suggested that RARVs 2–4, derived from young Rag1-/- mice,
were highly similar, but that sequences diverged substantially with increasing age.
This was supported by phylogenetic analysis, with viruses clustering according to the
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Figure 4.6: Relative quantitation of corrected and
non-corrected eMLV transcripts
(a)
(b)
(a) PCR and (b) qRT-PCR comparing corrected and uncorrected eMLV tran-
scripts. eMLV mRNA was reverse transcribed using a single reverse primer within
the ecotropic env and primers produced at the site of the Emv2 point mutation.
4 individual mice (duplicates prepared with separate reverse transcription kits in
(a)) are shown.
age of the mouse from which they were isolated (Fig. 4.8b).
Bootscanning against endogenous MLV sequences obtained from the literature was per-
formed to define the recombination events necessary for reversion of the point mutation
and for conversion to B-tropism, as well as to identify the cause of divergence over time.
The same pattern of recombination events was seen in RARVs 2–4, highlighting their
similarity and suggesting the existence of a single exogenous infectious virus within
the colony (Fig. 4.9). Recombination with Xmv41 or Xmv43 was responsible for the
correction of the G-3576-C inactivating mutation (Fig. 4.9). Supporting this finding,
Xmv43, otherwise known as Bxv1, has previously been identified as an active recom-
bination partner in a variety of settings (Stoye, Moroni & Coffin, 1991; Hook et al.,
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Figure 4.7: Point mutation correction and altered tropism
of RARV isolates
(a)
(b) (c)
(a) Sequence alignment of the area surrounding the Emv2 point mutation from
RARVs 2–8. Arrow indicates site of the Emv2 point mutation. (b) Detection of
infectious MLVs isolated from the plasma of a Rag1-/- mouse. Presence of an
infectious virus in the culture allows pseudotyping of a GFP-expressing retroviral
vector and subsequent quantitation using a FACS-based assay. (c) Fv1 tropism
determination of isolated RARVs, shown as the ratio of infectivity on B- and N-3T3
cells. B- and N-tropic F-MLV are shown for comparison.
2002).
Further recombinations, likely involving the same xenotropic partner, were also re-
vealed by the bootscanning, although their relevance has not been investigated and
does not impact areas previously defined as defining viral tropism. As such, a separate
recombination involving one of Xmv8, Xmv10, or Xmv13 was required for conversion
from N- to B-tropism, and is again seen in all viral isolates (Fig. 4.9).
As suggested by the separate grouping of viral isolates from young and older Rag1-/-
mice, RARVs 5–8 all contained further recombination events (Fig. 4.9). All events
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Figure 4.8: Sequence analysis of RARV isolates
(a) (b)
(a) Amino acids at positions 105–113 of the capsid, determining viral tropism.
Dots indicate identity. (b) Phylogenetic tree of RARV isolates. Scale represents
the probability of base substitution per site.
involved pMLVs endogenous to the B6 genome and consisted of varying substitutions
of env and the neighbouring region of pol (Fig. 4.9). Further alterations to pro-pol were
made in half of the isolates, although not necessarily with the same partner involved
in the env recombination (Fig. 4.9).
Thus, the Rag1-/- colony appeared to harbour an infectious eMLV derived from a re-
combination event involving Emv2 as the primary donor and a further two endogenous
MLVs. Importantly, both the sequence backbone and the regions of recombination
could be matched to MLVs endogenous to the B6 genome by bootscanning, ruling out
the potential of ‘contamination’ of the breeding line with an exogenous virus. Over
time, and apparently within each mouse, independent recombination events switch the
ecotropic env of Emv2 for an env with a polytropic host range. Consistent with this
hypothesis, the majority of transcription of ecotropic gag-pol mRNA appears to derive
from G-3576-C-corrected viruses, and 4-fold higher levels of eMLV env than eMLV gag
can be seen in analysis of the microarray data from peritoneal macrophages. eMLV env
is shared between Emv2 and early RARVs, whereas eMLV gag is only found completely
in Emv2 itself and is substantially altered in all RARVs isolated.
4.2.5 RARV infection occurs by vertical transmission to neonates
Analysis of RARV sequencing data suggested that a single infectious exogenous retro-
virus, represented by RARVs 2–4, existed in the Rag1-/- colony held in the NIMR SPF
breeding facilities. Subsequent to infection, de novo changes appear to occur within
each mouse to result in the formation of infectious virus with a polytropic env sequence.
To confirm this theory, Emv2-/- null congenics generated for the previous study (see
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Figure 4.9: Bootscan of RARV isolates against endogenous
B6 MLVs
Bootscanning of RARV sequences against MLVs endogenous to the B6 genome.
Scale represents evolutionary distance. Where sequence diverges from that of
Emv2, suggestive of a recombination event, the best matching sequence or se-
quences, where similarity does not allow distinction, are shown.
Chapter 3) were used for a series of crosses. A colony was firstly established through
use of an Emv2-/- male and a Rag1-/- female, followed by the intercrossing of selected
F1 progeny to produce a homozygous Rag1
-/-Emv2-/- line. Using this approach to
remove Emv2, any eMLV detected must derive from infectious virus passed vertically
from one of the parents. Both eMLV spliced env expression (Fig. 4.10a) and elevated
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levels of MLV SU product (Fig. 4.10b) were seen in these mice, supporting the presence
of an infectious exogenous virus.
Figure 4.10: eMLV are present in the absence of Emv2
(a) (b)
(a) qRT-PCR for eMLV spliced env in Rag1-/- and Rag1-/-Emv2-/- mice. eMLV
present in the latter must derive from an infectious virus. Each point represents
a single mouse. (b) FACS staining of MLV SU in the same strains. Data are
representative of 9 mice per group.
The Rag1-/- colony used within NIMR, originally obtained from The Jackson Labor-
atory (JAX), has been maintained at the institute for 45 filial generations (F45). All
mice obtained from an external source are re-derived by implantation of embryos into
pseudopregnant female recipients prior to introduction into the specific pathogen free
(SPF) animal facilities. This process ensures the removal of adventitious agents, in-
cluding retroviruses that are not carried in the germ-line. At an unknown point since
the re-derivation of the Rag1-/- strain, therefore, an infectious eMLV has been gener-
ated de novo through the previously described recombination events. This raised the
possibility of further germ-line eMLV integrations contributing to the expression seen
in this strain, but also to expression within Rag1-/-Emv2-/- mice.
Determination of germ-line eMLV copy number was performed by quantitative PCR,
using the single-copy Ifnar1 gene as a reference for sample concentration. To account for
the possibility of both ecotropic and polytropic RARVs being integrated, both eMLV
pol and env primers were used and subsequently compared. Despite an estimated
sensitivity of 0.0003 eMLV copies per haploid genome, determined with the use of
Emv2-/- mice, no significant increases in eMLV copy number (above Emv2, at 1 copy
per haploid genome) were seen in the germ-line of multiple Rag1-/- mice (Fig. 4.11).
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Figure 4.11: RARV integrations are absent from the
germ-line
eMLV env and pol copies per haploid genome in Rag1-/- spleen cells. Columns
represent individual mice. 1 copy (Emv2 ) would be expected per haploid genome
in the absence of infectious virus.
4.2.6 The implications of RARV infection
These data argued against the integration and germ-line inheritance of RARVs, further
suggesting the presence of an infectious virus within the colony. Neonatal models of
infection generally centre around breast-milk transmission and have long been studied
for both MMTVs and MLVs (Law, 1962; Buffett, Grace Jr, DiBerardino & Mirand,
1969; Gardner, Chiri, Dougherty, Casagrande & Estes, 1979). To directly assess the
point and route of RARV infection, a number of further crosses were made. These gave
no evidence for sexual transmission of RARVs from a Rag1-/-Emv2-/- male to two
Emv2-/- females or to the adult progeny of the matings (Fig. 4.12a). Further, progeny
from the reverse cross, a mating of Rag1-/-Emv2-/- females with an Emv2-/- male, did
not express high levels of eMLV at birth (Fig. 4.12b). Together, this suggested that
RARV transmission occurred neonatally rather than in utero.
The infectious potential of RARVs, determined as eMLV DNA copy number, had previ-
ously been assessed in Rag1-/- mice (Fig. 4.11). Being sufficient for Emv2, however, it
was possible that a certain level of interference, such as through blockade of mCAT-1,
was being observed in these mice. To fully assess the the infectious potential of RARVs,
therefore, eMLV copy number was also determined in Rag1-/-Emv2-/- mice. Any DNA
copies of eMLV present in these mice, in the absence of Emv2, must result from RARV
infection.
Around 1 integration per haploid genome (2 integrations per somatic cell) was seen in
these mice, with non-significant, but slight increases in copy number with increasing
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Figure 4.12: RARV transmission
(a) (b)
qRT-PCR assessment of eMLV spliced env. (a) A RARV-positive Rag1-/-Emv2-/-
male was mated with two RARV-negative Emv2-/- females and expression assessed
8 weeks after mating and in 6-week old progeny of the matings. (b) Two RARV-
positive Rag1-/-Emv2-/- females were mated with a RARV-negative Emv2-/- male
and expression assessed in the livers of newborn (1 day) progeny. Each point
represents a single mouse.
age (Fig. 4.13). Infectious potential was altered considerably in the absence of Emv2,
therefore.
The level of infection noted here has great mutagenic potential over time. To de-
termine the impacts of this burden on disease and tumourigenesis, cohorts of Rag1-/-,
Rag1-/-Emv2-/-, and control B6 mice were aged for over 12 months. Starting from
around 180 days (6 months), significant numbers of both Rag1-/- and Rag1-/-Emv2-/-
mice showed signs of morbidity, characterised by weight loss, loss of condition, unre-
sponsiveness, and partial paralysis. Examination of these mice revealed tumours, fre-
quently associated with anaemia, in all cases (Fig. 4.14a). At the point of termination
of the experiment, at day 380 (12.5 months), incidence of tumourigenesis in Rag1-/-
mice was 67% (Fig. 4.14b), although an additional 5% showed signs of sub-clinical tu-
mours upon internal examination. Tumour incidence occurred at an equal rate in the
cohort of Rag1-/-Emv2-/- mice, but was not observed in age-matched B6 wild-type
controls.
Determination of the clonal origin of tumours from Rag1-/- mice indicated that cells
from a variety of lineages could contribute to disease (Fig. 4.15a). Professional his-
tological analysis indicated sheets of monomorphic cells of lymphoblastic character,
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Figure 4.13: Potential for infection of Rag1-/-Emv2-/- mice
eMLV env and pol copies per haploid genome in Rag1-/-Emv2-/- spleen cells.
Columns represent individual mice. All eMLV copies derive from infectious virus.
with negligible intervening stroma, frequent apoptoses and a high rate of mitosis, fit-
ting with a retrovirus-induced leukaemia (Fig. 4.15b). In each case, a single MLV
SU-expressing cell type was seen to contribute the majority of cells for each tumour
sample studied (Fig. 4.15c). Consistent with the apparent clonal origin of cells within
individual tumours, distinct and significant chromosomal aberrations were detected by
array comparative genome hybridisation (Fig. 4.15d).
Supporting the retroviral origin of tumours in these mice, abundant extracellular C-type
retroviral particles were detectable by transmission electron microscopy within tumour
samples, but not within a spleen sample from a healthy Rag1-/- control (Figs. 4.16a
and 4.16b). Significant increases in RARV integrations were also noted though analysis
of eMLV DNA copy number (Fig. 4.16c). Interestingly, tumour 6 displayed elevated
eMLV pol but not env transcripts, suggesting that where the majority of tumours ap-
peared to be caused by ecotropic RARVs, this individual case originated from infection
with a RARV containing an env of a different tropism. Together, this is indicative of
copious amplification of RARVs within tumours.
Overall, these data suggest a model of vertical inheritance of infectious eMLVs within
antibody deficient mouse lines. Infectious eMLVs appear to be originally generated
through the recombination of various MLVs endogenous to the B6 genome, resulting
in the restoration of Emv2 infectivity. Within each mouse, further individual recom-
bination events can be seen that result in formation of virus with a polytopic env. The
presence of infectious MLVs leads to retroviremia and, over time, results in oncogenesis
in a manner similar to that well-defined in mouse strains carrying infectious germ-line
MLVs (Stoye, Moroni & Coffin, 1991).
4. RETROELEMENT EXPRESSION 114
Figure 4.14: Tumour incidence in aged Rag1-/- and
Rag1-/-Emv2-/- mice
(a)
(b)
(a) Selectively coloured images of culled Rag1-/- mice. Top images show healthy
mice, with the thymus (left) and spleen (right) highlighted to show reduced size
in these mice in comparison to wild-type B6. Below are images of Rag1-/- mice
presenting with leukaemias. Images show a thymic tumour, a thymic tumour with
metastasis into the rib cage, a splenic tumour, a splenic and hepatic tumour, and
a leukaemia impacting all three organs, respectively. (b) Tumour incidence in
cohorts of B6 (36 mice), Rag1-/- (38 mice, p<0.001 to B6), and Rag1-/-Emv2-/-
(23 mice, p<0.001 to B6).
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Figure 4.15: Characterisation of tumours from aged
Rag1-/- mice
(a) (b)
(c)
(d)
(a) FACS analysis of cell suspensions from Rag1-/- tumours to determine cellu-
lar origin. Cells representing >70% of total were taken as the predominant cell
type. (b) Histological examination of a lymph node lymphoma from a leukaemic
Rag1-/- mouse. Evident are sheets of monomorphic medium to large round cells
with lymphoblastic character. Cells have distinct borders but little intervening
stroma, minimal peripheral eosinophilic cytoplasm, and round nuclei with margin-
ated clumped chromatin and conspicuous basophilic nucleoli. Frequent apoptoses
and tangible body macrophages can be noted, and approximately five mitoses per
high power field (insert). (c) FACS analysis of MLV SU expression in a Rag1-/-
tumour of monocytic (Ly6-C+) origin. (d) Array comparative genomic hybridiz-
ation of DNA from individual splenic lymphomas from Rag1-/- mice. Spleen cells
from a healthy Rag1-/- mouse were used in the comparison. Red and blue colours
indicate chromosomal duplications and deletions, respectively.
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Figure 4.16: RARV infection in tumours from aged Rag1-/-
mice
(a)
(b)
(c)
Transmission electron micrographs from (a) a healthy Rag1-/- control and (b) a
lymph node lymphoma from a leukaemic Rag1-/- mouse. No viral particles are
visible in the healthy control, whereas numerous MLV-like retroviral particles can
be noted in the extracellular spaces of the leukeamic tissue (inserts). (c) eMLV
pol and env DNA copy number analysis for splenic lymphomas from individual
Rag1-/- mice.
4.2.7 Antibodies are required for the control of systemic microbial
products
Although previous data had indicated a requirement for antigen-specific antibodies,
the target of these was undetermined. Microbial products have a long-established role
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in the promotion of MLV expression, both in vivo and in vitro (Greenberger et al.,
1975; Moroni & Schumann, 1975; Moroni, Schumann, Robert-Guroff, Suter & Martin,
1975; Stoye & Moroni, 1983). In fact, Xmv43 itself, a recombination partner possibly
involved in the generation of RARVs in Rag1-/- mice, is known to be inducible by
bacterial LPS (Stoye & Moroni, 1985).
Interestingly, serum LPS is known to be elevated in B cell deficient mice (Reid et al.,
1997; Bourgeois, Hao, Rajewsky, Potocnik & Stockinger, 2008; Shulzhenko et al., 2011)
and indeed expression of many ERV families, including eMLV, was most highly elevated
in the colons of both B6 and Rag1-/- mice (Figs. 4.1c and 4.2b). It was thus possible
that increased ERV expression, giving increased likelihood of genome co-packaging and
subsequent recombination, was influenced by the presence of microbial products.
Control of microbes and microbial products may occur in either the gut lumen or,
subsequent to translocation, within the systemic circulation. IgA has a well defined
role in both settings (see Section 4.1.3), but previous data indicated that IgM alone
appeared necessary and sufficient for the control of eMLV expression (Fig. 4.4c). As
well as IgA, however, pentameric IgM is also excreted into the gut lumen, thus the exact
requirement and action of both IgA and IgM was further investigated. Mice specifically
deficient for IgA (Igha-/-) or the polymeric immunoglobulin receptor (pIgR, Pigr-/-),
required for transcytosis of dimeric IgA and pentameric IgM across mucosal surfaces,
were obtained from the the HCI Rodent Centre (RCHCI, ETH Zu¨rich) and analysed
for eMLV expression.
Figure 4.17: The affect of IgA deficiency and impaired
immunoglobulin transcytosis on eMLV expression
qRT-PCR for eMLV spliced env in spleens from the indicated strains from the
RCHCI SPF animal facility. Each point represents an individual mouse and the
dashed line shows the limit of detection. p<0.001 between Igh-j-/- and Pigr-/-
mice.
4. RETROELEMENT EXPRESSION 118
As expected from the absence of a requirement for CD4+ T cell help and the specific
requirement outlined for IgM, Igha-/- mice controlled eMLV expression in comparison
to B cell deficient positive controls (Fig. 4.17). Interestingly, Pigr-/- mice also con-
trolled expression, suggesting that the required specific IgM antibodies were required
for control of a systemic antigen (Fig. 4.17).
To investigate in greater detail the influence of microbial products on REs and ERVs,
REquest was again used to identify probesets reporting their expression from a publicly
available microarray dataset (Amit et al., 2009). The transcriptional profile of primary
mouse dendritic cells (DCs) was assessed over a time course following treatment with
Pam3CSK4, a synthetic bacterial lipoprotein mimic, polyinosine-polycytidylic acid
(poly(I:C)), a double-stranded RNA, LPS, an outer membrane protein from Gram-
negative bacteria, gardiquimod, a small-molecule agonist, and CpG, a synthetic single-
stranded DNA. Respectively, these are agonists of TLR1/2, TLR3, TLR4, TLR7, and
TLR9.
Figure 4.18: RE and ERV expression in mouse dendritic
cells following TLR stimulation
Heatmap of probesets found to correspond to REs and ERVs with REquest from
the Affymetrix Mouse Genome 430A microarray. Data were downloaded from a
public database (EBI Array Express E-GEOD-17721). Data are derived from a
timecourse dataset of B6 BMDCs stimulated with various TLR agonists. Black
arrows denote probesets that are significantly upregulated (p<0.05) by more than
2-fold by at least one stimulus. Grey arrows denote probesets corresponding to
Emv2.
Expression of non-ecotropic endogenous MLVs was significantly increased on treatment
with LPS and poly(I:C), yet suppressed by Pam3CSK4 (Fig. 4.18). This microarray
probeset does not report the expression of eMLVs, which were not seen to be signific-
antly affected by these treatments (Fig. 4.18). Early transposon (ETn) elements were
also significantly induced by poly(I:C) treatment. The induction of endogenous MLV
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expression, not inclusive of eMLVs, was confirmed through independent work under-
taken in vitro. B6 and Emv2-/- splenocytes were stimulated with LPS and were shown
to display comparable increases in MLV SU staining (Fig. 4.19).
Figure 4.19: MLV SU staining on LPS treatment of
splenocytes
FACS analysis of MLV SU expression in B6 or Emv2-/- splenocytes prior to (open
histograms) and after 48 hours of stimulation with 10 µg/ml LPS (grey histo-
grams). Cells are grouped according to their forward scatter (FSC) profile, with
blasting cells having the highest expression of MLV SU. Numbers represent per-
centages of cells staining positively with 83A25. Data are representative of 2 donors
analysed in duplicate.
Thus, microbial products were seen to be capable of inducing endogenous non-ecotropic
MLV expression, in agreement with previous data suggesting elevated expression in
the colons of both wild-type B6 and Rag1-/- mice. In a setting of IgM deficiency,
resulting in the ineffectual neutralisation of circulating systemic microbial products, this
potentially ensues in the increased expression of various recombination partners that
can be involved in the reversion of the Emv2 point mutation and tropism alteration. If
specific antibodies are indeed directed against microbial products, rather than emerging
infectious MLVs, then in the absence of microbial products, high eMLV expression
would not be noted.
To assess this directly, Rag1-/- were firstly assessed from a separate SPF breeding
colony within NIMR. Two main breeding units supply either high-use strains or low-
use and mutant lines for use within the institute, and can be separated in regards the
water offered breeding pairs. All Rag1-/- mice analysed thus far, bred within NIMR-
B1, were offered neutral, doubly-filtered, ultra-violet (UV)-irradiated water. A separate
Rag1-/- line within the second facility, NIMR-B2, was offered acidified (pH 2.5) water
– a frequent husbandry choice that reduces bacterial colonisation of the gastrointestinal
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tract and subsequent translocation of microbial products into the systemic circulation
(Wu et al., 2006).
Figure 4.20: The impact of gut microbiota on eMLV
expression in Rag1-/- mice
qRT-PCR for eMLV spliced env in Rag1-/- mice obtained from the indicated
facilities and husbandry conditions. Each symbol represents an individual mouse.
Dashed line denotes the limit of detection. p<0.016 between NIMR SPF mice,
housed in NIMR-B1, and all other groups.
Notably, Rag1-/- mice offered acidified water had significantly lower eMLV expression
than those offered neutral pH water (Fig. 4.20). This finding supported the involvement
of microbial products from the gut microbiota in the generation of infectious eMLV
within Rag1-/- mice. This was further confirmed by obtaining samples from the same
strain from JAX, where mice were again offered acidified water (pH 2.8). Again, low
eMLV expression was observed in this situation (Fig. 4.20).
To confirm that this impact was indeed related to the microbiota within these mice,
rather than a secondary effect of acidified water, further Rag1-/- mice were obtained
from the University of Michigan (UMICH) germ-free breeding facility and from RCHCI.
UMICH GF mice are maintained, following sterile re-derivation, on autoclaved neutral
water. Mice bred within RCHCI are maintained within individually ventilated cages
(IVCs) from entry and, being used for various microbiota-related experiments, have an
exceptionally low intestinal microbial diversity. Encouragingly, both sets of samples
revealed low eMLV expression (Fig. 4.20).
Reduction in eMLV expression could have been due to lack of a specific bacterial species
in Rag1-/- mice offered acidified water. To determine the likihood of this and to assess
the level of change imposed on the gut microbiome by water acidification, DNA was
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isolated from bacteria obtained from stool samples from the colon and the conserved
bacterial 16S ribosomal RNA region was deep-sequenced. This was undertaken for
Rag1-/- offered either neutral or acidified water at NIMR, as well as wild-type B6
controls offered neutral pH water, and for both Rag1-/- and B6 stool samples from
RCHCI.
Figure 4.21: 16S sequencing of the gut microbiota
(a) (b) (c)
(d) (e)
Comparison of colonic bacterial genera between (a) B6 and (b) Rag1-/- mice from
NIMR-B1, offered neutral water, (c) Rag1-/- from NIMR-B2, offered acidified
water, and (d) B6 and (e) Rag1-/- mice housed at RCHCI within IVCs and offered
neutral water. Genera were assigned from 16S sequencing of stool samples. Data
are averages of 4 mice per group.
Table 4.1: Bacterial diversity within the colon
NIMR NIMR NIMR RCHCI RCHCI
B6 Rag1-/- Rag1-/- B6 Rag1
-/-
pH 7 pH 7 pH 2.5 pH 7 pH 7
Shannon Diversity
Index (H’)
1.31 1.22 0.97 1.14 1.42
Species Richness 21 22 15 11 11
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All bacterial genera identified in significant numbers within B6 and Rag1-/- mice
offered neutral water were present in comparable proportions, with both microbio-
mes being dominated by Barnesiella species (Figs. 4.21a and 4.21b). Equally, both
species richness and diversity measures were relatively similar, although slightly re-
duced diversity was noted in Rag1-/- mice (Table 4.1). As would be expected, acidified
water reduced the species richness and diversity of the colonic microbiome consid-
erably (Fig. 4.21c and Table 4.1). Supporting the low eMLV expression in Rag1-/-
mice obtained from RCHCI, 16S sequencing revealed exceptionally low species richness
(Figs. 4.21d and 4.21e and Table 4.1).
Bacteria from the colon were chosen for 16S sequencing in this instance due to the
previous identification of elevated ERV expression within this tissue. Thus, these results
do not exclude greater differences in bacterial colonisation of different areas of the
gastrointestinal tract, or the presence of unidentified bacterial species within the colon,
but potentially support a theory that in the absence of systemic IgM, Rag1-/- mice
are unable to control the translocation of universal microbial products from the gut
lumen, rather than being colonised by a separate species that induces ERV expression.
This suggestion would be supported by previous work in the literature that suggests
the presence of elevated serum LPS, and a corresponding transcriptional signature, in
B cell-deficient mice in the absence of large differences in the composition of the gut
microbiota (Shulzhenko et al., 2011).
As evidenced by the differences in colonic bacterial composition of mice from NIMR
and RCHCI, as well as the differences between strains maintained within RCHCI, the
heritable and variable nature of the microbiome may have a large and unappreciated
impact in a diverse range of settings. To confirm that the differences in eMLV expression
observed in Rag1-/- were related to the microbiome, and that this could be extended
to other strains previously observed to mirror their eMLV levels, further samples were
requested from JAX. Ighm-/- and Tlr7-/- mice were both observed to have lower eMLV
expression than the same strains offered neutral pH water and maintained at NIMR
(Figs. 4.22a and 4.22b).
Thus, the processes resulting in the formation of infectious eMLVs within antibody-
deficient mice not only can be seen in varying strains and breeding facilities, but can
be linked to the hygiene status of the unit concerned.
4.2.8 The frequency of RARV generation
Interestingly, samples from Myd88-/- mice bred at JAX displayed a range of eMLV
expression levels, suggestive of the current and continued emergence and establishment
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Figure 4.22: The impact of gut microbiota on eMLV
expression
(a) (b)
qRT-PCR for eMLV spliced env in spleens from (a) Ighm-/- and (b) Tlr7-/-
mice housed at NIMR and offered neutral water or at JAX. p=0.005 for Ighm-/-,
p=0.029 for Tlr7-/- comparisons. Points represent individual mice. The dashed
lines indicate the limit of detection of the assay.
of eMLVs within this colony (Fig. 4.23a). Once generated, vertical inheritance of in-
fectious MLVs is unlikely to be impacted by acidification of the water supply and is
likely to affect the entire colony over time. Thus, the presence of a neutral pH water
SPF microbiota, whilst promoting RARV emergence in many cases, is not absolutely
required for the eventual generation of infectious virus.
It was thus of interest to determine the probability and frequency of RARV generation
over time. Given that the Rag1-/- line at NIMR has been maintained for 45 filial
generations, however, and that the presence of an infectious MLV had not previously
been identified in the line, a separate setting would be necessary to achieve this aim.
Firstly, Rag1-/- mice bred on acidified water and having low eMLV expression were
transferred to neutral water and followed for 120 days. At the end of this period, no
mice were seen to have developed eMLV expression above background levels (data not
shown).
The probability of RARV generation within a single mouse might be relatively low,
therefore, potentially taking several generations of breeding prior to eventual emer-
gence. Fortuitously, two re-derivations of Ighm-/- mice at NIMR have been conducted
recently, allowing the study of eMLV generation over time. Progeny of mice re-derived
and offered neutral pH water retained low eMLV expression for at least 2 filial gen-
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Figure 4.23: The emergence of infectious eMLVs
(a) (b)
qRT-PCR for eMLV spliced env in spleens from (a) Myd88-/- mice housed at NIMR
and offered neutral water or at JAX and (b) Igmh-/- mice from two independently
re-derived colonies at NIMR, one at F2 on neutral pH water (≤ F2) and one
after F4 on neutral pH water followed by F12 on acidified water (> F4). Points
represent individual mice. The dashed lines indicate the limit of detection of the
assay.
erations (Fig. 4.23b). In contrast, a colony re-derived and maintained on neutral pH
water for 4 filial generations, before being offered acidified water for a further 12 gener-
ations, until sampling, exhibited uniformly high eMLV expression, suggestive of RARV
emergence (Fig. 4.23b). Enquiry of the breeding history of Myd88-/- mice maintained
at JAX revealed the mice sampled had been maintained for 5 filial generations, fitting
with the suggested time frame.
Thus, although the probability of RARV generation within a single mouse might be
low, and potentially relies on the early establishment of a suitable microbiota, over time
the cumulative probability of generation of infectious eMLV rises. Thus, in separate
settings, the same or similar virological processes result in the correction of the Emv2
point mutation, tropism conversion, and de novo generation of an infectious eMLV.
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4.3 Discussion
These results present a novel link between antibody deficiency and the expression and
‘resurrection’ of ERVs. The B6 mouse, the most popular inbred strain used globally,
whilst harbouring no infectious ERVs in the germ-line, contains the necessary compon-
ents for the de novo creation and emergence of infectious MLVs. As sterile re-derivation
of strains into SPF animal facilities prevents the carriage of adventitious agents, and
expression can be separately seen in various antibody deficient mice obtained from a
variety of sources globally, the likelihood of a contaminating eMLV is low.
A proposed model for the generation of infectious inherited ecotropic RARVs, pro-
duction of polytropic variants and subsequent tumourigenesis is shown in Fig. 4.24.
Although this schematic may represent the virological events leading to resurrection of
a virus in the single strain from which viruses were sequenced in this study, differing
recombinations are likely to occur between strains and facilities. Indeed, sequence data
from collaborators at the NCI Center for Cancer Research differ greatly from sequences
presented here (data not shown) and further suggest that viruses are generated in an
independent manner.
Initial sequencing work revealed a number of recombination events between Emv2 and
Xmv41/43, of which only one would traditionally be seen as necessary to correct the G-
3576-C point mutation of Emv2. The virological processes involved in the correction and
tropism alteration of Emv2, along with the potential identification of further interacting
areas of the MLV genome, are thus a fascinating subject for further study. Similarly, the
nature, diversity, and size of the viral swarm within each mouse is a largely uncharted
area.
Whilst these data have outlined a strong requirement for systemic IgM, the precise
target of these antibodies and the means by which microbial products potentially ac-
tivate endogenous MLV recombination partners require further investigation. By their
nature, antibody deficient mice also lack antiviral antibodies that would likely act after
the generation of an infectious eMLV. In the absence of control of infection and pre-
vention of vertical transmission, an infectious virus can establish vertical transmission
in a colony and cause disease within individual mice.
Although there is a strong link between a complex gut microbiota, as influenced by
varying animal husbandry conditions, and eventual emergence of infectious RARVs,
this would equally need to be studied in detail to determine the exact complexity and
nature of a microbiome required for this process. In likelihood, this will require the
gnotobiotic colonisation of germ-free mice, followed by their continued observation over
successive generations.
The characterisation of bacterial diversity from the colon did not reveal a single bac-
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Figure 4.24: A model for RARV generation and disease in
antibody-deficient mice
A hypothesised model of the processes surrounding RARV generation. Green an-
tibodies denote specific IgM, involved in the control of microbial products, whilst
purple antibodies represent points of potential control by anti-retroviral antibodies.
terial genus likely to be responsible for the induction of ERVs in Rag1-/- that was not
present in either control B6 or Rag1-/- mice offered acidified water. However, variable
assignation percentages of 16S sequencing reads and the potential for miss-assignation
means that this cannot be formally excluded as a possibility. The colon was chosen for
study here as it contains the largest mass of bacteria per unit of luminal content and
could be shown to have high eMLV expression by qRT-PCR; however, variability in
other areas of the gastrointestinal tract may have been missed.
To determine the likelihood of this possibility, a publicly-available microarray dataset
studying expression profiles of varying regions of gut tissue (Larsson et al., 2012) in both
germ-free and SPF B6 mice was analysed with REquest. Encouragingly, tissues from
germ-free mice clustered separately to those from SPF conditions and had generally
lower expression values (Fig. 4.25). In SPF conditions, both Xmv18 and Pmv17 could
be uniquely identified as being upregulated, with strongest expression being seen in the
duodenum and jejunum (Fig. 4.25). Of the four tissues studied, the colon had the lowest
expression of all REs and ERVs in both germ-free and SPF mice (Fig. 4.25). Thus,
there remains a strong case to further investigate the effect of microbiota throughout the
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gastrointestinal tract on RE and ERV expression, including the potential interactions
with endogenous MLVs.
Figure 4.25: ERV expression throughout the
gastrointestinal tract
Heatmap of probesets found to correspond to REs and ERVs with REquest from
the Affymetrix Mouse Gene 1.0 ST microarray. Conditions are ordered by unsuper-
vised clustering. Data were downloaded from a public database (E-GEOD-17438).
Shown are probesets significantly upregulated (p<0.05) by more than 2-fold in at
least one condition. Probesets corresponding to individually-identifiable endogen-
ous MLVs are highlighted.
At present, only B6 background mice have been studied for the emergence of infectious
RARVs. Both Emv1 and Emv3 are present in many strains in frequent laboratory
use, however (Table 1.2), and the effects of antibody deficiency and the influence of the
microbiota have not been investigated in these situations.
Implications of this work
The existence of infectious eMLVs in antibody-deficient B6 background mouse strains
is a potentially large confounding factor in both previous and further immunological
and virological studies. Historically, for example, much Friend virus literature has
been affected by the contamination of viral stocks with lactate dehydrogenase-elevating
virus (LDV). FV/LDV co-infection drastically alters the progression and outcome of
FV infection (Marques et al., 2008; Miyazawa, Tsuji-Kawahara & Kanari, 2008; Pike
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et al., 2009) and significantly impacts the immune response. The potential existence of
RARVs in mice used for studies of retroviral immunology, and the unknown impact of
co-infection, now needs to be taken into account and investigated in these settings.
Further, the inheritance of infectious viruses neonatally complicates the breeding of
knock-out and other mutant mouse lines. Lines generated with use of males carrying
the desired genotype may avoid the vertical transmission of viruses, whilst those gen-
erated in the complementary manner would likely transmit viruses to progeny strains.
Increasingly, littermate controls are seen as preferable to the use of separate litters of
control mice in experimental models. Even here, however, the existence of a vertic-
ally inherited infectious MLV complicates interpretation. For example, where a mouse
heterozygous for a gene associated with antibody-deficiency (e.g. a Rag1+/- mouse)
may be used to represent ‘wild-type’ in a litter otherwise homozygous knock-out (e.g.
Rag1-/-), these would possess the necessary antiviral antibodies to likely control in-
fection resulting from inherited virus and prevent disease, where littermates would
succumb to infection and resulting pathogenesis.
The potential influence of the gut microbiome further complicates comparisons of data
obtained under varying husbandry conditions and between research centres. Even
within a single institute, mutant mouse lines with specific husbandry requirements or
reduced fecundity are frequently offered acidified water where standard stocks may be
treated in a different manner. This further complicates comparisons of data obtained
through the use of mutant mouse lines and, indeed, much early work involved in this
project had to be reinterpreted or repeated on discovery of the implications of acidified
water treatment.
Whilst all known human ERVs are non-functional, a proof-of-principle study was able
to construct an infectious virus from a consensus of HERV-K family sequences (Y. N.
Lee & Bieniasz, 2007). Thus, although well-studied in murine models, an infectious
and oncogenic potential of human ERVs has not been observed. Nevertheless, other
REs have been shown to be active in humans and have been associated with disease in
some cases (Iskow et al., 2010; E. Lee et al., 2012).
To investigate briefly if human ERVs and REs might be controlled in a similar manner
to those of mice, a human microarray dataset characterising LPS and R848 (a TLR 7/8
agonist) stimulation of monocyte-derived dendritic cells from 3 healthy donors (Cava-
lieri et al., 2010) was studied with REquest. Responses differed between cells derived
from each donor, but encouragingly, significant changes in expression could be noted
for probes corresponding to ERV-9-like elements (data not shown), HERV-K13-like
elements (Fig. 4.26a), and mammalian apparent long terminal repeat retrotransposon
(MaLR) elements (Fig. 4.26b).
These exploratory data open a large area of further study and may have great potential
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Figure 4.26: ERV expression in human cells stimulated
with TLR agonists
(a) (b)
Transcriptional profiling of human monocyte-derived dendritic cells from 3 healthy
donors in a publicly-available microarray dataset (EBI Array Express EMTAB-
448). Probes corresponding to REs and ERVs within the Illumina HT-12 expres-
sion microarray were determined with REquest and those significantly upregulated
(p<0.05) more than 2-fold determined. (a) LPS (left) and R848 (right) stimula-
tion causing increased expression of HERV-K13l. (b) R848 stimulation causing
increased MaLR expression. Each line represents an individual donor.
relevance in human disease and treatment options. Paralleling the results seen in mice,
increased risk of lymphoma has previously been associated with antibody-deficiency
in humans (Park, Li, Hagan, Maddox & Abraham, 2008), as well as infection and
inflammation (Trinchieri, 2012). A potential link between REs and ERVs and microbial
products is thus an intriguing research area and could link to factors such as antibiotic
use or conditions of excessive hygiene. Increased adiposity, for example, has been
correlated with antibiotic exposure in both humans and mice (Cho et al., 2012; Trasande
et al., 2012), yet changes such as these are unlikely to be found in isolation.
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Repetitive sequences, including REs and ERVs, comprise significant proportions of
mammalian genomes. These elements have accumulated throughout evolution and
whilst the majority are now unable to replicate, comparatively little research has
centred around their impacts on the host.
The work detailed here has focussed on the interaction of ERVs with the immune
system. Firstly, the single endogenous eMLV of B6 mice, Emv2, was seen to have a
significant affect on the development of thymocytes with potential reactivity in FV
infection. In spite of the large-scale deletion mediated by Emv2, however, this had
the effect of increasing overall proportions of high-avidity CD4+ T cells and is partly
responsible for the strong response to FV in this strain.
Secondly, the means by which the immune system impacts ERV expression was de-
termined. A requirement for specific antibodies could be identified in the control of
emergence of infectious virus within mouse colonies. Interestingly, the phenomenon of
‘resurrection’ of defective ERVs could be shown in multiple antibody-deficient stains
and across a further five animal facilities, impacting many commonly-used strains and
having significant implications for mouse experimentation. Whilst not examined ex-
haustively, the data presented further suggest an intriguing link to microbial stimulation
in the de novo emergence of infectious virus within these strains.
The murine model represents a versatile tool in biological research and the work detailed
in this thesis has exploited various congenic, transgenic and knock-out strains generated
over many years. Whilst there is significant variability in experimental systems defined
in mice or humans, there are also significant similarities (Su et al., 2002; Zheng-Bradley,
Rung, Parkinson & Brazma, 2010). In this way, whilst the compositions of human and
murine REs differ considerably, the overall proportions of these elements within the
two genomes is relatively similar. Thus whilst a considerable effort will be required
to translate these findings and to determine their possible relevance in human disease,
this is an exciting research opportunity.
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Abstract
Effective T cell responses can decisively influence the outcome of retroviral infection. However, what constitutes protective
T cell responses or determines the ability of the host to mount such responses is incompletely understood. Here we studied
the requirements for development and induction of CD4+ T cells that were essential for immunity to Friend virus (FV)
infection of mice, according to their TCR avidity for an FV-derived epitope. We showed that a self peptide, encoded by an
endogenous retrovirus, negatively selected a significant fraction of polyclonal FV-specific CD4+ T cells and diminished the
response to FV infection. Surprisingly, however, CD4+ T cell-mediated antiviral activity was fully preserved. Detailed
repertoire analysis revealed that clones with low avidity for FV-derived peptides were more cross-reactive with self peptides
and were consequently preferentially deleted. Negative selection of low-avidity FV-reactive CD4+ T cells was responsible for
the dominance of high-avidity clones in the response to FV infection, suggesting that protection against the primary
infecting virus was mediated exclusively by high-avidity CD4+ T cells. Thus, although negative selection reduced the size and
cross-reactivity of the available FV-reactive naı¨ve CD4+ T cell repertoire, it increased the overall avidity of the repertoire that
responded to infection. These findings demonstrate that self proteins expressed by replication-defective endogenous
retroviruses can heavily influence the formation of the TCR repertoire reactive with exogenous retroviruses and determine
the avidity of the response to retroviral infection. Given the overabundance of endogenous retroviruses in the human
genome, these findings also suggest that endogenous retroviral proteins, presented by products of highly polymorphic HLA
alleles, may shape the human TCR repertoire that reacts with exogenous retroviruses or other infecting pathogens, leading
to interindividual heterogeneity.
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Introduction
Adaptive immunity to viral infection relies on appropriate
activation of T cells by complexes of viral peptides with MHC
molecules. The host MHC haplotype, the nature of the viral
peptide targeted and the T cell receptor (TCR) repertoire of
responding T cells are three interconnected parameters that play a
decisive role in the outcome of infection. Indeed, the MHC is the
predominant genetic factor affecting susceptibility to many
infectious diseases [1–4]. For example, the HLA locus shows the
strongest genetic association with control of HIV infection, with
certain HLA alleles having been consistently found to confer a
protective advantage [3,5,6]. Although the precise underlying
mechanism is not completely understood, T cell responses
restricted by protective HLA/MHC alleles often comprise narrow-
er TCR repertoires, dominated by public TCR sequences, and
exhibit higher magnitude, avidity or depth, and thus greater
contribution to HIV or SIV control, than those restricted by non-
protective HLA/MHC alleles [7–9].
Bias in the use of certain TCRVa (Va) or TCRVb (Vb) chains
has been frequently observed in the T cell response to several
antigenic epitopes, and public T cell responses with identical or
similar TCRs have been found to dominate the response of
different individuals to a given epitope. Skewed TCR usage has
often correlated with higher functional avidity to a given antigenic
epitope, and, in diverse systems, also translated into more efficient
protection against infection [10–12]. Despite the potential
importance in cellular immunity to infection, however, the
mechanisms by which TCR biases (and particularly high-avidity
T cell responses to viral infections) are generated and maintained
remains incompletely understood. The mechanisms leading to bias
in the T cell response will vary considerably depending on the
antigenic peptide and MHC combination. TCR repertoire bias
can be generated during thymic selection, leaving only certain Va
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or Vb chains able to respond to a given antigen [10]. It can also be
generated at the initiation of the immune response, where clones
using particular Va or Vb chains may have a recruitment or
proliferative advantage and can quickly dominate the response
[10]. Lastly, bias can also be generated during chronic viral
infection either due to preferential maintenance of certain T cell
clones or differential margins for cross-reactivity with viral escape
mutations [10] or by prior or concurrent infection with
heterologous viruses, sharing cross-reactive epitopes [13].
We have previously described the TCRb-transgenic strain EF4.1,
which generates increased frequencies of CD4+ T cells reactive with
the H2-Ab-restricted env122-141 epitope of Friend murine leukemia
virus (F-MLV) [14]. Virus-specific EF4.1 CD4+ T cells show bias in
the use of endogenous Va2 chains in their response to infection with
Friend virus (FV), a retroviral complex of F-MLV and spleen focus-
forming virus (SFFV) [14,15]. Use of Va2 chains by virus-specific
CD4+ T cells creates higher avidity for the same epitope than use of
other Va chains, and although they represent a minority in the
naı¨ve repertoire, high-avidity Va2 T cells become the dominant
subset at the peak of the response [15]. Here we have examined the
potential mechanisms underlying the formation of TCR repertoire
diversity in this system, which might be responsible for the high-
avidity response to FV infection. We have found that a thymic
selection event was necessary for the dominance of Va2 virus-
specific CD4+ T cells during the response to FV infection. Selection
of virus-specific CD4+ T cells was mediated by a self peptide
encoded by an endogenous retrovirus with substantial similarity to
F-MLV. Unexpectedly, despite deleting a sizeable fraction of virus-
specific CD4+ T cells, negative selection by this endogenous
retrovirus was necessary for a predominantly high-avidity response
to FV infection.
Results
Higher functional avidity of Va2 F-MLV env122-141-specific
CD4+ T cells
On average, 4% of EF4.1 CD4+ T cells in virus-naı¨ve mice
react with the env122-141 peptide, of which approximately 25%
stain positive with the anti-Va2 monoclonal antibody B20.1
[14,15]. Va2 env-specific CD4+ T cells were previously [14,15]
found to be .30-fold more sensitive than non-Va2 T cells to
stimulation with a 20-mer env122-141 peptide spanning the core
env128-134 epitope [16]. This higher avidity of Va2 CD4
+ T cells
was not due to recognition of the core epitope-flanking residues by
this family of Va chains, as has been described for other TCR –
epitope combinations [17], since it was maintained against a series
of N-terminal truncated peptide epitopes (Figure S1A). Thus, Va2
CD4+ T cells would recognize with higher avidity all the nested
peptides of variable lengths likely to be generated during in vivo
processing of env [18].
To examine whether the polyclonal Va2 CD4+ T cell
population displayed higher affinity for F-MLV env-derived
epitopes even at the clonal level, we generated hybridoma cell
lines from primary EF4.1 CD4+ T cells stimulated in vitro with
either a low (1027 M) or a high (1025 M) peptide dose. In
agreement with our previous findings [14,15], 71% (20/28) and
30% (9/30) of hybridoma cell lines derived from CD4+ T cells
stimulated with the low or high peptide dose, respectively, were
Va2+. Similarly to primary EF4.1 CD4+ T cells, randomly selected
Va2 T cell hybridomas were more sensitive to stimulation with all
the peptides tested than non-Va2 ones, irrespective of whether a
high or low peptide dose was used for their generation (Figure
S1B). Thus, the higher avidity of Va2 CD4+ T cells for F-MLV
env-derived epitopes was also observed at the level of individual
clones.
To assess whether low-avidity F-MLV env-reactive CD4+ T
cells were characterized by expression of any particular family of
endogenous Va chains, we screened env122-141-specific non-Va2
CD4+ T cells for expression of Trav transcripts encoding different
Va families. Although this analysis indicated enrichment for
Trav9 expression (encoding Va3), only a small percentage of
env122-141-reactive non-Va2 CD4
+ T cells stained positive with
the anti-Va3.2 monoclonal antibody RR3-16 (unpublished data),
and only 2 out of 4 F-MLV env-reactive non-Va2 T cell
hybridomas were positive for Va3.2 (Table S1). However, Va3.2
is used preferentially in CD8+ T cells in B6 mice, whereas the
other three of the four expressed Va3 family members are
preferentially expressed in CD4+ T cells [19]. It was therefore
possible that env122-141-reactive non-Va2 CD4
+ T cells that did
not stain positive with the RR3-16 antibody were also expressing
Va3. Indeed, cloning and sequencing of expressed endogenous
Trav genes from theses hybridomas revealed that they were all
members of the Trav9 family (Table S1). Thus, similarly to
selective usage of Va2 chains in high-avidity cells, low-avidity F-
MLV env122-141-reactive CD4
+ T cells selectively used Va3
chains. However, in the absence of a Va3-specific antibody that
can detect all Va3 family members, these cells were referred to
here as non-Va2 cells.
Lastly, we tested whether biased use of Va2 chains also
characterized the response of non-transgenic CD4+ T cells to F-
MLV env. CD4+ T cells from wild-type (wt) C57BL/6 (B6) mice 7
days post FV infection were stained with an env123-141-presenting
tetramer (Ab-env123-141). In comparison with a control tetramer,
staining with Ab-env123-141 tetramer identified a measurable
population of env122-141-specific CD4
+ T cells in all infected mice
(Figure 1A), in agreement with published data [20,21]. FV
infection had no impact on the frequency of Va2 cells in naı¨ve
(CD44lo) and total memory (CD44hi) CD4+ T cells (15% and 12%,
respectively), with minimal variation between individual mice
(Figure 1B). In contrast, the frequency of Va2 cells in Ab-env123-141
tetramer+ CD4+ T cells varied considerably between 4% and 23%.
These results revealed substantial deviation in Va2 usage in Ab-
Author Summary
Our immune systems defend against viral infection.
However, the immune response to a virus often differs
substantially between individuals, as does the outcome of
infection. The antiviral immune response relies on recog-
nition of viral proteins by T lymphocytes using T cell
antigen receptors (TCRs). TCRs are created randomly in an
individual and each T lymphocyte has a different TCR. T
lymphocytes with TCRs that recognize our own (self)
proteins are removed during development, to prevent
autoimmunity. Our cells can also make proteins that
belong to endogenous retroviruses (ERVs), relics of
ancestral retroviral infection that accumulated during
evolution to constitute a large proportion of our genomes.
The impact of ERVs on lymphocyte development and the
subsequent influence on antiviral immunity is incomplete-
ly understood. Here, we use a mouse model to investigate
this link and show that the T lymphocyte response to
exogenous retrovirus infection is heavily influenced by an
ERV. Surprisingly, we find that ERVs do not always have a
negative impact on immunity, and in our model they
improve the sensitivity with which T lymphocytes react to
retroviral infection. This work may thus provide a basis for
the understanding of the heterogeneity in immunity to
retroviral infections in genetically diverse individuals.
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env123-141 tetramer
+ CD4+ T cells from the same usage in total
CD4+ T cells, but also indicated substantial heterogeneity.
However, this particular tetramer is known to bind only some
env122-141-specific T cell clones but not others [14,22]. Further-
more, at the peak of their response, env122-141-specific CD4
+ T cell
reversibly downregulate up to 70% of their surface TCR [15,23],
which could prevent tetramer binding. Indeed, combining
adoptive transfer of EF4.1 CD4+ T cells and tetramer staining
revealed that Ab-env123-141 tetramer staining was restricted to
env122-141-reactive CD4
+ T cells with above-average TCR levels,
independently of Va usage, and TCR re-expression improved
tetramer staining (Figure 1C–F). Thus, detection of env122-141-
reactive CD4+ T cells by Ab-env123-141 tetramer staining was
eclipsed by in vivo antigen-induced TCR downregulation. Collec-
tively, these results both validated and necessitated the use of
env122-141-reactive EF4.1 CD4
+ T cells that can be indelibly
identified, independently of Ab-env123-141 tetramer binding, to
study the requirements for induction of a high-avidity CD4+ T cell
response to F-MLV env.
Deletion of F-MLV env122-141-specific CD4
+ T cells by
Emv2-encoded env
F-MLV env122-141-reactive CD4
+ T cells in EF4.1 mice have a
naı¨ve phenotype [14], and it was therefore likely that the F-MLV
env122-141-reactive TCR repertoire and associated avidity differ-
ences were the result of thymic selection events. We searched the
mouse proteome for the presence of self-derived epitopes with
homology to F-MLV env122-141. This approach identified the
single-copy endogenous ecotropic MLV at the Emv2 locus [24].
Emv2 shares 80% homology with F-MLV at the DNA sequence
level, and although it represents a full-length provirus, it is unable
to produce infectious particles due to a single inactivating point-
mutation in the pol gene [24]. Nevertheless, Emv2 has full potential
for env expression, and, importantly, the env122-141 epitope is
almost identical between Emv2 and F-MLV, with the exception of
a Y instead of an L at position 128 (Figure S2A). For this reason,
Emv2 and F-MLV env-derived epitopes were referred to here as
env122-141Y and env122-141L, respectively. Position 128, together
with 129 and 133, have been previously mapped as important
Figure 1. Detection of env-specific CD4+ T cells by Ab-env123-141 tetramer eclipsed by antigen-induced TCR downregulation. (A) A
b-
hCLIP (control) or Ab-env123-141 tetramer staining in total CD4
+ T cells isolated from the spleen of wild-type B6 mice 7 days post FV infection. Plots are
representative of 7 mice. (B) Frequency of Va2 cells in either bulk naı¨ve (CD44lo), bulk memory (CD44hi) or Ab- env123-141 tetramer
+ CD4+ T cells from
the same FV infected mice. Horizontal short lines in naı¨ve and memory subsets denote the mean frequency of Va2 cells in the same populations from
uninfected mice. Each symbol represents an individual mouse. (C–F) CD45.1+ EF4.1 CD4+ T cells were adoptively transferred into wild-type B6
recipients that were infected with FV the same day. (C) Ab-env123-141 tetramer staining in host (CD45.1
2) or donor (CD45.1+) CD4+ T cells according to
TCRa or TCRb staining. Gates in donor CD4+ T cells are set around the median TCRa and TCRb staining, respectively. (D) Percentage of Ab-env123-141
tetramer+ cells in donor CD4+ T cells with TCRb (left) or TCRa (right) staining below or above the median. (E) Ab-hCLIP or Ab-env123-141 tetramer
staining in host or donor CD4+ T cells from the same recipients assessed directly ex vivo (top) or following 3-day in vitro culture in the absence of
antigenic stimulation (bottom). (F) Percentage of Ab-env123-141 tetramer
+ cells in donor CD4+ T cells before and after in vitro culture. In (D) and (F) each
symbol represents an individual mouse from one of two experiments.
doi:10.1371/journal.ppat.1002709.g001
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contact residues for the SB14-31 TCR (Figure S2B), which was the
donor of the TCRb chain transgene used in EF4.1 mice [16].
We next investigated whether or not Emv2 could be involved in
T cell selection. In vitro stimulation with the env124-138Y epitope
activated a fraction of EF4.1 CD4+ T cells, which was however
smaller than the fraction activated by the env124-138L epitope
(Figure 2A). As EF4.1 mice generate a polyclonal TCR repertoire,
it was unclear whether the same CD4+ T cells could respond to
both epitopes. However, analysis of env124-138L-reactive T cell
hybridomas revealed the same TCR could be activated by both
env124-138L and env124-138Y epitopes, albeit less potently by the
latter peptide (Figure 2B). Thus, F-MLV env124-138-reactive TCRs
have the potential to recognize Emv2 env. This analysis also
revealed that Emv2 was not causing complete tolerance of either
env124-138L or env124-138Y epitopes. We then confirmed that Emv2
was expressed in primary and secondary lymphoid organs. Using
primers specific to the spliced env mRNA that could distinguish
between genuine transcripts and contaminating genomic DNA,
Emv2 was found to be expressed at low levels in the majority of
mice tested (Figure 2C). This low level of expression was further
confirmed by comparison with a newly-generated B6 congenic
strain lacking Emv2 (Figure S3). To evaluate the extent of Emv2-
mediated deletion of env-reactive CD4+ T cells more directly, we
generated B6-Emv22/2 EF4.1 mice and compared them with
Emv2-expressing EF4.1 mice. Emv2-deficient EF4.1 mice con-
tained a significantly higher frequency of env124-138L-reactive
CD4+ T cells than Emv2-sufficient EF4.1 mice, with Emv2, when
present, being responsible for the deletion of approximately 35%
of these cells (Figure 2D). Thus, albeit low, expression of Emv2 in
B6 mice significantly impacted on the frequency of env124-138L-
reactive EF4.1 CD4+ T cells.
The Emv2-selected CD4+ T cell repertoire retains full
antiviral activity
Emv2-mediated deletion of a proportion of env124-138L-reactive
EF4.1 CD4+ T cells suggested that Emv2 may impinge on
resistance to FV infection. We therefore examined the possible
effect of Emv2 expression on FV control. Firstly, we infected non-
transgenic B6 and Emv2-deficient B6 mice and measured the levels
of infected cells in the spleen. B6 mice are relatively resistant to FV
infection due to genetic resistance at the Fv2 locus and due to
mounting a strong adaptive immune response [1,25], resulting in
control of the infection by the third week. Percentages of FV-
infected (glyco-Gag+) erythroid precursor (nucleated Ter119+) cells
were significantly lower in B6-Emv22/2 mice than in wt
counterparts at day 7 of infection (Figure 3A). Nevertheless, wt
B6 mice effectively controlled FV infection to levels comparable
with those in B6-Emv22/2 mice by the second week of infection
(Figure 3A). Thus, Emv2 deficiency did not extensively increase the
natural resistance of B6 mice to FV infection.
The modest increase in resistance to FV infection in B6-
Emv22/2 mice suggested that this low Emv2 expression was
immunologically relevant, but did not indicate if any arm of the
adaptive immune response was affected. We thus measured the
FV-specific CD4+ T cell, CD8+ T cell and antibody responses in
these mice. In contrast to the MHC class II-restricted env122-141L
epitope, the FV-derived MHC class I-restricted epitopes that have
been described do not share extensive homology or cross-reactivity
with those derived from Emv2 [26–28]. We examined the CD8+ T
cell response to FV by measuring numbers of activated
CD44hiCD43+CD8+ T cells, irrespective of antigen specificity, in
the spleens of B6 and B6-Emv22/2 mice 7 days post FV infection
(Figure S4A). The two types of host showed comparable expansion
of CD44hiCD43+CD8+ T cells, suggesting they mounted a CD8+
T cell response of similar magnitude (Figure S4A). We further
measured the CD8+ T cell response to the immunodominant Db-
restricted epitope from the leader sequence gPr80gag85-93 encoded
by the F-MuLV gag gene [28]. CD8+ T cells specific to the
gPr80gag85-93 epitope display strong bias for the use of Va3.2 and
Vb5.2 in combination, which allows their identification by flow
cytometry [29]. Expectedly, FV infection led to an increase in the
percentage of Va3.2+Vb5.2+ cells in antigen-experienced
(CD44hi), but not naı¨ve (CD44lo) CD8+ T cells (Figure S4B).
However, this expansion of Va3.2+Vb5.2+CD44hiCD8+ T cells
was comparable in B6 and B6-Emv22/2 mice 7 days post FV
infection (Figure S4B).
We next examined the FV-specific antibody response of B6 and
B6-Emv22/2 hosts. As FV-neutralizing antibodies are not readily
Figure 2. Emv2 selects against a fraction of env124-138L-specific CD4
+ T cells. (A) Dilution of prior CFSE label by primary EF4.1 CD4+ T cells
incubated for three days in vitro in the absence of peptide stimulation (-) or in the presence of 1025 M env124-138L or env124-138Y peptides. Numbers
within the plots denote the percentage of CFSE2 cells and are representative of 4 mice per condition. (B) IL-2 production by three env124-138L-specific
hybridoma T cell lines in response to in vitro stimulation with the same peptides at 561026 M. (C) Emv2 transcription, relative to Hprt transcription, in
thymi (Th) and spleens (Sp) of wild-type B6 or Emv2-deficient B6 mice (B6-Emv22/2). Each symbol is an individual mouse. The dashed line represents
the limit of detection. (D) Frequency of env124-138L-specific cells in primary CD4
+ T cells from B6 (B6-EF4.1) or Emv2-deficient B6 (B6-EF4.1 Emv22/2)
EF4.1 mice. Data are the means 6 SEM (n=9) from 3 experiments.
doi:10.1371/journal.ppat.1002709.g002
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detected in B6 mice on day 7 post FV infection [25], we measured
titers of antibodies that were able to bind F-MLV-infected cells
(Figure S4C). On day 7 post FV infection all mice produced both
IgG and IgM F-MLV-infected cell-binding antibodies that could
be measured by flow cytometry (unpublished data). However, titers of
these antibodies were low at this early time-point and in a
proportion of FV-infected mice they were below 50, a value that
we set as the detection limit (Figure S4C). Importantly, serum
titers of both IgG and IgM F-MLV-infected cell-binding
antibodies were similar between B6 and B6-Emv22/2 hosts (Figure
S4C).
Lastly, the frequency of Ab-env123-141 tetramer
+ CD4+ T cells as
well as the frequency of Va2 cells within this population was highly
variable between individual mice and as a result not statistically
different between groups of B6 and B6-Emv22/2 hosts on day 7
post FV infection (Figure S4D). However, staining with the Ab-
env123-141 tetramer may have underestimated the frequency of
env122-141L-reactive CD4
+ T cells (Figure 1) and it was also
possible that env122-141L-reactive CD4
+ T cells selected in the
presence or absence of Emv2 expressed TCRs with distinct Ab-
env123-141 tetramer-binding properties. Furthermore, virus-specific
CD4+ T cells can mediate both direct and indirect protection
against FV infection [15,23,30], and env122-141-specific CD4
+ T
cells have been shown to mediate direct cytotoxic activity [31]. It
was thus uncertain whether weakened immunity in Emv2-
expressing mice was directly linked to a potentially less effective
CD4+ T cell response. We therefore examined the effect of Emv2
expression on the FV-specific CD4+ T cell response functionally
and directly. To this end, equal numbers of Emv2-selected or -
nonselected EF4.1 CD4+ T cells were transferred into the same
type of host. This approach ensured that only donor EF4.1 CD4+
T cells differed with respect to exposure to Emv2. Surprisingly, the
two types of donor CD4+ T cells provided comparable and almost
complete protection of wild-type B6 hosts, at the peak of FV
replication on day 7 post infection (Figure 3B, C). To rule out that
differences in antiviral activity between the two types of donor
CD4+ T cells were not missed because this activity was already
maximal, we have additionally used B6.A-Fv2s hosts, expressing
the susceptibility allele at the Fv2 locus, which confers susceptibility
to FV infection by enhancing proliferation of infected erythroid
Figure 3. Emv2-selected CD4+ T cells retain full antiviral activity. (A) Mean frequency (6 SEM, n= 8–19) of FV-infected (glyco-Gag+) Ter119+
cells in the spleens of FV-infected B6 or Emv2-deficient B6 mice (B6-Emv22/2). (B–C) CD4+ T cells isolated from either B6 (B6-EF4.1) or Emv2-deficient
B6 (B6-EF4.1 Emv22/2) EF4.1 mice were adoptively transferred into B6 or B6.A-Fv2s recipients that were infected with FV the same day and analyzed 7
days later. (B) Flow cytometric example of FV-infected Ter119+ cells from B6 recipients and (C) frequency of FV-infected cells in Ter119+ cells from the
spleens of B6 or B6.A-Fv2s recipients of CD4+ T cells. Control B6 and B6.A-Fv2s mice that received no CD4+ T cells (-) are also included. Each symbol is
an individual mouse. (D) Spleen index (left) and RBC count (right) of B6-Rag12/2Fv2s mice that were infected with FV and either received the same day
CD4+ T cells isolated from either B6 (B6-EF4.1) or Emv2-deficient B6 (B6-EF4.1 Emv22/2) EF4.1 mice or no cells (-). Each symbol is an individual mouse
analyzed 3 weeks post infection. (E) Titers of FV-neutralizing antibodies during the course of FV infection (left) and titers of F-MLV-infected cell-
binding IgG (middle) and IgM (right) 7 days post FV infection, in the sera of B6-Tcra2/2 mice that either received CD4+ T cells isolated from either B6
(B6-EF4.1) or Emv2-deficient B6 (B6-EF4.1 Emv22/2) EF4.1 mice or no cells (-) the day of the infection. Dashed lines represent the limit of detection.
Data are the means 6 SEM (n= 11–12) from 2 experiments.
doi:10.1371/journal.ppat.1002709.g003
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precursors [25]. The two types of donor CD4+ T cells provided
significant, suboptimal and, importantly, comparable protection in
B6.A-Fv2s hosts, at the peak of FV replication and expansion of
infected erythroid precursors on day 7 post infection in this strain
(Figure 3C). Thus, Emv2-mediated selection did not impair the
antiviral activity of CD4+ T cells exerted in wt hosts. To further
examine direct CD4+ T cell-mediated protection we transferred
equal numbers of Emv2-selected or -nonselected EF4.1 CD4+ T
cells into T and B cell-deficient Rag12/2 Fv2s hosts. Both types of
donor CD4+ T cells were similarly protective against severe FV-
induced splenomegaly (Figure 3D) that otherwise develops in these
hosts [15]. In addition, the two types of donor CD4+ T cells caused
comparable levels of anemia in these T and B cell -deficient hosts
(Figure 3D), which results from bone marrow pathology [14].
Lastly, FV-neutralizing antibodies were similarly and efficiently
induced in T cell-deficient Tcra2/2 hosts by transfer of either type
of donor CD4+ T cells, although they were slightly, but not
significantly higher in hosts of Emv2-nonselected CD4+ T cells on
day 7 post infection (Figure 3E). Nevertheless, at this time-point,
the two types of donor CD4+ T cells induced comparable titers of
IgG or IgM antibodies that were able to bind F-MLV-infected
cells, which also included antibodies potentially mediating
antibody-dependent cell-mediated cytotoxicity (Figure 3E). Col-
lectively, these results demonstrated that despite selecting against a
significant fraction of env124-138L-reactive CD4
+ T cells, Emv2
expression did not compromise CD4+ T cell function against FV
infection.
Selection by Emv2 promotes a higher-avidity response to
F-MLV
Retention of full CD4+ T cell-mediated antiviral activity, despite
deletion of over a third of env124-138L-reactive CD4
+ T cells in
Emv2-expressing mice, suggested that the deleted cells were not
contributing to immunity against FV infection. We therefore
assessed the impact of Emv2 expression on both the magnitude and
composition of the CD4+ T cell response to FV. Equal numbers of
EF4.1 CD4+ T cells from either Emv2-sufficient or -deficient donor
B6 mice, positive for CD45.2 (encoded by the Ptprc2 allele), were
adoptively transferred into Ptprc1/2 syngeneic B6 recipients that
were positive for both CD45.1 and CD45.2. Recipient mice were
infected with FV on the day of T cell transfer and FV-responding
donor CD4+ T cells were identified as CD44hiCD45.2+CD45.12
cells (Figure S5). Consistent with increased precursor frequency in
Emv2-deficient donor mice, significantly higher numbers of total
responding CD4+ T cells could be recovered at the peak of the
response from secondary recipients that received Emv2-nonselect-
ed than those that received Emv2-selected donor CD4+ T cells
(Figure 4A). Notably, the two types of donor CD4+ T cells
generated comparable numbers of high-avidity responding CD4+
T cells, and the numerical increase in total numbers of responding
CD4+ T cells from Emv2-nonselected donors was due to
significantly higher expansion of low-avidity non-Va2 responding
CD4+ T cells from these donors in comparison with the expansion
of non-Va2 responding CD4+ T cells from Emv2-selected donors
(Figure 4A). As a result, peak expansion of Emv2-selected CD4+ T
cells was dominated by high-avidity Va2 CD4+ T cells, whereas
that of Emv2-nonselected CD4+ T cells was dominated by low-
avidity non-Va2 CD4+ T cells (Figure 4B, C). Thus, Emv2
expression converted a predominantly low-avidity response to FV
to a predominantly high-avidity response.
Emv2-encoded env preferentially deletes non-Va2 CD4+ T
cells
The shift from a predominantly Va2 response of Emv2-selected
CD4+ T cells to a predominantly non-Va2 response of Emv2-
nonselected CD4+ T cells could be the result of Emv2-induced
modulation of either the relative frequency in the naı¨ve repertoire
of the two subsets of env124-138L-reactive CD4
+ T cells, or their
relative avidity for env124-138L (or both). We first measured the
overall functional avidity to env124-138L of EF4.1 CD4
+ T cells
selected with or without Emv2 as an indicator of potential avidity
repertoire changes. Surprisingly, although the presence of Emv2
reduced the precursor frequency of env124-138L-reactive CD4
+ T
cells, it had no effect on the avidity with which they responded to
env124-138L stimulation (Figure 5A). This result suggested that
Emv2-mediated selection either affected high- and low-avidity cells
similarly, or that potential loss of higher-avidity T cells was
compensated by an increase in average avidity of the remaining T
cells. To examine whether Emv2 preferentially selected against
high-avidity env124-138L-reactive cells, we measured their frequen-
cy separately in either Va2 or non-Va2 CD4+ T cells from EF4.1
mice. Notably, Emv2 expression significantly reduced the frequen-
cy of non-Va2, but not Va2 env124-138L-reactive cells in EF4.1
CD4+ T cells (Figure 5B), indicating that it only selected against
Figure 4. Emv2-selected CD4+ T cells mount a predominantly high-avidity response. (A–C) CD45.2+ (Ptprc2/2) CD4+ T cells isolated from
either B6 (B6-EF4.1) or Emv2-deficient B6 (B6-EF4.1 Emv22/2) EF4.1 donor mice were adoptively transferred into Ptprc1/2 B6 recipients that were
infected with FV the same day and analyzed 7 days later. (A) Absolute number of total, Va2 or non-Va2 FV-responding (CD44hi) donor
(CD45.2+CD45.12) CD4+ T cells isolated from the spleens of recipient mice according to donor type. (B) Flow cytometric example and (C) frequency of
high-avidity Va2 cells in responding CD4+ T cells according to donor type. In (A) and (C) each symbol is an individual mouse.
doi:10.1371/journal.ppat.1002709.g004
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non-Va2 CD4+ T cells. Correspondingly, the avidity of Va2 CD4+
T cells to env124-138L was not altered by Emv2 expression, whereas
the avidity of non-Va2 CD4+ T cells was 3-fold higher in the
absence than in the presence of Emv2 (Figure 5C). Nevertheless,
non-Va2 CD4+ T cells from Emv2-deficienct mice still displayed
lower avidity than Va2 CD4+ T cells from either Emv2-deficienct
or -sufficient mice (Figure 5C).
To test whether Emv2-mediated changes in the frequency and
avidity for env124-138L of non-Va2 CD4
+ T cells could account
for the dominance of this subset in the in vivo response to FV of
Emv2-nonselected CD4+ T cells, we examined the in vitro response
of Emv2-selected or -nonselected primary naı¨ve EF4.1 CD4+ T
cells to env124-138L stimulation. As a result of differences in initial
frequency and functional avidity between virus-naı¨ve Va2 and
non-Va2 env122-141-specific cells, the composition of the respond-
ing population varied according to the amount of env122-141
presentation [14] and Va2 T cells dominated the response at
doses lower than 1027 M (Figure 5D). Importantly, this
percentage of Va2 cells was significantly lower at all peptide
doses in CD4+ T cells selected in the absence than in the presence
of Emv2 (Figure 5D), demonstrating that selection by this single
provirus heavily influenced the clonal composition of env124-138L-
reactive CD4+ T cells, in favor of high-avidity cells. We further
confirmed that this effect of Emv2 expression of reducing the
overall frequency of env124-138L-reactive cells, but significantly
increasing the percentage of high-avidity Va2 cells in the
env124-138L-reactive population was already evident in
CD4+CD82 thymocytes (Figure S6), consistent with a thymic,
rather than peripheral event.
Preferential deletion by Emv2 of non-Va2 CD4+ T cells, which
had low avidity for F-MLV env124-138L raised the possibility that
these cells may have been cross-reactive with Emv2-encoded
env124-138Y. Indeed, lack of Emv2 expression in EF4.1 mice had a
small, non-significant effect on env124-138Y-reactive Va2 CD4
+ T
cells, but caused a significant 3.5-fold increase in the frequency of
env124-138Y-reactive non-Va2 CD4
+ T cells (Figure 5E). Further-
more, Va2 CD4+ T cells from either Emv2-deficient or -sufficient
EF4.1 mice could only react with env124-138Y at the highest dose of
1025 M, whereas non-Va2 CD4+ T cells from Emv2- deficient
mice were markedly more sensitive to env124-138Y than those from
Emv2-sufficient mice (and as sensitive as Va2 CD4+ T cells to
env124-138L) (Figure 5F). Together, these findings indicated that
Emv2 expression was not affecting env124-138L-reactive Va2 CD4
+
T cells because they displayed low avidity for env124-138Y, but was
deleting a significant proportion of non-Va2 CD4+ T cells that
could react with either env124-138L or env124-138Y.
Figure 5. Emv2 preferentially selects against non-Va2 env-specific CD4+ T cells. (A) Dose-response to env124-138L stimulation of CD4
+ T cells
isolated from either B6 (B6-EF4.1) or Emv2-deficient B6 (B6-EF4.1 Emv22/2) EF4.1 mice. (B) Frequency of env124-138L-specific cells in Va2 or non-Va2
primary CD4+ T cells from the same donors. (C) Functional avidity of Emv2-selected (B6-EF4.1) or -nonselected (B6-EF4.1 Emv22/2) EF4.1 CD4+ T cells
for env124-138L. (D) Frequency of Va2 cells in env124-138L-specific CD4
+ T cells from the same donors as a function of peptide concentration. (E)
Frequency of env124-138Y-specific cells in Va2 or non-Va2 primary CD4
+ T cells from the same donors. (F) Functional avidity of Emv2-selected (B6-
EF4.1) or -nonselected (B6-EF4.1 Emv22/2) EF4.1 CD4+ T cells for env124-138Y. Numbers in (C) and (F) represent the ED50. Data in (A–F) are the means6
SEM (n= 9–12) of 18-hr stimulations from 3 experiments.
doi:10.1371/journal.ppat.1002709.g005
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Shaping of env-reactive CD4+ T cell repertoire depth by
Emv2
Although EF4.1 CD4+ T cells selected by Emv2 mounted high-
avidity responses to the index env124-138L sequence in vitro, and to
FV infection in vivo, and retained full antiviral activity, counter-
selection of env124-138Y-reactive clones indicated that this reper-
toire would be less able to respond to viral escape mutations, and
especially to an L128Y mutation. To extend these findings, we
used another variant of env, which differed from F-MLV env in
two of the three putative TCR-binding residues. This variant has
Y and S in positions 128 and 129, respectively (referred to as
env124-138YS) and is a naturally-occurring functional form of
ecotropic env, encoded by the Fv4 locus in certain strains and
species of mouse, other than the B6 strain [32,33]. Again, a very
small fraction of EF4.1 Va2 CD4+ T cells could react to
env124-138YS, regardless of the presence or absence of Emv2
(Figure 6A). In contrast, lack of Emv2 led to a 7-fold increase in the
frequency of env124-138YS-reactive EF4.1 non-Va2 CD4
+ T cells,
which now made a sizable fraction (Figure 6A). Thus, non-Va2
CD4+ T cells from Emv2-deficient EF4.1 mice could react with the
index sequence and the two env variants and with high avidity to
env124-138Y, suggesting that Emv2-mediated selection significantly
reduced the ability of CD4+ T cells, at the population level, to
recognize these env variants.
This analysis of polyclonal cells from Emv2-deficient EF4.1 mice
did not reveal whether the same T cell could react to all three env
variants or if env124-138L-, env124-138Y- and env124-138YS-reactive
non-Va2 CD4+ T cells were distinct. We therefore tested the
reactivity of hybridoma cell lines generated from env124-138L-
reactive EF4.1 CD4+ T cells that developed either in the presence
or the absence of Emv2 expression to other env variants. Similarly
to non-Va2 CD4+ T cell hybridomas from Emv2-sufficient donors,
all 4 non-Va2 CD4+ T cell hybridomas tested from Emv2-deficient
donors used members of the TCRVa3 family (encoded by the
Trav9 gene family; Table S2). Notably, neither Emv2-selected nor -
nonselected env124-138L-reactive non-Va2 CD4
+ T cell hybrid-
omas responded to env124-138Y more potently than Va2 CD4
+ T
cell hybridomas from the same donor strain, and only 1 out of 4
had a measureable response to env124-138YS (Figure 6B, C). These
findings suggested that the env124-138L-reactive non-Va2 CD4
+ T
cells that developed in Emv2-deficient EF4.1 mice were largely
distinct from env124-138Y- and env124-138YS-reactive T cells in the
same mice. They also indicated that env124-138L-reactive non-Va2
CD4+ T cells were not inherently more cross-reactive than env124-
138L-reactive Va2 CD4
+ T cells at the clonal level.
To gain a more detailed view of the depth, defined here as the
ability to tolerate epitope mutations, of env124-138L-reactive Va2
or non-Va2 TCRs, we screened Emv2-selected or -nonselected
env124-138L-reactive T cell hybridomas for reactivity against a
library of env126-138 peptide variants carrying all possible single
mutations in each of the amino acid residues in positions 128, 129
and 133 (Figure S7). Amino acids that elicited at least 40% of the
maximal response were listed in the order they were preferred by
the individual TCRs (Figure 7). All Va2 T cell hybridomas
displayed strong preference for L at position 128 and also
recognized similar amino acids with hydrophobic side chains,
namely F, I, M and V, but not the less hydrophobic Y (Figure 7A).
Va2 T cell hybridomas also showed strong preference and
specificity for the amino acid residues of the index sequence
against which they were derived, T or highly similar S at position
129, and N at position 133 (Figure 7B, C). Overall, the depth of
Va2 T cell hybridomas was highly homogeneous and unaffected
by Emv2 expression. In contrast to Va2 T cell hybridomas, and as
expected by their low avidity for the index env124-138L sequence,
none of the non-Va2 T cell hybridomas derived from Emv2-
deficient mice displayed strong preference for L at position 128
(Figure 7A). The latter hybridomas did, however, respond strongly
to env variants with a different amino acid residue at this position,
most frequently V or I, or in the case of clone E2H10 the
unrelated S (Figure 7A). Non-Va2 T cell hybridomas selected by
Emv2 were also heterogeneous, with two clones showing similar
preference and specificity for V or I, and two other clones showing
much wider reactivity to at least 10 different amino acid residues,
including L (Figure 7A). Furthermore, the low reactivity to the
index env124-138L sequence of two of the four non-Va2 T cell
hybridomas derived from Emv2-deficient mice, but not those
derived from Emv2-sufficient mice, could be enhanced by
substitutions at another position (C for clone E2H10, and S or
T for clone E2L18, instead of N at position 133) (Figure 7C). Non-
Va2 T cell hybridomas that could recognize L at position 128 also
preferred the amino acid residue of the index env124-138L sequence
at the two other positions (T and N for positions 129 and 133,
respectively) (Figure 7B, C). Collectively, these results confirmed
the differential preference for L at position 128 between Va2 and
Figure 6. Cross-reactivity of individual Va2 or non-Va2 CD4+ T cells. (A) Frequency of env124-138YS-reactive cells in Va2 or non-Va2 CD4
+ T
cells isolated from either B6 (B6-EF4.1) or Emv2-deficient B6 (B6-EF4.1 Emv22/2) EF4.1 mice. Data are the means 6 SEM (n= 9) of 18-hr stimulations
from 3 experiments. (B–C) IL-2 production in response to stimulation with 561026 M env124-138L (L), env124-138Y (Y) or env124-138YS (YS) in comparison
with the absence of peptide stimulation (-) of Va2 or non-Va2 env124-138L-reactive hybridoma T cell lines derived from Emv2
+/+ (B) or Emv22/2 (C)
EF4.1 mice.
doi:10.1371/journal.ppat.1002709.g006
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non-Va2 T cell hybridomas and further suggested that selection
by Emv2 enriched the non-Va2 repertoire for clones with relative
indifference for this position.
Genetic contribution to a high-avidity env124-138L-
reactive CD4+ T cell repertoire
Analysis of the env-reactive CD4+ T cell repertoire in B6 mice
revealed a clear effect of Emv2-mediated selection. However, in
addition to Emv2, the presence of numerous other endogenous
retroviruses could affect the formation of the env124-138L-reactive
CD4+ T cell repertoire, even if their primary amino acid sequence
is not closely homologous with that of F-MLV env. Furthermore,
the functional avidity of env124-138L-reactive CD4
+ T cells could
also be affected by additional genetic determinants other than
endogenous retroviruses. To address this question we generated
congenic EF4.1 mice on the 129S8 background. 129S8 mice share
the same MHC class II allele with B6 mice (H2-Ab), thus allowing
restriction of env124-138L-specific EF4.1 CD4
+ T cells. However,
they do differ substantially with respect to the composition of
endogenous retroviruses and, importantly, 129S8 mice are
naturally devoid of endogenous ecotropic MLVs [34,35]. Similar
frequency of env124-138L-reactive Va2 CD4
+ T cells developed in
B6 and 129S8 EF4.1 mice (Figure 8A). In contrast, the frequency
of env124-138L-reactive non-Va2 CD4
+ T cells was significantly
higher on the 129S8 than on the B6 background (Figure 8A), and
was comparable with that on the Emv2-deficient B6 background
Figure 7. Depth of Va2 or non-Va2 env-specific CD4+ T cell repertoires. (A–C) Va2 or non-Va env124-138L-reactive hybridoma T cell lines were
derived from Emv2+/+ (B6-EF4.1) or Emv22/2 (B6-EF4.1 Emv22/2) EF4.1 mice and tested for reactivity against a library of env126-138 peptide epitopes.
The amino acid residues in positions 128 (A), 129 (B) and 133 (C) that elicited at least 40% of the maximal response are listed in the order of
preference by the individual clones.
doi:10.1371/journal.ppat.1002709.g007
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(Figure 5B), as was their functional avidity (Figure 8B). This
finding indicated that deletion of env124-138L-reactive non-Va2
CD4+ T cells in B6, but not in B6-Emv22/2 or 129S8 mice was
mediated primarily by Emv2. Surprisingly, however, the functional
avidity of env124-138L-reactive Va2 CD4
+ T cells in 129S8 mice
was very much reduced in comparison with that of Va2 CD4+ T
cells in B6 mice (Figure 8B), and was as low as that of low-avidity
non-Va2 CD4+ T cells. As, a result of differences in frequency and
functional avidity, the env124-138L-specific response of 129S8 mice
was dominated by non-Va2 CD4+ T cells at all peptide doses, in
contrast to that of B6 mice, which was dominated by Va2 CD4+ T
cells at low peptide doses (Figure 8C).
To further explore the origin of high-avidity env124-138L-
reactive Va2 CD4+ T cells in B6, but not in 129S8 mice, we
tested the response of a series of B66129S8-EF4.1 F1 mice. In
comparison with B66129S8-EF4.1 F1 mice, which inherited Emv2
from the B6 parent, B6-Emv22/26129S8-EF4.1 F1 mice, which
lacked ecotropic MLVs, had elevated frequencies of env124-138L-
reactive non-Va2 CD4+ T cells, whereas frequencies of env124-
138L-reactive Va2 CD4
+ T cells were similar (Figure 8D). These
results confirmed that elevated frequencies of env124-138L-reactive
non-Va2 CD4+ T cells in 129S8 mice were indeed due to lack of
Emv2-mediated selection. Interestingly, both B66129S8-EF4.1
and B6-Emv22/26129S8-EF4.1 F1 mice generated env124-138L-
reactive Va2 CD4+ T cells with higher avidity than those of 129S8
mice (Figure 8E), suggesting that a genetic contribution of the B6
parent, other than Emv2, was necessary for the development of
high-avidity env124-138L-reactive Va2 CD4
+ T cells. To assess
whether this genetic contribution arose from polymorphisms in the
Trav locus itself, we tested B6-Tcra2/26129S8-EF4.1 F1 mice,
which inherited Emv2 from the B6 parent, but could generate
endogenous Va chains only from the locus inherited from the
129S8 parent. The presence of Emv2 in B6-Tcra2/26129S8-EF4.1
F1 mice had the predicable effect on the frequency of env124-138L-
reactive non-Va2 CD4+ T cells (Figure 8D), which displayed
comparably low avidity in all three F1 strains tested (Figure 8E).
Surprisingly, however, env124-138L-reactive Va2 CD4
+ T cells that
had developed in B6-Tcra2/26129S8-EF4.1 F1 mice were also
low-avidity, which was comparable with that of Va2 CD4+ T cells
in 129S8 mice (Figure 8E), suggesting that the ability of B6 mice to
generate high-avidity env124-138L-reactive Va2 CD4
+ T cells was
germline-encoded. Consequently, the env124-138L-specific response
of B66129S8-EF4.1 F1 mice, but not of isogenic mice lacking
either Emv2 or the B6-origin Trav, was dominated by Va2 CD4+ T
Figure 8. Genetic contribution to a high-avidity env-reactive CD4+ T cell repertoire. (A) Frequency of env124-138L- reactive cells in Va2 or
non-Va2 primary CD4+ T cells isolated from either B6 (B6-EF4.1) or 129S8 (129S8-EF4.1) EF4.1 mice. (B) Functional avidity of env124-138L-reactive Va2 or
non-Va2 primary CD4+ T cells from the same donors in A. (C) Frequency of Va2 cells in env124-138L-reactive CD4
+ T cells from the same donors in A as
a function of peptide concentration. (D) Frequency of env124-138L- reactive cells in Va2 or non-Va2 primary CD4
+ T cells isolated from either
B66129S8-EF4.1 F1, B6-Emv2
2/26129S8-EF4.1 F1 or B6-Tcra
2/26129S8-EF4.1 F1, EF4.1 mice. (E) Functional avidity of env124-138L-reactive Va2 or non-
Va2 primary CD4+ T cells from the same donors in D. (F) Frequency of Va2 cells in env124-138L-reactive CD4
+ T cells from the same donors in D as a
function of peptide concentration. Numbers in (B) and (E) represent the ED50. In (C) and (F) the CD4
+ T cell response elicited by the last peptide dose
(1028 M) was too small to allow accurate measurement of the frequency of Va2 cells and was therefore omitted. Data in (A–F) are the means 6 SEM
(n=4–8) of 18-hr stimulations from 3 experiments.
doi:10.1371/journal.ppat.1002709.g008
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cells at low peptide doses (Figure 8F). The peak percentage of Va2
CD4+ T cells in the env124-138L-reactive population was lower in
B66129S8-EF4.1 F1 mice than in B6 mice, as the former were
expressing endogenous Va chains from both parental Trav loci.
Thus, the combined effect of Emv2 on the frequency of non-Va2 T
cells and of Trav on the avidity of Va2 T cells was necessary for the
dominance of high-avidity Va2 CD4+ T cells in the response to
env124-138L.
Discussion
As a result of the combinatorial process that creates TCRs, their
specificity is random and has to undergo selection. Thymic
positive and negative selection of developing T cells ensures that
mature T cells in the periphery have a functional TCR and
minimal reactivity to self proteins, respectively [36]. Negative
selection is thought to decrease the frequency, avidity and cross-
reactivity of the developing TCR repertoire specific to foreign
epitopes that may be similar to self-derived epitopes presented in
the thymus [36] and promote peptide specificity [37]. Here we
used a well-characterized molecular system to show that negative
selection by a defined self peptide from Emv2 env indeed decreased
the frequency in the naı¨ve CD4+ T cell repertoire of clones specific
to a range of foreign env epitopes, thus reducing the magnitude of
the CD4+ T cell response to all env epitope variants. However,
negative selection counter-intuitively also promoted the avidity of
the CD4+ T cell response to F-MLV env by shifting the clonal
composition of responding CD4+ T cells in favor of high-avidity
cells.
CD4+ T cells play a central coordinating role in the
orchestration of adaptive immunity to infection, and may also
mediate direct antiviral activity. Recent studies in diverse systems
have indicated an essential role for the CD4+ T cell response in the
control of retroviral infection [15,38–42]. We have previously
shown that protection of wt mice against acute FV infection is
proportional to the frequency of virus-specific CD4+ T cells [23].
Surprisingly, we found that although negative selection signifi-
cantly reduced both the precursor frequency and peak expansion
of F-MLV env-specific CD4+ T cells, it did not compromise CD4+
T cell-mediated antiviral activity. This finding suggested that not
all virus-specific CD4+ T cells were equal in their ability to
mediate antiviral functions. Indeed, negative selection by Emv2 env
affected CD4+ T cells with low avidity for F-MLV env, but not
those with high avidity for the same epitope. Preservation of full
antiviral activity in the Emv2-selected CD4+ T cell repertoire
therefore indicated that this activity is primarily, if not exclusively,
exerted by high-avidity CD4+ T cells.
High-avidity virus-specific CD4+ T cells may be superior in
certain direct antiviral or indirect helper functions than low-avidity
ones, but there may also be important exceptions. High-avidity
CD4+ T cells responding to FV infection have been reported to
show enhanced ex vivo production of IFN-c and IL-21 cytokines
and reduced expression of PD-1 inhibitory receptor [15] than low-
avidity counterparts, properties that may contribute to superior
antiviral activity. However, T follicular helper (Tfh) differentiation
and function were previously found to be similar between high-
and low-avidity virus-specific CD4+ T cells [15], suggesting that
provision of T cell help for the production of virus-neutralizing
antibodies may be more sensitive to the frequency of virus-specific
CD4+ T cells, rather than their avidity. However, in addition to
the frequency of virus-specific CD4+ T cells, the virus-specific
antibody response is also proportional to the frequency of rare
antigen-specific B cells. Thus, when availability of T cell help is
abundant, the virus-specific antibody response may be limited by
the frequency of antigen-specific B cells and additional T cell help
would not be expected to enhance antibody production. Consis-
tent with this idea, adoptive transfer of virus-specific EF4.1 CD4+
T cells into wt B6 mice did not accelerate the virus-neutralizing
antibody response [23]. In addition to an effect of Emv2 on the
availability of T cell help for the FV-specific antibody response,
Emv2 could in principle also directly affect the development of
virus-specific B cells [43]. Although we observed comparably low
FV-specific antibody responses between B6 and B6-Emv22/2 mice
at the peak of FV infection, our results did not exclude a potential
direct effect of Emv2 on FV-specific B cell and antibody responses
at later time-points, when these responses are fully induced.
Indeed, Emv2-encoded env shares 79% amino acid identity with F-
MLV env and it is therefore possible that Emv2 expression,
especially when upregulated, might affect the FV-specific antibody
response.
As previously shown, high-avidity F-MLV env122-141L-specific
Va2 CD4+ T cells are a minority subset in the naı¨ve repertoire and
only dominate the immune response to FV as a result of their
preferential expansion during infection [15]. We have now found
that for this ability of high-avidity F-MLV env122-141L-specific
Va2 CD4+ T cells to dominate the peak response, negative
selection by Emv2 of at least some of the competitor low-avidity F-
MLV env122-141L-specific non-Va2 CD4
+ T cells is necessary.
These findings indicate that even subtle thymic events can have
profound effects on the induction of an effective T cell response to
retroviral infection. Recently, a comprehensive theoretical study
has indicated that HLA class I alleles that associated with control of
HIV infection, such as HLA-B*5701, sample far fewer self peptides
than other HLA alleles [5]. As a result of less stringent negative
selection, a higher frequency of CD8+ T cells restricted by these
protective alleles were predicted to recognize viral peptide epitopes
and to cross-react with variants of the targeted epitopes [5].
Our results with a single self peptide provide further experi-
mental confirmation of negative selection reducing both the
precursor frequency and cross-reactivity of env-specific CD4+ T
cells, although in this case the effect on cross-reactivity was more
pronounced at the population, rather than the single-cell level.
These results also suggest that from the thousands of self peptides
that can mediate thymic selection of retrovirus-specific T cells, the
main effects may be mediated by only a few self peptides.
Moreover, self peptides with such strong influence may also be
polymorphic between different individuals, which might contrib-
ute to the partial association of HLA polymorphisms with virus
control [3,5,6].
In addition to polymorphisms at the MHC/HLA locus or of self
peptides mediating thymic selection, the Trav/TRAV and Trbv/
TRBV loci may also display allelic sequence variation. A
polymorphism in the TRBV9 gene has been shown to affect
TCR affinity for and functional recognition of an HLA-B*3501-
restricted epitope from the EBNA-1 protein of Epstein-Barr virus
(EBV), leading to a public T cell response dominated by the high-
affinity variant [44]. Similarly, we found that the ability of Va2
chains to confer high avidity for env122-141L in EF4.1 mice seems
to be germline-encoded, as only Va2 chains encoded by the B6,
but not the 129 Trav locus had this ability. It is tempting to
speculate that amino acid residues unique to the B6-germline
Trav14-encoded Va2 chains participate in recognition of the
strongly interacting L (or a limited set of amino acids with similar
properties) at env position 128. Notably, the CD8+ T cell response
to an HLA-B8-restricted epitope from the latent antigen EBNA
3A of EBV uses almost exclusively identical Va and Vb, as well as
other TCR-region sequences, and comprehensive structural
studies have shown that a unique amino acid residue in the
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germline-encoded complementarity-determining region 2 (CDR2)
of the preferred Va chain, encoded by TRAV26-2, is critically
required for binding to a residue from the peptide epitope [45].
Despite the vast number of somatically-generated random TCRs
that can arise during T cell development, these studies highlight
the potential for germline-encoded residues to provide exquisite
specificity and competitive advantage to the TCRs that carry
them.
In addition to likely representing the best-fit for recognition of Ab-
restricted env122-141L, the dominance of Va2 EF4.1 CD4
+ T cells
could also result from preferential pairing of the transgenic TCRb
chain with Va2 chains in general. This is unlikely to be the case as
the usage of Va2 cells was not increased in either total or
env122-141L-reactive EF4.1 CD4
+ T cells, and indeed in the env122-
141L-reactive preimmune repertoire clones using other Va chains
were at least 3 times more frequent than those using Va2. However,
although non-Va2 env122-141L-reactive CD4
+ T cells were still the
majority in Emv2-expressing mice, their ability to participate in the
response to FV and compete with env122-141L-reactive Va2 CD4
+ T
cells was severely compromised by Emv2. Thus, the dominance of
Va2 CD4+ T cells in the response to FV infection can be seen as a
combination of germline-encoded advantage in Ab-restricted
env122-141L recognition conferred to Va2 CD4
+ T cells and of
Emv2-mediated self-tolerance of other non-Va2 CD4+ T cells
capable of recognizing Ab-restricted env122-141L.
One important novel insight of the current study is the proof of
principle that negative selection is not necessarily always impairing
high-avidity T cell responses. By counter-selecting some cross-
reactive CD4+ T cells, negatively selecting self peptides have the
ability to significantly enhance the avidity for the response to at
least some epitope variants. Higher precursor frequency and cross-
reactivity with emerging epitope variants seem to be the best
correlates for an effective cytotoxic CD8+ T cell response [5].
Whether higher avidity for the primary infecting epitope, rather
than cross-reactivity with epitope variants better describes an
effective CD4+ T cell response to retroviral infection needs to be
further addressed.
It should be noted that differences in avidity for antigen in this
system were defined functionally. Indeed, Va2 env122-141L-specific
primary CD4+ T cells or hybridomas reacted to much lower
concentrations of env122-141L peptide stimulation in vitro than their
non-Va2 counterparts. Furthermore, this higher sensitivity trans-
lated to higher in vivo expansion and increased potential for
cytokine production [15]. It is currently unclear whether
differences in functional avidity between Va2 and non-Va2
env122-141L-specific CD4
+ T cells resulted from overall higher
affinity of individual TCRs of these polyclonal populations for the
peptide-MHC class II complex. Although dissociation kinetics
between TCRs and peptide-MHC class II tetramers are often
informative with respect to the biochemical affinity of these TCRs,
they may not be universally useful. For example, the available
env123-141-A
b tetramer (Ab-env) is known to bind only some
env124-138L-specific CD4
+ T cell clones but not others, irrespective
of their functional avidity or Va usage [14,22]. Therefore, this
reagent could not be used to access the biochemical affinity of all
env124-138L-specific CD4
+ T cells in the polyclonal repertoire.
Furthermore, identification of antigen-specific cells using a
sensitive two-dimensional binding assay has recently demonstrated
that the affinity of many CD4+ T cells that participate in the
response to two separate antigens is below detection with peptide-
MHC class II tetramers [46]. Thus, peptide-MHC class II
tetramers may generally only detect some but not all antigen-
specific CD4+ T cells. In addition, such detection is conditional on
expression of sufficient TCR levels. Indeed, we have found that the
extensive, antigen-induced downregulation of their TCR in vivo,
eclipses detection with the Ab-env123-141 tetramer of even the
env122-141L-reactive CD4
+ T cells that could otherwise bind this
reagent. Similar observations have been recently made with
peptide-MHC class I tetramer staining of virus-specific effector
CD8+ T cells [47], suggesting that the inability of peptide-MHC
multimers to identify antigen-specific effector T cells that have
downregulated their TCRs may be a general problem for T cells
restricted by both classes of MHC molecules.
Negative selection ensures minimal reactivity of developing
thymocytes to self proteins. However, endogenous retroviruses are a
large constituent of mammalian genomes and thus represent a
potentially large pool of self proteins able to mediate selection, both
positive and negative. Self peptides encoded by endogenous MLVs
have been shown to mediate positive selection of CD4+ T cells with
specificity for an unrelated H2-Ek-restricted moth cytochrome C
peptide, and to enhance the response of mature CD4+ T cells with
this specificity in the periphery [48]. We found that Emv2 was
expressed at very low levels in the thymus of B6 mice, in agreement
with a previous report [49], and was undetectable by qRT-PCR in
some of the mice. It should be noted, however, that the qRT-PCR
method employed was specific only for the spliced env mRNA that is
transcribed by Emv2. This was chosen to eliminate the possibility of
detecting contaminating genomic DNA or viral genomic RNA, but
may underestimate the total amount of spliced and unspliced
mRNA that leads to the production of other viral proteins.
Nevertheless, as demonstrated by its effect on thymic development,
this low level of Emv2 expression was clearly functional.
Endogenous retroviruses have been known for many years to
cause a range of different diseases in mice, including cancer,
immunodeficiency and autoimmunity, although a similar causal
effect in humans has been questioned [50]. Immune reactivity to
endogenous retroviruses has been amply demonstrated in mice
where is has been strongly associated with the development of
spontaneous autoimmune conditions [51,52]. Interestingly, immune
reactivity to endogenous retroviruses has also been frequently
observed in humans during infection, inflammation, autoimmunity
and cancer [50,53–56]. Expression of human endogenous retrovi-
ruses, as well as CD8+ T cell responses against their antigens, have
been documented in HIV infection [57,58]. Furthermore, a whole-
genome association study has suggested that part of the effect of the
protective HLA-B*5701 allele during the asymptomatic period of
HIV infection may be mediated by a linked human endogenous
retrovirus at the same locus [59]. Human endogenous retroviral
antigens have also been reported to serve as targets for CD8+ T cell-
mediated rejection of cancer cells [60]. It might be evident from the
studies in humans and the results of the current study that peptide
epitopes encoded by endogenous retroviruses have a strong influence
on T cell thymic selection and may also participate in the shaping of
the peripheral T cell response. It is also clear that endogenous
retroviruses do not always cause immunological tolerance, and
although their activation in infected or transformed cells may
provide a non-mutable target for immune attack, activation of
endogenous retroviruses may also trigger inflammatory or autoim-
mune phenomena frequently associated with infection and cancer.
Further study of endogenous retrovirus regulation during infection,
autoimmunity or cancer, and of the immune responsiveness to them
should shed more light into their pathogenic potential.
Materials and Methods
Ethics statement
All animal experiments were approved by the ethical committee
of the NIMR, and conducted according to local guidelines and
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UK Home Office regulations under the Animals Scientific
Procedures Act 1986 (ASPA).
Mice
Inbred C57BL/6J (B6), A/J and B6.SJL-Ptprca Pep3b/BoyJ
(CD45.1+ B6) mice were originally obtained from The Jackson
Laboratory (Bar Harbor, Maine, USA) and were subsequently
maintained at NIMR animal facilities. Inbred 129S8/SvEvNimrJ
(129S8) mice were developed from an 129/Sv substrain, maintained
at NIMR animal facilities, and were subsequently deposited at The
Jackson Laboratory. The B6 TCRb-transgenic strain EF4.1,
expressing a transgenic TCRb chain from a T cell clone specific
to F-MuLV env122-141 presented by H2-A
b, has been described
[14]. 129S8-congenic EF4.1 mice were generated by serial
backcrossing of B6-EF4.1 mice for 10 nuclear generations onto
the 129S8 genetic background. B6-backcrossed Rag1-deficient
(Rag12/2) mice [61] and T cell receptor a-deficient (Tcra2/2) mice
[62] were also maintained at NIMR animal facilities. Fv2s-congenic
B6 (Fv2s) and Rag12/2 (Fv2s Rag12/2) mice have been previously
described [25]. Emv2-deficient (Emv22/2) B6 mice were created by
introducing the Emv2 integration site of chromosome 8 from the A/J
strain, which lacks this proviral integration, by serial backcrossing
for at least 12 nuclear generations onto the B6 genetic background.
Lack of Emv2 was validated by PCR for both the D8Mit49
microsatellite marker close to the locus that detects polymorphisms
in A/J (Emv22) and B6 (Emv2+) strains of mice (D8Mit49 forward 59-
TCTGTGCATGGCTGTGTATG-39 and D8Mit49 reverse 59-
TGGTGTGCTGCTGATGCT-39), and also for the actual inte-
gration site using three primers, two of which were flanking the
integration site (forward 59-ACCCACTAAGTAACCCAG-
GCTGCCTCAGCT-39 and reverse 59-GACCAGAATAGAAA-
GACGTTCAAGTGAGCT-39) and one located in the Emv2 LTR
(59-ATCAGCTCGCTTCTCGCTTCTGTACCCGCG-39) (Fig-
ure S3).
In vitro T cell activation
Spleen or lymph node single-cell suspensions were prepared
from EF4.1 mice and 56105 cells per well were stimulated in 96-
well plates with the indicated amount of env peptide variants. The
frequency of env-reactive cells in stimulated CD4+ T cells was
defined as the frequency of cells that responded to 18-hr
stimulation, before cell division or death had occurred, by
upregulating CD69 expression. Correct identification of env-
reactive CD4+ T cells by CD69 upregulation was confirmed in
control experiments by co-staining for CD154 (CD40L) expression
in stimulated T cells. Both antibodies were obtained from
eBiosciences. For assessment of T cell activation on day 3, cells
were labeled with CFSE before stimulation and responding cells
were identified by CFSE dilution.
Hybridoma cell line generation and stimulation
Single-cell suspensions were prepared from spleens and lymph
nodes from Emv2-sufficient or -deficient EF4.1 mice and stimu-
lated in vitro with 1027 M or 1025 M env122-141L peptide and
4 ng/ml recombinant human IL-2 for 4 days. CD4+ T cells were
subsequently purified from stimulated cultures using immuno-
magnetic positive selection (StemCell Technologies, Vancouver,
BC, Canada) and fused to TCRab-negative BW5147 thymoma
cells to produce hybridoma cell lines. Established hybridoma cell
lines were stimulated with a range of env peptide variants
presented by dendritic cells. Dendritic cells were obtained from
cultures of bone marrow cells isolated from B6 mice and
supplemented with granulocyte macrophage colony-stimulating
factor (GM-CSF). GM-CSF was obtained from culture superna-
tant of663 cells transfected with mouse Csf2 and was used at 1:10
dilution. Bone marrow cells were culture in these conditions for 7
days, at which point they consisted of 50–70% dendritic cells.
These cells were then used to stimulate hybridoma cells at a ratio
of 56104 dendritic cells to 16105 hybridoma cells, for 18 hrs, in
the presence or absence of env peptide variants. Dendritic cell-
hybridoma cell co-cultures were plated in flat-bottom 96-well
plates in 200 ml final volume. The concentration of peptides used
is indicated in individual figures and figure legends. In additional
experiments peritoneal macrophages were also used as antigen-
presenting cells with results comparable to the use of dendritic
cells. Macrophages were isolated from B6 mice following plating of
the peritoneal cavity exudate cells for 1 hr and washing off the
non-adherent fraction. Env-specific responses were assessed by
measuring the amount of IL-2 secreted in co-culture supernatants
using an AlamarBlue (Invitrogen, Carlsbad, CA, USA)-based
CTLL-2 assay.
Tra gene usage
Trav and Traj usage by T cell hybridomas was probed by
staining with an anti-Va2 (clone B20.1) or anti-Va3.2 (clone RR3-
16) monoclonal antibodies, and by reverse transcription (RT)-PCR
amplification and sequencing of expressed Trav genes, using
previously described primers [63]. Trav and Traj segment
identification and alignment, and confirmation of productive
rearrangements were performed on the International Immunoge-
netics Information System website (http://www.imgt.org).
Viruses and infections
The FV used in this study was a retroviral complex of a
replication-competent B-tropic F-MuLV and a replication-defec-
tive polycythemia-inducing spleen focus-forming virus (SFFVp).
Stocks were propagated in vivo and prepared as 10% w/v
homogenate from the spleen of 12-day infected BALB/c mice.
Mice received an inoculum of ,1,000 spleen focus-forming units
of FV. All viral stocks were free of Sendai virus, Murine hepatitis
virus, Parvoviruses 1 and 2, Reovirus 3, Theiler’s murine
encephalomyelitis virus, Murine rotavirus, Ectromelia virus,
Murine cytomegalovirus, K virus, Polyomavirus, Hantaan virus,
Murine norovirus, Lymphocytic choriomeningitis virus, Murine
adenoviruses FL and K87, and Lactate dehydrogenase-elevating
virus. Virus inocula were injected via the tail vein in 0.1 ml of
phosphate-buffered saline. FV-infected cells were detected by flow
cytometry using surface staining for the glycosylated product of the
viral gag gene (glyco-Gag), using the matrix (MA)-specific
monoclonal antibody 34 (mouse IgG2b), followed by an anti-
mouse IgG2b-FITC secondary reagent (BD, San Jose, CA, USA).
For the assessment of anemia, mice were bled by a small incision
of the tail vein and blood was collected into heparinized capillary
tubes. Complete blood counts were measured on a VetScan HMII
hematology analyzer (Abaxis, CA, USA), following the manufac-
turer’s instructions. RBC counts of uninfected mice were
,9.956106 per mm3 of blood. FV-induced splenomegaly in
infected mice was expressed as spleen index, which is the ratio of
the weight of the spleen (in mg) to the weight of the rest of the
body (in g).
FV-neutralizing and F-MLV-infected cell-binding antibody
assays
Serum titers of FV-neutralizing antibodies were measured as
previously described [25]. The dilution of serum which resulted in
75% neutralization was taken as the neutralizing titer. Serum titers
of F-MLV-infected cell-binding antibodies were determined by
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flow cytometry following primary staining of F-MLV-infected Mus
dunni cells with serial dilutions of serum samples and secondary
staining with fluorescently labeled anti-mouse IgG1 (clone A85-1),
anti-mouse IgG2a/c (clone R19-15), anti-mouse IgG2b (clone
R12-3) or anti-mouse IgM (clone R6-60.2) antibodies (BD). B6
mice express the IgG2c isotype, which may not be efficiently
detected by anti-IgG2a reagents [64]. Although the R19-15
monoclonal antibody has higher affinity for IgG2a, it can be
effectively used for detection of IgG2c. This was confirmed by
staining of F-MLV-infected Mus dunni cells that were first
incubated with serum from FV-infected mice, with the anti-IgG1
or anti-IgG2a/c or anti-IgG2b reagents separately (Figure S8A).
The three reagents used separately resulted in comparable staining
intensity, which allowed us to use all three IgG subclass-specific
antibodies in combination. For IgG titers, F-MLV-infected Mus
dunni cells were first incubated with serum samples and then with
anti-IgG1, anti-IgG2a/c and anti-IgG2b antibodies mixed togeth-
er. Serum samples were 2-fold serially diluted, starting from an
initial dilution of 1:50. The last positive serum dilution resulting in
staining intensity at least twice the background level was taken as
the binding titer (Figure S8B).
T cell purification and adoptive transfer
Single-cell suspensions were prepared from the spleens and
lymph nodes of donor CD45.2+ EF4.1 mice by mechanical
disruption. Spleen suspensions were treated with ammonium
chloride for erythrocyte lysis. CD4+ T cells were enriched using
immunomagnetic positive selection (StemCell Technologies)
according to the manufacturer’s instructions. Purity of the isolated
CD4+ T-cell population was routinely higher than 92%. A total of
approximately 16106 EF4.1 CD4+ T cells were injected in B6-
congenic CD45.1+CD45.2+ recipients via the tail vein in 0.1 ml of
air-buffered Iscove’s Modified Dulbecco’s Media. When adoptive
transfer of CD4+ T cells was combined with FV infection, purified
CD4+ T cells and virus stocks were injected separately into
recipient mice within a 24 hour-period.
Flow cytometry
Spleen-cell suspensions were stained with directly-conjugated
antibodies to surface markers, obtained from eBiosciences (San
Diego, CA, USA), CALTAG/Invitrogen, BD Biosciences (San
Jose, CA, USA) or BioLegend (San Diego, CA, USA). Donor-type
env-specific CD4+ T cells were identified as
CD44hiCD45.2+CD45.12CD4+ cells. Four- and 8-color cytome-
try were performed on FACSCalibur (BD Biosciences) and CyAn
(Dako, Fort Collins, CO) flow cytometers, respectively, and
analyzed with FlowJo v8.7 (Tree Star Inc., Ashland, OR, USA)
or Summit v4.3 (Dako) analysis software, respectively.
Emv2 expression by quantitative reverse transcription
(qRT)-PCR
Total RNA was extracted from whole organs using TRI-reagent
(Sigma-Aldrich, St. Louis, US) according to the manufacturer’s
instructions, precipitated with isopropanol and washed in 75%
ethanol before being dissolved in water. DNase digestion and
cleanup was performed with the RNeasy Mini Kit (Qiagen,
Hilden, Germany) and cDNA produced with the high capacity
reverse transcription kit (Applied Biosystems, Carlsbad, US) with
an added RNase inhibitor (Promega Biosciences, Madison, US). A
final clean-up was performed with the QIAquick PCR purification
kit (Qiagen). Level of expression of Emv2 RNA was determined by
qRT-PCR using DNA Master SYBR Green I kit (Roche,
Mannheim, Germany) and the ABI Prism 7000 or 7900HT
Detection System (TaqMan, Applied Biosystems, Foster City, CA).
The following primers were used for the amplification of target
transcripts: Hprt: forward 59-TTGTATACCTAATCATTA-
TGCCGAG-39 and reverse 59- CATCTCGAGCAAGTCT-
TTCA-39; Emv2: forward 59-CCAGGGACCACCGACCCA-
CCGT-39 and reverse 59-TAGTCGGTCCCGGTAGGCC-
TCG-39. Emv2-specific primers amplified only the spliced form
of env mRNA, thus eliminating the possibility of residual genomic
DNA or RNA contamination contributing to Emv2 signal. The
housekeeping gene Hprt was used to normalize the Critical
Threshold (CT) values for Emv2. Analysis was conducted with the
DCT method [65] and Emv2 expression corresponding to an Emv2
CT value of 40 (the total number of amplification cycles used) was
set at 1 arbitrary unit. A theoretical detection limit of 2 arbitrary
units was also used, which represents the detectable Emv2 signal in
the penultimate cycle of amplification.
Statistical analysis
Statistical comparisons were made using SigmaPlot 12.0 (Systat
Software Inc., Germany). Parametric comparisons of normally-
distributed values that satisfied the variance criteria were made by
unpaired Student’s t-tests. Linear percentages of FV-infected cells,
spleen indices and nAb titers, which did not pass the variance test,
were compared with non-parametric two-tailed Mann-Whitney
Rank Sum or Wilcoxon Signed Rank tests.
Accession numbers
N Cd4 cluster of differentiation 4 antigen [Mus musculus]; Gene
ID: 12504; Protein ID: NP_038516.1
N Rag1 recombination activating gene 1 [Mus musculus]; Gene ID:
19373; Protein ID: NP_033045.2
N Fv2 Friend virus susceptibility 2 [Mus musculus]; Gene ID:
19882; Protein ID: NP_033100.1
N Tcra T cell receptor alpha chain [Mus musculus]; Gene ID:
21473
N Tcrb T cell receptor beta chain [Mus musculus]; Gene ID: 21577
N Emv2 endogenous ecotropic MuLV 2 [Mus musculus]; Gene ID:
111372
N env envelope protein [Friend murine leukemia virus]; Gene ID:
1491875; Protein ID: NP_040334.1
Supporting Information
Figure S1 Effect of N-terminal epitope length on TCR
recognition by primary and hybridoma EF4.1 envL-
specific CD4+ T cells. (A) Frequency of CD69+ cells in Va2 or
non-Va2 CD4+ T cells (expressed as percentage of the maximal
response elicited by the env122-141L peptide), following 18-hr in
vitro stimulation of spleen cell suspensions from EF4.1 mice with
the indicated range of N-terminal truncated envL peptides. (B) IL-
2 production in the supernatant of hybridoma cells lines
established from Va2 or non-Va2 env-specific EF4.1 CD4+ T
clones following 24-hr in vitro stimulation with the indicated range
of N-terminal truncated envL peptides. Data are pooled from 3
separate experiments.
(PDF)
Figure S2 Sequence and TCR SB14-31 contact residues
of F-MLV- and Emv2-encoded env123-140. (A) Amino acid
sequence, in single-letter code, of env123-140 encoded by either F-
MLV or Emv2. Differences in sequence are indicated by red color.
(B) Important contact residues for the SB14-31 TCR (indicated in
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red) and for H2-Ab (indicated in blue) in F-MLV-encoded env123-
140L. Numbers underneath amino acid residues correspond to
amino acid positions in env.
(PDF)
Figure S3 Chromosomal location of Emv2 in B6 mice
and screening of Emv22/2 B6 mice. Emv2 is integrated near
the telomere of Chromosome 8 of B6 mice in reverse orientation
relative to the forward strand, between the Tubb3 and Def8 genes
(Search for Mela on http://www.ncbi.nlm.nih.gov/mapview), and
it is absent from A/J mice. Lack of Emv2 on Emv22/2 congenic B6
mice is shown by PCR for the actual integration site (red arrows) or
for the polymorphic D8Mit49 microsatellite marker that is further
telomeric with respect to Emv2 (not shown on map).
(PDF)
Figure S4 Effect of Emv2 on the endogenous CD4+ T
cell, CD8+ T cell and antibody responses. B6 and B6-
Emv22/2 mice were infected with FV and their adaptive responses
were measured 7 days later. T cell responses were measured in
cells isolated from the spleens and antibody responses from the
sera of these mice. (A) Percentage of CD44hiCD43+ cells in total
CD8+ T cells. (B) Percentage of Va3.2+Vb5.2+ cells in either
CD44hi (left) or CD44lo (right) CD8+ T cells. The dashes horizontal
line represents the same frequency in uninfected control mice. The
dashed horizontal lines in (A) and (B) represent the depicted
frequencies in uninfected control mice. (C) Serum titers of F-
MLV-infected cell-binding IgG (left) and IgM (right). Dashed lines
represent the limit of detection. (D) Percentage of Ab-env123-141
tetramer+ cells in total CD4+ T cells. Horizontal short lines denote
the median frequencies and the dashed line denotes the median
frequency of Ab-hCLIP (control) tetramer+ cells in the same
populations. (E) Percentage of Va2 cells in Ab-env123-141 tetramer
+
CD4+ T cells from the same mice. The dashed horizontal line
represents the frequency of Va2 cells in total CD4+ T cells from
the same mice. In (A) to (E) each symbol represents an individual
mouse.
(PDF)
Figure S5 Gating strategy for the identification of env-
specific donor CD4+ T cells. CD45.2+ (Ptprc2/2) EF4.1 CD4+
T cells (106) were adoptively transferred into wild-type Ptprc1/2 B6
recipients that were infected with FV the same day. Host cells were
identified as CD45.1 CD45.2 double-positive whereas donor cells
were CD45.2 single-positive.
(PDF)
Figure S6 Effect of Emv2 on the frequency and compo-
sition of env124-138L-specific CD4
+ thymocytes. Thymo-
cytes from Emv2+/+ or Emv22/2 EF4.1 mice were stimulated for
18 hrs in vitro with the indicated amount of env124-13L peptide
presented by bone marrow-derived dendritic cells and responding
cells were identified by upregulation of CD69 expression.
Frequency of responding (CD69+) cells in gated CD4+ thymocytes
(left) and frequency of Va2 cells in env124-13L-specific cells (right) is
shown, with p,0.006 and p,0.002, respectively, for 1026 M
peptide concentration. Results are the means 6 SEM (n= 8–10).
(PDF)
Figure S7 Depth of env epitope recognition by Emv2-
selected and -nonselected T cell hybridomas. Va2 or non-
Va2 (Va3) env124-138L-reactive T cell hybridomas were established
from Emv2+/+ or Emv22/2 EF4.1 mice and tested for reactivity
against a library of env126-138 peptide epitopes (at 5610
26 M
concentration), in which positions 128, 129 and 133 were
individually replaced by all natural amino acids. The response of
each clone was measured by secretion of IL-2 and is expressed as a
percentage of the maximal response obtained with the most potent
variant. Results are the means of triplicate cultures.
(PDF)
Figure S8 Determining titers of F-MLV-infected cell-
binding antibodies. (A) Mus dunni cells, chronically infected
with F-MLV, were stained with an 1:50 dilution of pooled serum
samples from wt B6 mice that were infected with FV 35 days
earlier (serum sample) or with a dilution of the anti-gp70 of F-
MLV monoclonal antibody 48 (mAb 48; IgG2a) that gives similar
in vitro FV neutralization as 1:50 dilution of the serum sample.
Cells stained with the serum sample were subsequently stained
with anti-IgG1, anti-IgG2a/c or anti-IgG2c antibodies separately
or with all three antibodies mixed together, and cells stained with
mAb 48 were stained with anti-IgG2a/c. Black-filled histograms
show staining with both primary and secondary antibodies, and
gray-shaded histograms show staining with the secondary antibody
only. Note comparable staining intensity between all three IgG
subclass-specific antibodies used separately as secondary reagents
in combination with the serum sample and also in comparison
with the mAb 48. (B) Example of titer determination. Experimen-
tal serum samples were serially diluted 2-fold (starting from 1:50)
and used for staining F-MLV-infected Mus dunni cells. The median
fluorescent intensity (MFI) of co-staining with all three IgG
subclass-specific antibodies at the same time is plotted against the
serum dilution. The horizontal dashed line represents the MFI of
unstained cells. Data were fitted to a sigmoidal curve. The red
lines connect the MFI that is twice the background level and the
serum dilution that results in that MFI. The inverse of the serum
dilution that results in an MFI at least twice the background level
was taken as the titer. This was preferred over titer determination
based on half the maximal response, as in none of the samples
were an obvious maximum (plateau of the curve) reached.
(PDF)
Table S1 Va3.2 expression (determined by FACS), Trav
and Traj segment usage, and amino acid residues at the
VJ junction of env124-138L-reactive hybridoma T cell lines
generated from Emv2+/+ EF4.1 mice.
(PDF)
Table S2 Va3.2 expression (determined by FACS), Trav
and Traj segment usage, and amino acid residues at the
VJ junction of env124-138L-reactive hybridoma T cell lines
generated from Emv22/2 EF4.1 mice.
(PDF)
Acknowledgments
We wish to thank Kim Hasenkrug for critical reading of the manuscript.
We are grateful for assistance from the Division of Biological Services and
the Flow Cytometry Facility at NIMR.
Author Contributions
Conceived and designed the experiments: GK JPS GRY. Performed the
experiments: GRY MJYP UE MW. Analyzed the data: GRY MJYP UE
MW GK. Wrote the paper: GK JPS GRY.
References
1. Hasenkrug KJ, Chesebro B (1997) Immunity to retroviral infection: The Friend
virus model. Proc Natl Acad Sci U S A 94: 7811–7816.
2. Miyazawa M, Tsuji-Kawahara S, Kanari Y (2008) Host genetic factors that
control immune responses to retrovirus infections. Vaccine 26: 2981–2996.
Negative Selection Promotes High-Avidity T Cells
PLoS Pathogens | www.plospathogens.org 15 May 2012 | Volume 8 | Issue 5 | e1002709
3. McMichael AJ, Borrow P, Tomaras GD, Goonetilleke N, Haynes BF (2010) The
immune response during acute HIV-1 infection: clues for vaccine development.
Nat Rev Immunol 10: 11–23.
4. Handunnetthi L, Ramagopalan SV, Ebers GC, Knight JC (2010) Regulation of
major histocompatibility complex class II gene expression, genetic variation and
disease. Genes Immun 11: 99–112.
5. Kosmrlj A, Read EL, Qi Y, Allen TM, Altfeld M, et al. (2010) Effects of thymic
selection of the T-cell repertoire on HLA class I-associated control of HIV
infection. Nature 465: 350–354.
6. The International HIV Controllers Study (2010) The Major Genetic
Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation.
Science 330: 1551–1557.
7. Berger CT, Frahm N, Price DA, Mothe B, Ghebremichael M, et al. (2011)
High-Functional-Avidity Cytotoxic T Lymphocyte Responses to HLA-B-
Restricted Gag-Derived Epitopes Associated with Relative HIV Control.
J Virol 85: 9334–9345.
8. Iglesias MC, Almeida JR, Fastenackels Sn, van Bockel DJ, Hashimoto M, et al.
(2011) Escape from highly effective public CD8+ T-cell clonotypes by HIV.
Blood 118: 2138–2149.
9. Price DA, Asher TE, Wilson NA, Nason MC, Brenchley JM, et al. (2009) Public
clonotype usage identifies protective Gag-specific CD8+ T cell responses in SIV
infection. J Exp Med 206: 923–936.
10. Turner SJ, Doherty PC, McCluskey J, Rossjohn J (2006) Structural determinants
of T-cell receptor bias in immunity. Nat Rev Immunol 6: 883–894.
11. Bridgeman JS, Sewell AK, Miles JJ, Price DA, Cole DK (2011) Structural and
biophysical determinants of alphabeta T-cell antigen recognition. Immunology
135: 9–18.
12. Davenport MP, Price DA, McMichael AJ (2007) The T cell repertoire in
infection and vaccination: implications for control of persistent viruses. Curr
Opin Immunol 19: 294–300.
13. Welsh RM, Che JW, Brehm MA, Selin LK (2010) Heterologous immunity
between viruses. Immunol Rev 235: 244–266.
14. Antunes I, Tolaini M, Kissenpfennig A, Iwashiro M, Kuribayashi K, et al.
(2008) Retrovirus-specificity of regulatory T cells is neither present nor required
in preventing retrovirus-induced bone marrow immune pathology. Immunity
29: 782–794.
15. Ploquin MJ, Eksmond U, Kassiotis G (2011) B cells and TCR avidity determine
distinct functions of CD4+ T cells in retroviral infection. J Immunol 187:
3321–3330.
16. Shimizu T, Uenishi H, Teramura Y, Iwashiro M, Kuribayashi K, et al. (1994)
Fine structure of a virus-encoded helper T-cell epitope expressed on FBL-3
tumor cells. J Virol 68: 7704–7708.
17. Carson RT, Vignali KM, Woodland DL, Vignali DA (1997) T cell receptor
recognition of MHC class II-bound peptide flanking residues enhances
immunogenicity and results in altered TCR V region usage. Immunity 7:
387–399.
18. Rudensky AY, Preston-Hurlburt P, Hong SC, Barlow A, Janeway CA, Jr. (1991)
Sequence analysis of peptides bound to MHC class II molecules. Nature 353:
622–627.
19. Sim BC, Wung JL, Gascoigne NRJ (1998) Polymorphism within a TCRAV
family influences the repertoire through Class I/II restriction. J Immunol 160:
1204–1211.
20. Robertson SJ, Ammann CG, Messer RJ, Carmody AB, Myers L, et al. (2008)
Suppression of acute anti-friend virus CD8+ T-cell responses by coinfection with
lactate dehydrogenase-elevating virus. J Virol 82: 408–418.
21. Nair SR, Zelinskyy G, Schimmer S, Gerlach N, Kassiotis G, et al. (2010)
Mechanisms of control of acute Friend virus infection by CD4+ T helper cells
and their functional impairment by regulatory T cells. J Gen Virol 91: 440–451.
22. Schepers K, Toebes M, Sotthewes G, Vyth-Dreese FA, Dellemijn TA, et al.
(2002) Differential kinetics of antigen-specific CD4+ and CD8+ T cell responses
in the regression of retrovirus-induced sarcomas. J Immunol 169: 3191–3199.
23. Pike R, Filby A, Ploquin MJ, Eksmond U, Marques R, et al. (2009) Race
between retroviral spread and CD4+ T-cell response determines the outcome of
acute Friend virus infection. J Virol 83: 11211–11222.
24. King SR, Berson BJ, Risser R (1988) Mechanism of interaction between
endogenous ecotropic murine leukemia viruses in (BALB/c X C57BL/6) hybrid
cells. Virology 162: 1–11.
25. Marques R, Antunes I, Eksmond U, Stoye J, Hasenkrug K, et al. (2008) B
lymphocyte activation by coinfection prevents immune control of friend virus
infection. J Immunol 181: 3432–3440.
26. Green WR (1999) Cytotoxic T lymphocytes to endogenous mouse retroviruses
and mechanisms of retroviral escape. Immunol Rev 168: 271–286.
27. Ruan KS, Lilly F (1991) Identification of an epitope encoded in the env gene of
Friend murine leukemia virus recognized by anti-Friend virus cytotoxic T
lymphocytes. Virology 181: 91–100.
28. Chen W, Qin H, Chesebro B, Cheever MA (1996) Identification of a gag-
encoded cytotoxic T-lymphocyte epitope from FBL- 3 leukemia shared by
Friend, Moloney, and Rauscher murine leukemia virus-induced tumors. J Virol
70: 7773–7782.
29. Brawand P, Biasi G, Horvath C, Cerottini JC, MacDonald HR (1998) Flow-
Microfluorometric Monitoring of Oligoclonal CD8+ T Cell Responses to an
Immunodominant Moloney Leukemia Virus-Encoded Epitope In Vivo.
J Immunol 160: 1659–1665.
30. Hasenkrug KJ, Brooks DM, Dittmer U (1998) Critical Role for CD4+ T Cells in
Controlling Retrovirus Replication and Spread in Persistently Infected Mice.
J Virol 72: 6559–6564.
31. Iwanami N, Niwa A, Yasutomi Y, Tabata N, Miyazawa M (2001) Role of
natural killer cells in resistance against friend retrovirus-induced leukemia. J Virol
75: 3152–3163.
32. Goff SP (2004) Retrovirus Restriction Factors. Molecular Cell 16: 849–859.
33. Nethe M, Berkhout B, van der Kuyl AC (2005) Retroviral superinfection
resistance. Retrovirology 2: 52.
34. Lowy DR, Chattopadhyay SK, Teich NM, Rowe WP, Levine AS (1974) AKR
murine leukemia virus genome: frequency of sequences in DNA of high-, low-,
and non-virus-yielding mouse strains. Proc Natl Acad Sci U S A 71: 3555–3559.
35. Chattopadhyay SK, Lander MR, Rands E, Lowy DR (1980) Structure of
endogenous murine leukemia virus DNA in mouse genomes. Proc Natl Acad
Sci U S A 77: 5774–5778.
36. Jenkins MK, Chu HH, McLachlan JB, Moon JJ (2010) On the composition of
the preimmune repertoire of T cells specific for Peptide-major histocompatibility
complex ligands. Annu Rev Immunol 28: 275–294.
37. Huseby ES, Crawford F, White J, Kappler J, Marrack P (2003) Negative
selection imparts peptide specificity to the mature T cell repertoire. Proc Natl
Acad Sci U S A 100: 11565–11570.
38. Virgin HW, Walker BD (2010) Immunology and the elusive AIDS vaccine.
Nature 464: 224–231.
39. Chevalier MF, Julg B, Pyo A, Flanders M, Ranasinghe S, et al. (2011) HIV-1-
Specific Interleukin-21+ CD4+ T Cell Responses Contribute to Durable Viral
Control through the Modulation of HIV-Specific CD8+ T Cell Function. J Virol
85: 733–741.
40. Yue FY, Lo C, Sakhdari A, Lee EY, Kovacs CM, et al. (2010) HIV-Specific IL-
21 Producing CD4+ T Cells Are Induced in Acute and Chronic Progressive
HIV Infection and Are Associated with Relative Viral Control. J Immunol 185:
498–506.
41. Vingert B, Perez-Patrigeon S, Jeannin P, Lambotte O, Boufassa F, et al. (2010)
HIV controller CD4+ T cells respond to minimal amounts of gag antigen due to
high TCR avidity. PLoS Pathog 6: e1000780.
42. Ortiz AM, Klatt NR, Li B, Yi Y, Tabb B, et al. (2011) Depletion of CD4+ T cells
abrogates post-peak decline of viremia in SIV-infected rhesus macaques. J Clin
Invest 121: 4433–4445.
43. Portis JL (1994) Endogenous retroviral envelope antigens recognized by B
lymphocytes during graft-versus-host reaction. Tohoku J Exp Med 173: 83–89.
44. Gras S, Chen Z, Miles JJ, Liu YC, Bell MJ, et al. (2010) Allelic polymorphism in
the T cell receptor and its impact on immune responses. J Exp Med 207:
1555–1567.
45. Kjer-Nielsen L, Clements CS, Purcell AW, Brooks AG, Whisstock JC, et al.
(2003) A structural basis for the selection of dominant alphabeta T cell receptors
in antiviral immunity. Immunity 18: 53–64.
46. Sabatino JJ, Jr., Huang J, Zhu C, Evavold BD (2011) High prevalence of low
affinity peptide-MHC II tetramer-negative effectors during polyclonal CD4+ T
cell responses. J Exp Med 208: 81–90.
47. Munitic I, Decaluwe H, Evaristo C, Lemos S, Wlodarczyk M, et al. (2009)
Epitope specificity and relative clonal abundance do not affect CD8
differentiation patterns during lymphocytic choriomeningitis virus infection.
J Virol 83: 11795–11807.
48. Ebert PJR, Jiang S, Xie J, Li QJ, Davis MM (2009) An endogenous positively
selecting peptide enhances mature T cell responses and becomes an autoantigen
in the absence of microRNA miR-181a. Nat Immunol 10: 1162–1169.
49. Pothlichet J, Mangeney M, Heidmann T (2006) Mobility and integration sites of
a murine C57BL/6 melanoma endogenous retrovirus involved in tumor
progression in vivo. Int J Cancer 119: 1869–1877.
50. Stoye JP (1999) The pathogenic potential of endogenous retroviruses: a sceptical
view. Trends Microbiol 7: 430.
51. Baudino L, Yoshinobu K, Morito N, Santiago-Raber ML, Izui S (2010) Role of
endogenous retroviruses in murine SLE. Autoimmun Rev 10: 27–34.
52. Nakagawa K, Harrison LC (1996) The potential roles of endogenous
retroviruses in autoimmunity. Immunol Rev. pp 193–236.
53. Christensen T (2005) Association of human endogenous retroviruses with
multiple sclerosis and possible interactions with herpes viruses. Rev Med Virol
15: 179–211.
54. Perl A, Nagy G, Koncz A, Gergely P, Fernandez D, et al. (2008) Molecular
mimicry and immunomodulation by the HRES-1 endogenous retrovirus in SLE.
Autoimmunity 41: 287–297.
55. Kleiman A, Senyuta N, Tryakin A, Sauter M, Karseladze A, et al. (2004)
HERV-K(HML-2) GAG/ENV antibodies as indicator for therapy effect in
patients with germ cell tumors. Int J Cancer 110: 459–461.
56. Humer J, Waltenberger A, Grassauer A, Kurz M, Valencak J, et al. (2006)
Identification of a melanoma marker derived from melanoma-associated
endogenous retroviruses. Cancer Res 66: 1658–1663.
57. Contreras-Galindo R, Kaplan MH, Markovitz DM, Lorenzo E, Yamamura Y
(2006) Detection of HERV-K(HML-2) viral RNA in plasma of HIV type 1-
infected individuals. AIDS Res Hum Retroviruses 22: 979–984.
58. Garrison KE, Jones RB, Meiklejohn DA, Anwar N, Ndhlovu LC, et al. (2007) T
Cell Responses to Human Endogenous Retroviruses in HIV-1 Infection. PLoS
Pathog 3: e165.
Negative Selection Promotes High-Avidity T Cells
PLoS Pathogens | www.plospathogens.org 16 May 2012 | Volume 8 | Issue 5 | e1002709
59. Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, et al. (2007) A Whole-
Genome Association Study of Major Determinants for Host Control of HIV-1.
Science 317: 944–947.
60. Takahashi Y, Harashima N, Kajigaya S, Yokoyama H, Cherkasova E, et al.
(2008) Regression of human kidney cancer following allogeneic stem cell
transplantation is associated with recognition of an HERV-E antigen by T cells.
J Clin Invest 118: 1099–1109.
61. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, et al. (1992)
RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68: 869–877.
62. Philpott KL, Viney JL, Kay G, Rastan S, Gardiner EM, et al. (1992) Lymphoid
development in mice congenitally lacking T cell receptor alpha beta-expressing
cells. Science 256: 1448–1452.
63. Casanova JL, Romero P, Widmann C, Kourilsky P, Maryanski JL (1991) T cell
receptor genes in a series of class I major histocompatibility complex-restricted
cytotoxic T lymphocyte clones specific for a Plasmodium berghei nonapeptide:
implications for T cell allelic exclusion and antigen-specific repertoire. J Exp
Med 174: 1371–1383.
64. Martin RM, Brady JL, Lew AM (1998) The need for IgG2c specific antiserum
when isotyping antibodies from C57BL/6 and NOD mice. J Immunol Methods
212: 187–192.
65. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using
real-time quantitative PCR and the 2(2Delta Delta C(T)) Method. Methods 25:
402–408.
Negative Selection Promotes High-Avidity T Cells
PLoS Pathogens | www.plospathogens.org 17 May 2012 | Volume 8 | Issue 5 | e1002709
